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Background: Although New Zealand has not yet reported local transmission of a mosquito-
borne virus (arbovirus), several risk factors are present. While current literature is 
inconsistent on the risk status, to date, no evidence-based approach has been used to assess 
major risk factors and elements likely to facilitate local transmission. 
Aims: 1) To identify and evaluate the current status of major risk factors and favourable 
conditions likely to facilitate local transmission of arbovirus infections in New Zealand 
2) To outline likely scenarios and identify combinations of circumstances under which the 
elements of arbovirus transmission and related risk factors might coincide to trigger a local 
outbreak 
Methods: Information on arbovirus notified cases and traveller arrivals were used to evaluate 
the risk of arbovirus introduction via viraemic travellers by describing trends in importation 
rates, seasonality and route of travel and likely origins of infection. Information on mosquito 
interception records and air and sea freight imports, and international passenger flight 
arrivals was obtained to assess the risk of exotic mosquito introduction and establishment by 
describing trends in the border interceptions and the role of imported goods and air travel as 
a mean of transport. Using occurrence records obtained from biosecurity surveillance 
programmes, country-scale environmental suitability maps for Aedes notoscriptus were 
created to evaluate the role of this species in potential local Ross River virus (RRV) 
transmission. Trap surveillance mosquito counts were examined for association with selected 
v 
environmental factors to identify the environmental conditions favourable for local mosquito 
biting activity and, therefore, disease transmission.  
Results: The risk of an arbovirus outbreak in New Zealand exists and is exacerbated. This is 
supported by the following findings:  
i.  The increases in imported arbovirus cases: a total of 1912 reported cases between 
2001-2017, with more than half of these were reported in the final four years and 
dengue cases comprised 81.1%. 
ii. Regular interception of exotic mosquitoes at the borders: Aedes (Stegomyia) aegypti 
(Linnaeus) and Ae. (Stegomyia) albopictus (Skuse) were the two most commonly 
intercepted species, 
iii. Ongoing growth of international trade and travel with arbovirus endemic and/or 
mosquito vector-established countries: a 71% increase in the number of international 
flights to New Zealand between 2001-2017 and a ten-fold increase in the number of 
flights from Queensland, where Ae. aegypti is established and RRV is endemic. 
iv. Ongoing expansion and widespread distribution of Ae. (Finlaya) notoscriptus (Skuse) 
and its occurrence in relatively high counts in different types of habitats of New 
Zealand. 
Conclusions: Dengue and Ross River virus diseases are the most likely infections to cause local 
outbreaks. All requirements to initiate a local Ross River virus epidemic exist, while the 
absence of a competent vector is the limiting factor for dengue virus transmission. Auckland 
is the most likely point of virus and vector entry. The most likely mode of virus introduction is 
viraemic travellers entering the country through Auckland from Australia and/or the Pacific 
vi 
Islands, while Australia, the Pacific Islands and Japan are the most likely source of the vector. 
The northern North Island (where the number of adult Aedes notoscriptus collected was 40 
times more than that collected from all other areas) is the most likely receptive location for 
introduction of RRV, while Auckland (where Ae. albopictus and Ae. aegypti were intercepted) 
would be receptive to dengue. Raised awareness among travellers, medical and public health 
authorities on arbovirus diseases, country-scale mosquito surveillance programmes, and a 
national early warning system would reduce the risk of a local epidemic. 
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Chapter 1 : Introduction, aims and framework 
This chapter sets the scene for this research project, providing a brief review of the current 
epidemiological situation and risk factors for local arbovirus transmission in New Zealand. It 
also sets out the significance, aims and framework of the proposed research. 
1.1 Introduction 
Mosquito-borne diseases kill up to 2.7 million people annually [1], with more than 70 million 
cases [2] and more than four billion people at risk [3]. In the past 50 years, mosquito-borne 
viral infections, notably dengue, chikungunya, and Zika, have re-emerged as significant global 
health problems [4-7]. These arbovirus infections have expanded their geographic range to 
new areas and affected previously unexposed populations [4, 8, 9]. 
To date, New Zealand has not reported local transmission of a mosquito-borne virus [10]. 
However, several factors make it at risk [11-22]. These include: i) imported diseases, as 
indicated by case notifications of arbovirus infection in overseas visitors and returning 
travellers [11, 23], ii) high burden of arbovirus diseases in the Asia-Pacific region and most 
popular overseas destinations for New Zealand travellers[24, 25], iii) growth of international 
trade and travel with Australia and Pacific Islands [26], iv) presence of vector capable1 (Aedes 
(Halaedes) australis (Erichson), Ae. (Finlaya) notoscriptus (Skuse), and Culex (Cx) 
quinquefasciatus (Say) [27] and vector potential2 species [e.g. Ae. (Ochlerotatus) antipodeus 
(Edwards) and Cx. (Cx.) pervigilans Bergroth)] [12], v) border interceptions of major mosquito 
vectors (in particular Ae. albopictus and Ae. aegypti) [12], vi) climate change and climate 
 
1 Implicated in arbovirus transmission on epidemiological grounds 
2 Implicated in arbovirus transmission on laboratory grounds 
2 
suitability for the establishment and dispersal of vector species that are currently limited to 
the tropical and subtropical areas [28], vii) urbanization and vector habitat modification [14], 
and viii) local population is immunologically naive to exotic viruses [20]. According to the 
World Health Organization (WHO) [29, 30], identifying and monitoring disease risk factors is 
necessary to provide key inputs to develop Early Warning Systems (EWSs), which would be 
invaluable for epidemic prediction, preparedness and prevention. 
While some studies have suggested that the risk of a local arbovirus outbreak in New Zealand 
is “very low” [26] and “less than current opinion suggests” [31], others have indicated 
significant concerns [11-22]. However, there has been no unified evidence-based approach 
used to assess major risk factors and elements likely to facilitate a local transmission in New 
Zealand. Developing tools to anticipate and manage mosquito-borne infections requires 
understanding of the complex interactions between components of disease cycles, including 
infectious virus, a susceptible human population, a competent mosquito vector, and 
favourable environmental conditions. 
1.2 Study aims 
The overall aims of this study are: 
i. Aim 1: To evaluate the current status of major risk factors and identify favourable 
conditions likely to facilitate local transmission of arbovirus infections in New Zealand. 
ii. Aim 2: To outline likely scenarios and identify combinations of circumstances under 
which the elements of arbovirus transmission and related risk factors coincide to 
trigger an outbreak in New Zealand. 
3 
1.3 Study framework 
This project investigates the complex of major risk factors for transmission of arbovirus 
disease in New Zealand. These involve the viruses, mosquito vectors, human hosts, animal 
reservoirs, and both climate and non-climate environmental factors (Figure 1). These are 
presented in eight chapters. Chapter 2 (Literature Reviews 1-4) provides the background 
information for identifying research aims and basis for constructing the subsequent chapters. 
Chapters 3-6 assess the risk factors (Aim 1), Chapter 7 examines the circumstances under 
which these risk factors might coincide to initiate an outbreak (Aim 2). Chapter 8 presents 
main findings, conclusion and key recommendations. The framework of the Thesis is as 
follows: 
 
Figure 1: Study outline (Chapters and Reviews), elements (circles) and risk factors (rectangles) of a 
mosquito-borne viral outbreak in New Zealand 
  
4 
Chapter 2: Literature reviews 
This chapter is divided into four reviews, as follows:  
− Review One: Arboviruses and associated risk factors. Developing interventions to 
prevent or control an arbovirus epidemic requires understanding of disease ecology (i.e. 
environmental conditions and processes driving host, vector and pathogen distribution 
and abundance patterns) and pathology (i.e. cause, origin and nature) [32, 33]. This 
review provides an overview on arbovirus infection pathogenesis and climatic and non-
climatic drivers associated with virus introduction and geographical expansion. 
− Review Two: Risk assessment of arbovirus transmission in New Zealand. Identification 
of local risk factors for transmission of mosquito-borne diseases provides a means of 
detecting (rather than predicting) the onset of epidemics [30]. This section reviews 
known risk factors, components and burden (international, Pacific and local) of arbovirus 
infections likely to be locally transmitted in New Zealand under current and/or future 
climatic conditions and transmission circumstances. 
− Review Three: Modelling of mosquito-borne diseases. While assessment of disease 
factors provides a means of epidemic detection, modelling provides a means of epidemic 
onset prediction. Disease modelling seeks to predict location and/or timing of future 
course of disease outbreaks within a quantitative framework. Disease modelling 
economises resources, improves health outcomes, and designs and evaluates prevention 
and control strategies [34, 35], as well as provides the foundation to develop EWSs. This 
review also provides an overview of EWSs for infectious diseases. 
− Review Four: Mosquito surveillance system in New Zealand. Disease risk assessment 
(identification of related climatic and non-climatic risk factors) provides the basis for 
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taking action to detect, manage and reduce the public health risks of arbovirus diseases 
[36]. On the other hand, regular systematic collection, analysis and interpretation of 
disease risk factors via powerful and up-to-date monitoring surveillance systems provide 
a vital input to transmission predictive models and EWS development [29]. This section 
reviews current national biosecurity and other public health surveillance relevant to 
arbovirus diseases in New Zealand. 
Chapter 3: Imported arbovirus infections in New Zealand, 2001 to 2017 
Over the last decade, and facilitated by increased economic globalization, there has been an 
increased global emergence and spread of travel-associated epidemics of arbovirus diseases 
involving local pathogen transmission [4-9, 37-39]. Following international trends, there have 
been increasing reports of arbovirus infections, notably dengue fever, chikungunya, and Zika, 
in travellers arriving in New Zealand, mainly from Australia and the Pacific Islands [40]. 
Aim: To examine trends in the notifications of imported arbovirus disease cases, in particular 
dengue, chikungunya, Zika and RRV Infections, as a potential source of pathogens and risk 
factor for local transmission of arbovirus diseases. 
Objectives:  
i. To review and characterize imported arbovirus disease cases reported in New 
Zealand from January 2001 to December 2017 
ii. To compare trends in notifications with those in international travel arrivals 
iii. To assess the risk of local transmission of these infections in New Zealand by way 
of infected travellers 
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iv. To review mosquito avoidance precautions taken by the cases visiting risk areas 
and recommend measures to reduce the burden of imported disease and risks of 
pathogen importation by travellers 
Methods: Information on traveller arrivals, notified cases and risk factors for disease 
acquisition were obtained from national sources. Trends in importation rates, seasonality and 
route of travel and likely origins of infection were described and relationships of notifications 
with traveller arrivals examined. 
Chapter 4: Intercepted mosquitoes at New Zealand ports of entry, 2001 to 2018: 
current status and future concerns 
International travel and trade have greatly extended the geographical range of several highly 
competent mosquito vectors, notably the container-breeding species Ae. albopictus and Ae. 
aegypti [7, 41-43]. New Zealand’s highly modified landscape [18] and peculiar fauna lacking 
indigenous land mammals, combined with increasing global trade and tourism make it 
susceptible to invasion by exotic mosquitoes. All three local mosquito species that are known 
vectors of human diseases (Ae. notoscriptus, Ae. australis and Cx. quinquefasciatus) are 
introduced [44]. Their establishment may serve as a blueprint for the establishment of other 
exotic mosquitoes [45, 46]. 
Aim: To describe trends in border interceptions of exotic mosquitoes and evaluate the 
effectiveness of measures undertaken to reduce border arrivals of larvae transported by way 





i. To examine New Zealand exotic mosquito interception data, pathways and ports 
of entry for the period July 2001 to March 2018 
ii. To examine New Zealand import data for water receptacles (used tyres and used 
machinery) which might provide larval habitat in the same period of time 
iii. To evaluate the role of used tyres and vehicles imports as a contributor to exotic 
mosquito introductions, especially for the container-breeding species, Ae 
albopictus and Ae aegypti 
iv. To examine interceptions of new vector mosquitoes as a risk factor for local 
transmission of arbovirus disease in New Zealand, and to consider implications of 
identified trends for present and projected climate conditions and for biosecurity 
practices 
Methods: Mosquito interception records, trade data imports and international flights were 
obtained from national sources. The data were reviewed according to mosquito species, 
country of origin, mode and port of entry, and date of interception. Further, interception data 
were examined in relation to date, origin, and size of trade imports to assess the risk of exotic 
mosquitoes arriving in New Zealand and their pathways of entry. 
Chapter 5: Mapping the potential spatial distribution of Aedes notoscriptus, a 
significant biting nuisance and potential public health threat in urban New 
Zealand 
Ae. notoscriptus is one of two local mosquitoes in New Zealand that transmit human arbovirus 
disease in other countries [47]. There are also concerns that this species could act together 
with Ae. albopictus so greatly extending the geographic range of transmission [17, 45, 48], 
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assuming the establishment or introduction of the latter. Ground-based surveillance such as 
trapping provides information on seasonal and daily timing in relation to environmental 
variables [49] that can be used in species distribution models (SDMs) [50]. SDMs predict the 
spatiotemporal distribution of species in unsampled areas and in different time periods by 
relating species occurrence data to geographically referenced climatic and/or environmental 
data [51]. 
Aim: To estimate the spatial distribution of Ae. notoscriptus in areas of New Zealand not 
covered by the existing surveillance systems  
Objectives: 
i. To determine the relationships of Ae. notoscriptus occurrence with environmental 
data  
ii. To develop national environmental suitability maps to estimate physical 
environment with high suitability for Ae. notoscriptus 
iii. To estimate the human exposures with this species and regions that could be 
affected by the transmission of arboviruses 
iv. To estimate the potential spatial distribution of Ae. albopictus if introduced to 
New Zealand  
Methods: Mosquito collection data were obtained from surveillance programmes conducted 
by Public Health Units and New Zealand Ministry of Health between 2004 and 2018. The data 
consist of 125,000 presence-absence mosquito records collected from about 1,000 locations 
across New Zealand. Logistic regression was used to model the distribution of Ae. notoscriptus 
based on the following environmental variables: urban/rural land areas, mean annual 
temperature, mean annual vapour pressure deficit and induration. 
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Chapter 6: Surveillance case study: mosquito activity and environmental variables in 
selected built environments 
Weather is a key determinant of mosquito-borne disease transmission, with a direct influence 
on mosquito vector, host and pathogen [29, 30]. Prevention and control of vector-borne 
infections require understanding of disease ecology [32, 33]. Mosquitoes experience weather 
variables, mainly temperature and humidity, at fine spatial scales (i.e. microclimate) [52, 53]. 
Variations in microclimate can affect mosquito activity (e.g. composition, distribution, 
abundance) [54, 55] in ways that may be undetected by weather station or remotely sensed 
data [56, 57]. Routinely collected data provide a basis to identify the co-incidence of 
meteorological and environmental circumstances favourable for mosquito biting activity. This 
also provides a basis for modelling projections of vector distribution in current and future 
climatic conditions [52, 58-63]. 
Aims: To describe the seasonal pattern of activity (with trap counts representing relative 
numbers of biting females) according to species and to monitor associated environmental and 
meteorological variables to identify conditions associated with biting activity 
Objectives:  
i. To monitor overnight and seasonal activity of mosquito species at sites with 
human exposure 
ii. Examine association of weather and site characteristics with mosquito trap catch 
iii. To compare the use of weather station data and on-site measurements for 
predicting build-up of mosquito populations as a research tool, and potential 
public health tool to anticipate high risk conditions 
10 
Methods: Surveillance trapping was used to represent female biting activity in three lower 
North Island areas (Kapiti, Palmerston North and Wellington north). Over an 18-month period 
between early 2019 and mid-2020, stranded CO2-baited Centres for Disease Control (CDC) 
light traps were placed at suburban residential sites and in adjacent green areas used for self-
organised recreation as typical places of human exposure. Sampling sites were characterized 
according to physical attributes and hourly ambient temperature and moisture conditions will 
be logged on-site on each trapping occasion. Weather data from the nearest government 
climate station and data from biosecurity monitoring of mosquitoes at NZ ports of entry were 
obtained from publicly available databases. 
Chapter 7: Scenarios for outbreaks of arbovirus infections in New Zealand 
The risk of a virgin soil outbreak is suggested to be increasing in New Zealand [21] since risk 
factors connected to key components of arbovirus disease transmission are already present. 
Identifying combinations of circumstances under which these factors coincide in time and 
space could enable coordinated responses and communication with relevant agencies (e.g. 
mosquito control, public health) to promote awareness and suitable precautions. 
Aim: Suggest scenarios for the most likely arbovirus infections to cause outbreaks in New 
Zealand under current and future conditions. 
Objectives:  
i. To assess facilitating and limiting conditions and circumstances of mosquito 
vector (arrival, establishment and spread) and pathogen (means, source, season 
and location) introduction. 
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ii. To identify the most likely paths to arbovirus disease outbreaks associated with 
the establishment of introduced mosquito vectors 
iii. To assess the likelihood of a novel arbovirus disease outbreak via infected 
travellers in non-endemic, but vector-established, area 
Methods: On the basis of findings presented in previous chapters, likely scenarios were 
proposed and conditions and combinations of circumstances identified, under which the 
components of the most likely arbovirus infections to cause outbreaks in New Zealand 
coincide in time and space to trigger a local outbreak. Further, limiting factors of local 
transmission of each infection will be identified and described. 
Chapter 8: Main research findings, conclusion and recommendations 
This chapter summarises key research findings and show how these are consistent with the 
aims of the Thesis. Highlights and limitations were acknowledged and recommendations for 
mosquito surveillance and anticipating risk levels for local arbovirus transmission are 
outlined. Suggestions for future research to extend these findings are made.   
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Chapter 2 : Literature review 
2.1 Review One: Arboviruses and associated risk factors 
2.1.1 Introduction to the arboviruses 
The first revelation that mosquitoes could transmit pathogens to humans was noted by Sir 
Patrick Manson in 1878 [64]. Three years later, Carlos Finlay assumed that the causative agent 
responsible for yellow fever might be vectored by mosquitoes and his assumption was 
confirmed experimentally by Major Walter Reed in 1900. The term “arthropod-borne virus” 
or arbovirus transmission was first presented to the field of microbiology in 1942 [65]. 
Arboviruses are viruses that are transmitted biologically to vertebrates by hematophagous or 
(i.e. blood feeding) arthropods, most commonly mosquitoes or other blood-sucking insects 
and ticks. Biological transmission involves virus replication in both the arthropod (as the virus 
must infect a range of arthropod vector tissues to be transmittable [66]) and vertebrate hosts. 
This is in contrast to mechanical transmission, which occurs typically through contamination 
of arthropod mouthparts [67]. Biological transmission can be vertical by the passing of virus 
from a female vector to its offspring, or horizontal by sexual contact with an infected person 
or, more commonly, from a vector arthropod to a vertebrate host via infected salivary 
secretions during blood feeding [68, 69]. 
Following the consumption of a virus laden blood meal from an infected host, the virus must 
first infect and replicate in the mosquito midgut epithelia. This gut tissue is a barrier to virus 
progression, and some viruses do not proceed beyond this stage) [66]. To be successfully 
transmitted to a new host, viruses traverse a range of tissues (including muscle, haemolymph, 
fat body) in the body cavity of an arthropod, until they reach the salivary glands before 
secreting the virions into the saliva[70]. The period between a mosquito taking a viraemic 
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blood meal and when it becomes able to transmit the virus is termed the Extrinsic Incubation 
Period (EIP), which is strongly influenced by ambient temperature [71]. 
Mathematically, EIP, as well as longevity of the female vector are the main determinants of 
vector competence (i.e. the efficiency of an arthropod vector to transmit a pathogen) [72]. 
The time interval between a vertebrate host (usually human) being infected until the onset 
of symptoms comprises the intrinsic incubation period (IIP) [73]. This part of the cycle varies 
between two and greater than 10 days [71]. Various factors influence the circulation of 
arboviruses. These include host/vector dynamics, mosquito nutrition, and viral and mosquito 
genotypes, climate, landscape and host population immune status [74]. Globally, more than 
100 arboviruses cause diseases in humans [75], with all major clinically important arboviruses 
belonging to five families [68, 71] (Table 1). 
Arboviruses are distributed nearly worldwide, representing about one-third of all infectious 
diseases in the last 10 years [76]. While the factors associated with the epidemiology of each 
virus are specific, there are some common environmental, ecological and socio-economic 
factors that are typically associated with arbovirus diseases [77]. Humans play a key role in 
the dissemination of most arbovirus diseases. International travel and trade are identified as 
major factors in the global spread of arboviruses and their mosquito vectors, particularly Ae. 
aegypti and Ae. albopictus [78, 79]. Additionally, ecological factors, including, urban 
expansion and agricultural development provide suitable mosquito habitats, while population 
growth increases human contact with vectors [71]. Unplanned urbanization may play a key 
role in expanding urban virus cycles by providing new larval habitats (especially wastewater 
drains and artificial water containers). As well as shelter from weather and “heat island” 
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effects and available hosts. Such conditions may increase larval development rates, adult 
densities and longevity and the efficiency of pathogen transmission (i.e. vectorial capacity) 
[54]. Climatic fluctuations are also having a key role in the emergence and re-emergence of 
arbovirus diseases [80]. Global warming probably favours mosquito populations and in turn 
expands the areas susceptible to mosquito-borne infections [81, 82]. Hence, the rise in 
average temperatures in previously uninhabited areas probably increases the potential of 
disease outbreaks, with the provision of suitable climates allowing for greater vector range, 
dynamics and composition [28]. 
Table 1: Major clinically important arboviruses [83] 
Family Genera Arbovirus examples 
Togaviridae Alphavirus Eastern equine encephalitis virus (EEE) 
Ross River virus (RRV) 
Venezuelan equine encephalitis virus (VEE) 
Western equine encephalitis virus (WEE) 
Chikungunya virus (CHIKV) 
Barmah Forest virus (BFV) 
Bunyaviridae Nairovirus Crimean–Congo hemorrhagic fever virus (CCHF) 
Orthobunyavirus Bunyamwera virus 
California encephalitis virus 
Jamestown Canyon virus (JCV) 
La Crosse encephalitis virus (LACV) 
Phlebovirus Rift Valley fever virus (RVFV) 
Toscana virus (TOSV) 
Heartland virus 
Flaviviridae Flavivirus Dengue virus (DENV) 
Japanese encephalitis virus (JEV) 
Murray Valley encephalitis virus (MVEV) 
St. Louis encephalitis virus (SLEV) 
West Nile virus (WNV) 
Spondweni virus 
Zika virus (ZIKV) 
Yellow fever virus (YFV) 
Reoviridae Orbivirus African horse sickness virus (AHSV) 
Bluetongue disease virus (BTV) 
Equine encephalosis virus (EEV) 
Seadornavirus Banna virus (BAV) 
Coltivirus Colorado tick fever virus (CTFV) 
Asfarviridae Asfarvirus African swine fever virus (ASFV) 
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2.1.2 Factors affecting arbovirus transmission 
Developing interventions to prevent and control mosquito-borne infections requires some 
understanding of disease ecology (i.e. environmental conditions and processes driving host, 
vector and pathogen distribution and abundance patterns) [32, 33]. The main factors 
associated with the introduction and expansion of mosquito borne diseases have been 
broadly classified as climatic (e.g. rainfall, temperature, relative humidity) and non-climatic 
(e.g. ecological interactions such as host availability and preferences, vegetation cover and 
genetic factors, and anthropogenic factors such as population immunity, socioeconomic 
status, urbanisation, globalisation and vector control activities) [18, 84-87]. 
2.1.2.1 Climatic factors  
Climate can be viewed as the long-term pattern of weather in a particular area [88]. The 
climate of the earth has always been in a state of change [88]. “Climate change” represents 
the long-term alteration in average weather patterns in specific regions or globally. While 
“climate variability” is viewed as short-term changes (e.g. daily temperature fluctuations) or 
intermittent periodic inter-annual patterns (e.g. La Niña, El Niño) [89] [90]). Climate is a key 
parameter affecting all ecosystems, human health and wellbeing [82]. Yet, climate is one of 
the most influential determinants of vector-borne diseases, with a direct influence on 
mosquito vectors (e.g. distribution, survival, abundance behaviour, development, longevity, 
and transmission rate), hosts (e.g. abundance, distribution and behaviour), pathogens (e.g. 
incubation period, replication and lineage) and their interactions [91]. While temperature, 
relative humidity and rainfall are the main drivers of mosquito-borne diseases [43, 82, 92], 
other factors, such as altitude [93], wind, and the photoperiod may also be significant [82]. 
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Accordingly, both “climate variability” and “climate change” have key impacts on mosquito 
borne disease transmission [94]. 
2.1.2.1.1 Climate variations and mosquito-borne diseases 
Changes in the climate can be over timescales from tens to thousands of years. However, 
recording climatic variables, mainly temperature, relative humidity and rainfall, in a short-
term time-based way (daily, weekly, monthly) has been more closely associated with disease 
occurrence than these based only on mean conditions (long-term based) [95]. For example, 
heavy rain can be expected in New Zealand in June, but it may or may not happen on a 
particular day. These short-term changes can affect vector-borne diseases transmission [96]. 
Below are some examples of effects of climate variations on arbovirus infection transmission. 
Example 1: Temperature 
Empirical evidence: 
Cool temperatures have been most frequently identified as a limiting factor for arbovirus 
emergence and re-emergence [3]. Temperature affects mosquito-borne disease transmission 
by: (i) shifting or expanding vector geographic ranges; (ii) affecting vector abundance, 
increasing development, maturation, fecundity and bite rates (as an ectotherm, mosquito 
body temperature varies with ambient temperatures); (iii) affecting viral replication rate and 
EIP; (iv) affecting abundance of natural host; (v) contributing to the extinction of predators of 
natural vertebrate hosts mosquito vector; (vi) changing migration patterns of natural 
vertebrate host [97]; and (vii) lengthening the biting and transmission seasons [98]. 
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Most studies to date investigating the impact of temperature on mosquito-borne disease 
transmission have involved only laboratory-based constant temperatures (e.g. mean monthly 
temperatures) [99]. However, mosquito natural habitats are highly variable, with diurnal 
temperature ranges (DTRs, the difference between the minimum and maximum 
temperatures within one day) of 5 to >20 °C detected across many mosquito-borne infection 
transmission settings across the world [94, 100, 101]. Few studies, however, present empirical 
evidence to confirm that, in addition to mean temperatures, daily temperature variations 
greatly affect vector bionomics in general, and pathogen-vector interactions, and thus 
transmission dynamics [100-104]. In a recent theoretical study on malaria transmission in 
Africa, it was proposed that daily temperature fluctuations could significantly change the 
incubation period of malaria parasites within the vector and, therefore, influence malaria 
transmission rates [104]. Another study by the same research group [101]confirmed that not 
only is the incubation period of the Plasmodium parasite substantially influenced by DTRs, so 
too are the essential mosquito and pathogen parameters that define the transmission 
intensity (i.e. vectorial capacity) of mosquito borne infections. Short-term temperature 
elevation has been identified as the key driver affecting incidence rates of arbovirus infections 
in several endemic regions in the world, including Singapore [105], Thailand [106], Puerto 
Rico[107], and Taiwan [108, 109]. 
Warmer temperatures, however, do not necessarily increase transmission rates [110]. High 
temperatures (i.e. upper temperature thresholds) reduce mosquito lifespan, flight activity 
and blood meal sourcing [111]. For instance, in a study conducted in Guangdong Province, 
China, while the daily minimum and mean temperatures were positively associated with 
DENV transmission, maximum temperatures were negatively associated [112]. Furthermore, 
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the daily maximum ambient temperatures (31.1°C) during the DENV transmission season 
(February-May) in Ecuador surpasses the optimal temperature for DENV transmission which 
ranges from 26 to 29°C [113]. In Thailand [100], Ae. aegypti vectors survived longer and were 
more susceptible to DENV infection under moderate daily temperature variations (i.e. high 
DENV transmission season) than under greater temperature variations (i.e. low DENV 
transmission season). This negative impact was due to short-term temperature variations on 
two temperature-dependent elements of transmission dynamics, vector survival and vector 
competence. In an experimental study, Ae. albopictus had a high survival probability for 50–
60 days when the daily temperature range was 20-30°C. Ae. aegypti also survived this 
temperature range but for a shorter period of about 40 days [114]. At a daily temperature of 
40°C and above, the longevity of Ae. aegypti was shorter; similarly, for Ae. albopictus at 35°C 
and above [102]. Further, in a study conducted to examine the effect of environmental 
temperature variations on the susceptibility of Ae. taeniorhynchus mosquitoes for RVFV and 
Venezuelan equine encephalitis virus (VEEV), mosquitoes reared at lower daily temperatures 
were significantly more susceptible to infection with either RVFV or VEEV [115]. 
On a broader scale, the El Niño–Southern Oscillation (ENSO) appears to be an important factor 
contributing to the recent resurgence mosquito-borne epidemics around the Pacific [116-
118]. ENSO is a short-term “see–saw” fluctuation in sea surface temperatures (SSTs) between 
the eastern and western sides of the Pacific Ocean bringing unusually warm (El Niño) or cooler 
(La Niña) weather conditions over the tropical and subtropical eastern Pacific Ocean. The 
effects are opposite in the western Pacific including New Zealand [119]. These events typically 
occur every 2–7 years and may last several months. The two periods are accompanied by 
large-scale oscillations in the pattern of the atmospheric pressure (El Niño is associated with 
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high air surface pressure and La Niña with low air surface pressure) known as the Southern 
Oscillation. ENSO also affects short-term inter-annual weather variations and the likelihood 
of regional disasters, such as floods and droughts across the globe. Impacts of ENSO on 
mosquito-borne diseases transmission are debated in the literature. For instance, dengue 
epidemics in Thailand, Colombia, French Guiana, Suriname, Indonesia, and Mexico were 
strongly linked to El Niño events [106, 120-122]. ENSO has been significantly associated with 
the emergence/re-emergence of malaria in Venezuela and India [123, 124]. While a weak or 
no association was reported between ENSO events and incidences in Puerto Rico, Mexico, 
Thailand [107, 125-127] and Bangladesh [128]. In Guangdong Province, China, dengue 
transmission showed a negative associated with ENSO [112]. 
Seasonal fluctuations in the amplitude of DTRs or daily temperature variations help to 
elucidate seasonal forcing of mosquito-borne disease transmission in areas where mean 
temperatures do not fluctuate seasonally and mosquito vector abundance is not linked with 
disease incidence [100]. Findings on short-term temperature fluctuations reveal that impacts 
of climate on transmission dynamics of arbovirus diseases cannot be fully explained by mean 
conditions [101]. 
Temperature-dependant mechanistic components of mosquito vectorial capacity: 
As they are small-bodied ectotherms, mosquitoes’ biology and bionomics, and thus 
transmission dynamics, are strongly dependent on ambient temperature [129]. The EIP of 
many mosquito-borne pathogens are temperature sensitive [130]. Vectorial capacity, 
therefore, is dependent upon daily environmental temperature [94]. Vectorial capacity refers 
to the efficiency of a vector in transmitting a pathogen to a new susceptible population. 
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Vectorial capacity captures temperature-dependent components in pathogen transmission, 
such as biting rate, fecundity, adult mortality rate, longevity, vector competence, pathogen 
development rate, vector density, and pathogen incubation period [113, 131, 132]. Using day 
as the unit of time, as originally suggested by Garrett-Jones and Grab in 1964 [133], vectorial 
capacity can be also referred to as the daily reproduction rate [131]. Mathematically, Garret-
Jones [133, 134] expressed the vectorial capacity as: 
………………………………………………Equation (1) 
Where V= vectorial capacity, m= ratio of female mosquitoes to human hosts (i.e. vector 
density), a= biting (contact) rate per mosquito, n=extrinsic incubation period for the vector, 
and p= daily survival probability. 
Biting (contact) rate per mosquito (a) (bites/day): The length of the mosquito vector 
gonotrophic cycle (the time interval between the blood meal and oviposition [135]) is an 
estimate of its human biting rate and, thus, the frequency of acquisition and transmission of 
pathogens [136, 137]. Unlike many mosquito vectors (e.g. Anopheles species), host-seeking 
behaviour of Ae. aegypti and Ae. albopictus is inhibited during the gonotrophic cycle and until 
eggs are laid [137]. This behaviour limits their feeding rate to once during each gonotrophic 
cycle and, therefore, reduces the likelihood of pathogen transmission [137-140]. However, 
many field studies have recorded the occurrence of multiple feeding (two or more blood 
meals taken from different vertebrate hosts during single gonotrophic cycle). Multiple feeding 
maybe a result of ingestion of small blood meals mainly due to feeding disruption, failure of 
egg development from initial blood ingestion, suboptimal nutritional state, or scarce or 
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absence male accessory gland components [141]. According to several studies, at 30°C, the 
duration of the gonotrophic cycle was 4–6 days for Ae. albopictus and ∼4 days for Ae. aegypti, 
while at 20°C, it was 7–15 days and ∼6 days, respectively [131, 142]. 
Extrinsic incubation period (n): It is the period between the acquisition of an infected blood 
meal and the time at which the virus appears in the saliva and the mosquito becomes 
infectious [143]. EIP is a critical temperature-dependence component in the assessment of 
arbovirus transmission potential. The ability of mosquitoes to transmit an arbovirus depends 
mainly on ability to outlive the EIP of the virus [113] (i.e. the longer the lifespan of the female 
vector beyond the EIP the greater its vectorial capacity). For instance, in the Murray Valley of 
Australia, population size of Cx. annulirostris increases only between 17.5oC and 25oC [144] 
and their maximum longevity occurs at 25oC. The extrinsic incubation period of MVEV 
decreased linearly between 20oC and 35oC [145]. At 17oC and below, Cx. annulirostris lose 
their ability to transmit MVEV because at this point their average lifespan (16.26 days) is 
shorter than the EIP of the virus (17.67 days). Similarly, within the suitable temperature range 
(16-37°C), a meta-analysis has showed that the amplification of DENV in both Ae. albopictus 
and Ae. aegypti accelerated, and the EIP reduced with a higher temperature [143, 146, 147]. 
In Ae. albopictus, the shortest EIP for DENV occurred at 30 °C (3.5 days) [148], while it 
occurred at 26 ◦C (3 days) and 30 °C (2.5 days) in Ae. aegypti. [111]. Density of DENV in the 
vector salivary glands at 28–23–18°C was greatly decreased [148]. In another study in 
Australia, DENV transmission stopped similarly when the temperature dropped below 14oC 
[114], because the EIP was longer and the mortality rate is higher. 
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Mortality rate (μm): It is the estimated total number of female mosquito deaths in a mosquito 
population divided by the total number of this population, expressed per a given mosquito 
number, for a given time period, in a given location/experiment. It can be expressed 
mathematically as: 
  
Where p is daily adult survival probability. Hence p can be expressed as: 
 
The survival of mosquito vectors is a key temperature-dependence element of their potential 
to transmit vector-borne pathogens. Increased survival allows mosquito vector to increase 
infection probability, to produce more offspring, to expand their geographical ranges, and to 
increase the biting rate [114]. 
Vector competence (bm): Refers to the ability of healthy mosquitoes to acquire, maintain 
(i.e. virus replication), and transmit pathogens (i.e. infective) [149]. For ectotherm Aedes 
vectors, it is temperature dependent and can be determined experimentally by exposing 
female mosquito vectors to the virus during blood feeding. If the virus is detected in the 
vector’s midgut, it is considered to be “infected” [100]. This is defined as a probabilistic event, 
and represented by bmi. If the virus moves further to the head and other peripheral tissues, 
it is considered to be disseminated. Finally, if the virus successfully reaches the vector’s 
salivary glands, the vector is considered “infective”. The latter event is also probabilistic, and 
represented by bmt [131]. 
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A vector is considered “competent” if the product of the probability of getting infected (bmi) 
and then infective (bmt) is > Zero. Therefore, bm is determined as bm = bmibmt, and is 
dependent on variability of both diurnal and average temperatures [150]. Later, the vector 
competence (bm) was incorporated into the vectorial capacity formulation and expressed as 
[151]: 
 ………………………………………… Equation (2) 
Under human population stability, mosquito density (m) can be calculated by the ratio of the 
hatching rate to the mortality rate (µm) [134], if the  
Vectorial capacity is also expressed as: 
V = R0 rh / bh ……………………………….……………… Equation (3) 
Where rh is per capita host recovery rate, bh is probability of host becoming infected per 
infectious mosquito bite, and R0 the basic reproduction number. 
The basic reproduction number (R0): It is defined by Macdonald in 1952 [152, 153] as the 
“mean daily number of secondary infections produced by a single infectious case over the 
entire course of the infectious period after being introduced to a totally susceptible human 
population, via mosquito vectors who have survived the EIP after being infected by the 
infective primary case” [153]. Vectorial capacity is determined by vector bionomics and is 
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intrinsically linked to R0 for arbovirus diseases [134]. R0 is a constant that is determined by 
three parameters. According to equation (1) and (3), R0 depends on contact rate (a), the 
transmission probability per infectious bite to susceptible host (bh), and the infectiousness 
duration (rh; i.e. duration of viremia in a host). Based on a review conducted by Lambrechts 
et al. in 2010, bh for dengue transmission by Ae. aegypti is assumed to be 0.7 and rh has been 
calculated at five days (between 4-10 days). [154]. 
According to equation (2) and (3), R0 can be formulated as:  
…………………………… Equation (4) 
This equation was achieved by Macdonald in 1950’s in his classical study on malaria [152, 
153]. R0 is used as a threshold value to estimate the occurrence of an outbreak (i.e. 
transmission potential of a disease) in a completely susceptible population. If R0 > 1 (i.e. 
secondary cases generated per a single new case are less than one), the prevalence increases 
and the epidemic will spread. While if R0 <1 (i.e. secondary cases generated per a single new 
case are more than one), the prevalence decreases and the epidemic will die down [154, 155]. 
New cases generated by secondary cases are not included in R0. The thermal responses of 
the six previously mentioned temperature-dependent parameters of the R0 equation that 
drive transmission (nm, µm, a, bmi, bmt, bh) can be plotted (Figure 2). In short, R0 integrates 
all factors that determine the likelihood of pathogen establishment. 
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Some studies adapted the basic widely used Macdonald’s expression for R0 (equation 4) for 
vector by including/excluding temperature-dependent traits that control mosquito 
population densities. For example, Mordecai et al. (2013) [156] formulated a fully 
temperature‐sensitive R0 model (Equation 5) and used it in Mordecai et al. (2017) [113] to 
detect the impact of temperature on transmission of ZIKV, DENV, and CHIKV using 
mechanistic models. They assumed that all mosquito and pathogen factors are temperature 
dependent and that human density (N) and human recovery rate (r), which directly 




Figure 2: Thermal responses of Ae. aegypti and DENV traits that determine R0. From top to bottom: 
nm, a, bmt, µm, bmi, and bh.(Source: [149]) 
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Here, (T) indicates that the trait is temperature-dependent, a is the biting rate, bc is the 
vector competence (i.e. b is the probability of susceptible humans getting infected, c is the 
probability of mosquitoes getting infective), μ is the female mosquito mortality rate (lifespan, 
lf = 1/μ), PDR is the pathogen development rate (i.e. the opposite of the EIP), EFD is the 
fecundity (i.e. the number of eggs/female mosquito/day), pEA is egg‐to‐adult survival 
probability, and MDR is the larval development rate (i.e. the opposite of the egg-to-adult 
development time). The biting rate (a) is elevated at power two (equations 1 and 5) as it 
includes both the numbers of infective bites from sick human to mosquitoes and from 
mosquito to man, with probability of infecting a mosquito (c) and probability of infecting a 
human (b), respectively [157]. Mordecai et al. (2017) [113] plotted thermal performance 
curves for an eight life-history traits (a, b, c, p, PDR, pEA, MDR and EFD) of Ae. albopictus 




Figure 3: Thermal responses of Ae. albopictus and DENV traits that determine R0. Black solid curves 




Figure 4: Thermal responses of Ae. aegypti and DENV traits that determine R0. (Source [113]) 
Example 2: Relative humidity (RH %) 
Humidity is a major influence on the life cycle and ecological dynamics of mosquitoes [158, 
159]. Laboratory studies have shown variable tolerance according to species. For example, 
Ae. albopictus is more tolerant of lower temperatures than Ae. aegypti [160], while Ae. 
aegypti has greater tolerance of lower humidity with eggs showing higher survival rates at 
lower humidity [161]. Furthermore, when RH is reduced, the host-biting frequency of Ae. 
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aegypti does not decrease. This probably explains how Ae. aegypti may cause a high incidence 
of arbovirus infection where this is endemic in areas of typically low humidity (e.g. DENV, 
Charters Towers in Queensland, Australia) [162]. Therefore, these two species can establish 
in distinct but overlapping conditions (i.e. Ae. albopictus in relatively wetter but cooler regions 
and Ae. aegypti in relatively drier but warmer areas), which is likely to reduce competition 
and, thereby, expand the potential geographic area for disease transmission.  
Vapour pressure (a measure of absolute humidity) has been linked directly and indirectly to 
Aedes abundance and, therefore, to the incidence of associated viral diseases [148, 163-170]. 
Humidity affects the survival of Aedes mosquitoes directly through desiccation (e.g. [171]), 
which is in turn greatly influences their body haemolymph volume and osmolarity (i.e. as 
humidity decreases the percentage of water loss in mosquitoes increases). Normal body 
water content in adult mosquitoes varies from 40-90% of wet mass [172], and adult Aedes 
mosquitoes, under severe desiccation’ conditions, might dehydrate up to half of their water 
content [173]. These conditions put mosquitoes under stress [174], with reduced ability to 
fight off the viral infection, reduced fecundity and longevity hence also reduced vectorial 
capacity [175]. Further, humidity might indirectly affect Aedes mosquitoes via evaporation 
rates from breeding containers [176] [177]. The evaporation rate at 40% RH is about four 
times greater than at 80% RH. Water evaporation will reduce larval breeding site volume (via 
drying) and increase larval competition, which in turn can decrease the body size of Aedes 
females with resulting loss of vector ability [178-180]. 
Predictive models have attempted to include a predictor of desiccation effects. Hales et al. 
[181] reported annual average vapour pressure to be the best single climatic predictor of the 
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DENV global distribution. According to the same study, the average vapour pressure is high 
only where temperature and rainfall are both high. These conditions are conducive to survival 
and breeding of mosquito populations, and rapid amplification of the virus. Studies have 
recorded mixed impacts of relative humidity on dengue incidences [182]. However, most 
studies report a positive correlation [183] with high humidity favouring longevity and 
shortening blood-feeding intervals and IEPs [184]. The absence of quantitative modelling 
studies and comprehensive reviews of humidity-associated vectorial capacity and survival 
in Aedes has limited its full inclusion into epidemiological and ecological models [114, 185]. 
Example 3: Rainfall 
Since mosquito larvae and pupae are exclusively aquatic stages, places with waterbodies are 
conducive to breeding of mosquitoes [186]. Rainfall is considered a major climatic driver 
affecting mosquito vector dynamics and, therefore, infection for mosquito-borne diseases 
[193, 194].  
A significant correlation between rainfall, abundance of Aedes population and the seasonal 
number of dengue cases, has been observed not only in tropical regions [187-193] but also in 
subtropical regions, such as Vietnam [194] and Mexico [195]; and temperate regions, 
including Argentina [196] and the USA [197]. Natural disasters such as cyclones and floods 
that increase rainfall have been widely associated with mosquito-borne disease outbreaks 
[86]. In an 11-year study (1990/91 – 2000/01) in the Northern Territory, Australia, an increase 
in the cases of MVEV infection was recorded with unusually heavy rainfall and subsequent 
high mosquito (Cx. annulirostris) numbers. The resulting floods and pooling expanded 
breeding habitats for the mosquitoes [198]. However, the relationship between rainfall and 
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occurrence of mosquito vectors, and hence the transmitted diseases, is non-linear. This will 
be likely due to the fact that heavy rainfall can be detrimental to mosquito vectors [33–35], 
by “flushing out” and destroying mosquito immature stages, or disrupting and washing away 
their breeding sites [199]. This depends on rainfall intensity, growth stage and container size 
[200]. Studies conducted in Curaçao [201], Sri Lanka[202], Senegal[203], China [204], and 
Singapore [199], showed a reduction in mosquito-borne disease incidence during and/or 
following excess rainfall events. 
Although pools created by rainfall are a key contributor to seasonal abundance of many 
mosquito species (e.g. [28, 53]), these are not a prerequisite for many Aedes species, which 
preferentially breed in anthropogenic water containers, typically in urban settings, that are 
filled by other means throughout the year [159] (e.g. plant pots, air-conditioner drip pans and 
water tanks [205]). Interestingly, in Brisbane, Australia, a strong drop in rainfall frequency and 
intensity followed by drought was also associated with an increase in densities of Ae. aegypti. 
This secondary effect of climate change has been linked to human water storage behavioural 
changes to drought (i.e. increased water storage has resulted in new habitats for urban 
container-breeding Aedes mosquitoes such as garden accoutrements, water storage 
containers, discarded household items) [206]. Another explanation for increased mosquito 
densities following dry conditions that droughts turn drainage channels and irrigation ditches 
in urban and suburban areas into stagnant water bodies, which then become suitable 
breeding habitats for mosquitoes. Therefore, some mosquito-borne epidemics are associated 
with hot as well as dry weather [207]. 
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The socioeconomic status of peridomestic or domestic settings has been found to be 
significant factors in influencing the number and types of water holding containers in and 
around households [208-211]. Several studies have recorded a significant positive association 
between rubbish container habitats in deprived areas, and prevalence of Aedes species and 
arboviruses [208, 209, 211, 212]. 
2.1.2.1.2 Climate change and mosquito-borne diseases 
See Appendix A 
2.1.2.2 Non-climatic factors 
2.1.2.2.1 Genetic determinants 
These include human susceptibility, pathogen virulence and infectivity in the host, and 
vectorial capacity of the transmitting mosquito strain [85, 213]. 
2.1.2.2.2 Urbanization 
Expansion of urban centres and migration to cities are especially relevant to arbovirus 
infections, because main urban vectors (Aedes spp.) are highly adapted to anthropogenic 
habitats, and prefer breeding in man-made containers [214]. The majority of arboviruses in 
built environments are maintained in human-mosquito cycles [215]. In the 2nd half of the 
20th century, driven by economic growth after World War II, rapid unplanned urbanization 
was a key driver in aiding the expansion of dengue and dengue haemorrhagic fever (DHF) in 
different cities around the world [214, 216]. For instance, Asian cities like Manila, Bangkok 
and Jakarta, experienced unprecedented unplanned urbanization coinciding with rapid 
economic growth in the mid-1990s. The result was susceptible populations migrating to cities 
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and living in slums with inadequate housing and poor or no access to basic services and 
facilities such as water, drainage network, sanitation and waste management. This created 
ideal conditions for Aedes mosquito proliferation and mosquito-borne disease transmission 
[214]. Built-up areas (lacking agricultural and forested habitat) of these cities acquired the 
highest incidence of mosquito-borne diseases [217]. In North America and South America, the 
re-infestation with Ae. aegypti was a direct result of the massive urban growth in the 1970s 
(currently, over three-quarters of the population live in urban/urbanized areas, almost all of 
which have been re-infested with the yellow fever mosquito) [214, 216, 218]. This coincided 
with the emergence and re-emergence dengue epidemics, which accelerated in the 1980s 
and 1990s [214, 216]. The relationship between human activities and mosquito vectors has 
been extensively examined in previous studies [3, 219-221]. 
2.1.2.2.3 Globalization 
While urbanisation has facilitated dengue vector proliferation locally, globalisation helped it 
to distribute globally. In the 15th to 18th centuries, Ae. aegypti expanded from its origin in 
Sub-Saharan Africa to the New World, assisted by the slave trade and colonisation, from 
where it subsequently spread to Asia, Australia, and then to most tropical and subtropical 
regions [219, 220, 222]. Similarly, Ae. albopictus, originating in South-Asia and islands of the 
Pacific and Indian Oceans, has been recorded in all five continents in the last five decades 
[148, 223]. This rapid and global spread of both Aedes species has been facilitated by 
international travel and trade [214] (mainly used tyres and bamboo for Ae. albopictus [224, 
225]). This globalized system escalated during the last century, spurred via major 
improvements in transportation, and economic and demographic growth [214, 226], placing 
40% of the world's population, about 3 billion people, at risk of DENV infection [3, 227]. 
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In addition to mosquito vectors, globalization has also facilitated the global expansion of 
pathogens, including arboviruses [4, 8, 9, 214], which has been known as “pathogen 
pollution” [228]. The past decade has seen an unprecedented emergence of travel-associated 
epidemics of arbovirus diseases in non-endemic areas. This includes DENV in Australia [229], 
southern Europe [230-232], the United States [233] and China [234]; chikungunya in the 
Caribbean Islands and the Americas [235, 236]; Zika in the United States [237], Pacific Islands 
[238] and southeast Asia [239], and RRV infection in the Pacific Islands [11, 240, 241]. 
Travellers can easily contract an infectious disease if it is rare in their native countries, and 
they therefore lack immunity. 
2.1.2.2.4 Immunity 
The probability of symptomatic arbovirus infection varies according to immune status [9]. The 
first seroepidemiology evaluation came from Sabin’s work on experimental infection showing 
immunity against DENV and/or symptoms after a previous DENV infection [242, 243]. A 
previous DENV infection induces a serotype-specific life-long immunity (i.e. production of 
DENV-specific antibodies that react only with similar virus serotype). However, a subsequent 
infection with a heterologous DENV serotype carries a higher risk of complicated 
manifestation [244]. Further, a number of recent studies have shown immunological cross-
reactivity between different arboviruses. For instance, ZIKV showed a significant cross-
neutralization by DENV antibodies and vice-versa [245-248].   
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2.2 Review Two: Risk assessment of arbovirus transmission in New Zealand 
2.2.1 Risk factors for arbovirus disease transmission in New Zealand 
New Zealand has no local transmission of human arbovirus diseases [249]. However, this 
situation is threatened by several climatic and non-climatic variables. Identification of local 
risk factors of mosquito-borne diseases provides a mean of detecting (rather than predicting) 
the start of outbreaks.  
2.2.1.1 Vector competence 
At the present time (October 2020), there are 16 known species in New Zealand. Thirteen 
species are endemic and three are introduced (naturalized). The three introduced species are 
potential arbovirus vectors: Ae. (Finlaya) notoscriptus (Skuse), Ae. (Halaedes) australis 
(Erichson), and Culex (Culex) quinquefasciatus (Say)[27, 47]. The potential vector status of the 
endemic Cx. (Cx.) pervigilans Bergroth, is unknown. However, this is a potential vector for 
several enzootic viruses, and known laboratory host of human viruses [27].  
i. Aedes notoscriptus 
Biology and habitat: Ae. notoscriptus is a peri-domestic, freshwater container-breeding 
mosquito. Larvae are usually found in shaded natural reservoirs, including tree-holes, rock-
holes, palm fronds, and leaf axils. They are also found in a variety of man-made reservoirs, 
including tyres, tin cans, roof gutters, pot-plant bases and drinking water tanks [250, 251], 
indicating that this species has adapted from natural to artificial containers [251]. Ae. 
notoscriptus females are primarily night biters, but they also can bite in shaded areas during 
the day [252]. 
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Distribution in New Zealand: Ae. notoscriptus is widespread and well established through-
out the North Island, and appears to be expanding its range southwards on the South Island 
[47, 253, 254]. According to Snell (2006), this species was found at three sites on the South 
Island including; Nelson, Blenheim and Christchurch. This container breeding fresh water 
mosquito mainly occurs in domestic and peri-domestic areas [27]. 
Public health significance: The vector competence of Ae. notoscriptus has been studied 
extensively in Australia for BFV [255, 256], CHIKV [257], RRV [240, 258], ZIKV [259, 260], DENV 
[255, 261] and MVEV [252]. On the basis of these studies, Ae. notoscriptus could act as an 
efficient vector of BFV, RRV, ZIKV and MVEV in urban environments, but it is unlikely to be an 
important vector of the other viruses. However, according to Watson and Kay (1998 and 
1999), Ae. notoscriptus can also transmit DENV with very low infection levels. In New Zealand, 
Ae. notoscriptus is capable of harbouring Whataroa virus [262], the only indigenous mosquito-
borne virus isolated to date in New Zealand from birds [263]. No human cases of infection 
with Whataroa virus have been reported [47]. Laboratory studies with New Zealand Ae. 
notoscriptus have shown the mosquito to be a competent experimental vector of DENV [264] 
and BFV [27]. 
ii. Aedes australis 
Biology and habitat: Ae. australis is a saltwater breeder [250]. It usually breeds in salt pools 
and marshes as its larvae are extremely salt tolerant [265]. However, its larvae have also been 
found in 90% fresh water and fresh water ditches on roadsides [14, 254]. Adult females are 
autogenous and generally don’t disperse far from their larval breeding sites, and are rarely 
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found in close association with humans [47, 266]. However, at high densities they have been 
found in anthropogenic sites [251, 253]. 
Distribution in New Zealand: Ae. australis is mainly confined to southern South Island [14, 
254] including Southland, Westland [267] and north up to Timaru [46, 47, 254, 268]. 
Public health significance: Ae. australis is considered as a potential vector of RRV [269], is 
capable of harbouring Whataroa virus under laboratory conditions [265] and is a competent 
laboratory vector of DENV [264]. However, it has not been considered a major public health 
threat due to its remoteness from humans around the southern coast of the South Island, and 
cooler climates further south [47, 270]. However, Kramer (2011) has demonstrated that New 
Zealand Ae. australis is a competent laboratory vector of WNV, BFV, RRV and Sindbis virus 
(SINV). 
iii. Culex quinquefasciatus 
Biology and habitat: New Zealand Cx. quinquefasciatus larvae prefer man-made nutrient-rich 
aquatic reservoirs [47, 48]. In some other countries, larvae of Cx. quinquefasciatus often occur 
with larvae of Ae. aegypti in the same larval habitats. However, unlike Ae. aegypti, Cx. 
quinquefasciatus larvae can survive winter temperatures in New Zealand by their ability to 
overwinter in cold conditions [47, 250, 271]. Adult females are predominately anthropophilic, 
live indoors and outdoors, are nocturnal, and opportunistic blood feeders [47, 271]. However, 
they can feed on animals like pigs, cattle, horse, sheep, rabbits, dogs and amphibians 
(zoophilic) or birds (ornithophilic) [253, 271]. 
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Distribution in New Zealand: After Cx. pervigilans and Ae. notoscriptus, Cx. quinquefasciatus 
is the third most widespread mosquito. Initially, this species was geographically restricted to 
areas around ports of entry in the north of the North Island through which it was introduced. 
However, its range of distribution has expanded southwards and is now well established 
throughout most of the North Island [46, 47, 253, 254] and northern parts of the South Island 
[47, 254]. New distribution records of Cx. quinquefasciatus on the North and South Islands 
were verified by Snell in 2006 [254] indicating that this species is probably now much more 
widespread than previously thought. 
Public health significance: Cx. quinquefasciatus is considered as a potential vector of JEV 
[272], WNV [273], and SLEV [272, 274] in many areas of the world. Additionally, it is a 
competent laboratory vector of many arboviruses including RRV, Almpiwar, Alfuy, Corriparta, 
Sindbis [275], Reticuloendotheliosis virus [253], MVEV [47], Getah, Kokobera, Edge Hill, 
Eubenangee, Stratford, Trubanaman, Wongal, Koongol, Reovirus type 3, Kowanyama, Kunjin, 
CHIKV [253, 271], and ZIKV [276]. These findings were confirmed with BFV, RRV and MVEV in 
Kramer et al. (2006) [27].  
iv. Culex pervigilans:  
Biology and habitat: According to Baber in 1934 Cx. pervigilans breeds almost anywhere 
there is a waterbody [277]. Immature stages have been collected from fresh, salt and polluted 
water, as well as permanent and temporarily waterbodies, and artificial and natural 
containers [250, 253]. Derraik and colleagues in 2005 reported that Cx. pervigilans was more 
commonly found in urban and rural areas than under forest covers [278]. Cx. pervigilans 
breeds in all seasons with peak activity peak between late summer and spring [277]. Their 
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eggs are not desiccation resistant. Larvae have been observed actively swimming under ice 
[277] and may overwinter without development [249]. 
Distribution in New Zealand: The endemic Cx. pervigilans [249] is the most widespread and 
abundant mosquito species in New Zealand [48, 249, 253, 279] as it is primarily ornithophilic. 
Public health significance: Cx. pervigilans also can be zoophilic and anthropophilic [253]. It is 
a vector of Whataroa virus [280], reovirus type 3 and avian malaria [253]. Under laboratory 
conditions, Cx. pervigilans is a competent vector of RRV, WNV and DENV [27]. 
2.2.1.2 Imported exotic species  
More than 30 exotic species have been detected at New Zealand’s ports, including several 
major vectors of arboviruses, such as, Ae. albopictus, Ae. aegypti, Ae. (Finlaya) japonicus 
(Theobald), Ae. (Stegomyia) polynesiensis (Marks) Ae. (Ochlerotatus) camptorhynchus 
(Thomson), and Cx. (Cx.) sitiens Wiedemann [281]. In March 2018, the latter has been found 
as larvae near the Kaipara Harbour (north of Auckland) during Biosecurity New Zealand 
regular surveillance, which is part of a National Saltmarsh Mosquito Surveillance Programme 
[282]. Fortunately, this incursion has been contained. Cx. sitiens is widespread in Australia, 
the Pacific Islands and Southeast Asia [283].  
The southern saltmarsh mosquito, Ae. camptorhynchus, was first detected in New Zealand in 
December 1998. A possible pathway includes by sea via the Port of Napier in soft-top 
containers or tyre imports from Australia. In Australia, Ae. camptorhynchus is a vector for a 
number of arboviruses, including RRV, MVE and BFV.  Although it was declared to be 
eradicated from New Zealand in June 2010, it remains a high-risk species on the register [249]. 
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2.2.1.3 Travel and trade  
Following international trends [4, 37, 39], mosquito-borne infections have been increasingly 
reported in New Zealand (mainly in Auckland) in returning travellers over the past 10 years 
[40]. New Zealand is recorded to have the highest rate of international travel in the world 
[284]. More than 50% of international travellers coming to New Zealand are from Australia 
and the Pacific Islands [285]. Since 2012, there have been over 120,000 arbovirus 
notifications, and most of the Pacific Islands have reported ongoing transmission of DF, 
chikungunya and Zika infections [24]. RRV is endemic in Australia and is the most common 
and widespread arbovirus disease [175] in the Solomon Islands [286] and Papua New Guinea 
[287-291]. DENV, CHIKV, RRV, and more recently ZIKV, are New Zealand’s most common 
imported arboviruses [40]. In 2002 Kelly-Hope reported that more than 100 people annually 
travel to New Zealand from Australia with symptomatic and asymptomatic infections of RRV 
[292]. With these high mobility conditions and the epidemiological status of our Australian 
neighbours, Weinstein and colleagues warned that, if a competent mosquito vector exists, 
the circulating viremia in these people could initiate a New Zealand outbreak [22]. 
Furthermore, since 1990 shipments have been responsible for 51 records of 62 exotic 
mosquitoes, including Ae. aegypti and Ae. albopictus, in New Zealand entry ports [11]. A 
major source of these imported exotic mosquito vectors has been the used tyre trade [45]. 
Laird and colleagues reported that around one hundred Ae. albopictus larvae were found in 
a used tyre freight from Japan. In 2006 Derraik reported that used tyres and machinery 
imports were the main mode of entry for about 75% of all mosquito interceptions arriving in 
New Zealand via shipping vessels [12]. 
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2.2.1.4 Urbanization and vector habitat modification 
Over the past 800 years, since the arrival of humans, the landscape of New Zealand has 
dramatically changed [293, 294]. The current forest and woodland cover represents more 
than a 70% reduction from its original pre-human form (from 21 million ha to c.6 million ha 
[295]). This is due to deforestation, logging and historical fires [296]. According to Ministry for 
the Environment, the rate of deforestation in New Zealand since 2008 has been greater than 
the rate of plantation, averaging around 8,500 ha., annually [297]. According to Environment 
Aotearoa report in 2015, New Zealand lost more than 10,000 Ha, of regenerating and native 
forest between 1996 and 2014 [298]. In addition, 90% of New Zealand’s natural wetlands 
have been converted to freehold farming land, which has more economic value [18, 299]. This 
dramatic modification and reduction of the indigenous ecosystems has led to extensive 
habitat and biodiversity loss and fragmentation, ecological collapse, and, therefore, has 
facilitated exotic and invasive species to settle [300, 301]. 
With urban population growth at 2.1% annually, the urban population in New Zealand has 
grown rapidly, and in 2018 accounted for 86.5% of its total population [302]. There is 
accumulating evidence showing that mosquito species replacement has occurred in New 
Zealand as a direct consequence of urbanisation [18]. This situation has been recorded in 
urban areas in Auckland, where the primarily ornithophilic endemic mosquitoes (Cx. 
pervigilans; of unknown vector status) have been replaced by two anthropophilic introduced 
species (Ae. notoscriptus and Cx. quinquefasciatus) [14]. An exception is the synanthropic Cx. 
pervigilans, the only endemic species capable of inhabiting urban areas and human-modified 
habitats [14, 18]. In general, urbanization increases the development rate, longevity and 
density of urban mosquitoes (e.g. many Aedes spp.) In general, urbanization increases the 
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development rate, longevity, fecundity and density of urban mosquitoes (e.g. many Aedes 
spp.), which sequentially increases their vectorial capacity [303]. 
2.2.1.5 Habitat underutilisation 
Several studies have reported that mosquito larval habitats in northern New Zealand are 
underutilised [14, 15, 28, 48]. This situation may provide available breeding habitat for 
introduced vector species, in particular Ae. albopictus, and consequently aid in their 
establishment [15, 17, 18]. The establishment of Ae. notoscriptus may serve as a blueprint for 
the establishment of other exotic container-breeding mosquitoes in New Zealand, especially 
Ae. albopictus [17, 45, 46]. 
2.2.1.6 Inexperienced non-immune local population  
Given that New Zealand has been free of human arbovirus local transmission, the human 
population is predominantly immunologically naïve [11, 20]. This susceptibility is 
compounded by the lack of public education about mosquito-borne illnesses or mosquito 
avoidance measures to minimise the infection risk. Furthermore, a lack of experience with 
the diagnosis of arbovirus infection among New Zealand medical professionals, coupled with 
lack of adequate laboratory testing services could result in a delay in recognition of any local 
transmission that may occur, and therefore, the response [269]. This naïve situation could 
strengthen the speed and spread of an exotic arboviruses outbreak in New Zealand [11, 269]. 
2.2.1.7 Climate change 
The immature stages of the two Aedes vectors vary in their dependency on temperature. The 
main difference is the ability of Ae. albopictus to produce diapausing cold-tolerant eggs that 
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can survive cold temperatures down to -10°C [304], which is not recorded in Ae. aegypti [160, 
223]. This ability assists establishment of Ae. albopictus in higher latitudes in Asia, Europe and 
North America [100, 305]. 
Accordingly, de Wet et al. reported that under the current climatic conditions, the northern 
New Zealand climate is suitable for the establishment of Ae. albopictus [28] [306]. 
Furthermore, model-based projections of temperature, precipitation and humidity increases 
would make these regions also habitable for Ae. aegypti and expand the geographic range of 
Ae. albopictus to other areas of New Zealand [28, 306]. 
2.2.1.8 Climate variability  
Cyclical and short-term changing ecological conditions as a result of ENSO events represent a 
threat to New Zealand. Raised temperatures and precipitation would extend both micro and 
macro habitats that support introduced and exotic mosquito vectors [269]. 
2.2.2 Arbovirus diseases of potential concern  
Arbovirus diseases are a potential concern for New Zealand. This Thesis will focus on dengue, 
chikungunya, Zika and RRV infections. 
2.2.2.1 Dengue 
Overview: Dengue is an acute febrile illness transmitted by the mosquito-borne DENV that is 
a member of the family flaviviridae, genus flavivirus [307]. There are four globally agreed 
antigenically distinct serotype of DENV, DENV-1, DENV-2, DENV-3 and DENV-4. However, in 
2015, a study in Malaysia claimed discovery of a fifth serotype (DENV-5) [308]. The disease 
severity varies from flu-like illness, classical dengue fever, to the life-threatening conditions, 
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including DHF and dengue shock syndrome (DSS) [309]. Typically, dengue cases are 
asymptomatic (80%) or have mild symptoms such as fever [310]. Others have more 
complicated symptoms (5%), which begins with an acute febrile pain with one or more of the 
following: high fever, vomiting, retro-orbital or ocular pain, headache, myalgia, arthralgia, a 
characteristic skin rash, leucopenia, and hemorrhagic manifestations. Recovery generally 
takes 2-7 days [311-313]. Symptoms typically begin 3-14 days after infection (usually 4 to 7 
days). Travellers leaving endemic regions are unlikely to have dengue if their fever begins 
more than two weeks after arriving home [314]. 
Treatment options are limited, but early detection and appropriate medical care commonly 
save the lives of cases with DSS or DHF and can lower the fatality rates to below 1% [315]. In 
December 2015, a world first dengue vaccine, Dengvaxia, was licensed in Mexico. Later, the 
vaccine was registered by several National Regulatory Authorities for those aged between 9 
and 45 years living in endemic settings [316]. However, Dengvaxia has been shown to have 
different degrees of efficacy, and is not yet believed to be a cost-effective solution [317, 318]. 
The WHO recommends that use be limited to endemic areas because vaccination may actually 
increase the risk of dengue fever in non-immune populations who have not been previously 
infected with DENV [315]. So far, the most effective way to prevent DENV transmission is to 
control the mosquito vector [313]. 
Mosquito vectors: Epidemiological evidence and virus field isolations demonstrate that Ae. 
aegypti, and to a lesser extent Ae. albopictus, are the major dengue vectors [319]. While Ae. 
aegypti is the primary vector in tropical and. subtropical regions of the world, Ae. albopictus 
also has been implicated in dengue transmission in temperate regions (Figure 5). Over the 
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past few decades, Ae. albopictus has largely expanded from its native range in Southeast Asia 
to Europe, the Americas and Africa [150].  
In the Australasia-Pacific, Ae. aegypti is established throughout most of the area, including 
Australia (mainly Queensland), Futuna, Hawaii, and a number of remote islands. While Ae. 
albopictus is widely distributed in Papua New Guinea, Tonga, Fiji, Vanuatu, the Marshall 
Islands, Yap, Palau, Chuuk, the Solomon Islands, the Northern Mariana Islands, and the 
Federated States of Micronesia. Dengue outbreaks in this region have also been attributed to 
Ae. polynesiensis [24, 313], Ae. hensilli, Ae. rotumae, Ae. scutellaris, Ae. marshallensis, Ae. 
hebrideus, Ae. cooki, Ae. tongae, Ae. tabu, Ae. kesseli and Ae. pseudoscutellaris [24]. 
In New Zealand, five species have shown DENV vector competence only under laboratory 
conditions include Ae. antipodeus, Ae. australis, Ae. notoscriptus, Cx. pervigilans and Opifex 
(Op.) fuscus [27].  
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Figure 5: Global distribution of Aedes mosquitoes (Source: [226]) 
Disease burden and distribution 
Global burden: Dengue is one of the most ancient diseases known to humans. Dengue fever-
like illness was identified in Chinese literature as far back as 992 CE [320]. Although epidemics 
of febrile illness consistent with dengue have been recorded for centuries, it was not until 
1943 when the first DENV was isolated in Japan [321]. It was during this time that dengue 
emerged as a worldwide problem and has since became the most rapidly spread arbovirus 
infection in the world, with a 30-fold increase globally over the past five decades [315] [322]. 
Each year it is estimated that dengue accounts for more than 10,000 deaths. While there are 
50-100 million new cases and symptomatic infections over 125 countries, across five 
continents [322-325] (Figure 6). South-East Asia, the Western Pacific and the Americas are 
the most severely affected regions with over 1.2 million dengue cases were reported in 2008 
and more than 3.2 million in 2015 [326].  
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Figure 6: Global evidence consensus of dengue (Source: [3]) 
In temperate regions across Europe, more than 10 countries have recorded dengue epidemics 
since 2010 [325, 326]. Local transmission was first reported in Croatia and France in 2010. In 
2012, an outbreak of dengue was confirmed in the Madeira islands of Portugal, with more 
than 2,000 cases reported [312]. A recent study estimated that approximately 390 million 
dengue infections are reported annually in Europe, of which 96 million manifests clinically or 
sub-clinically, leaving most cases undetected [3, 315]. Indeed, recent modelling [3, 181, 327-
329] and epidemiological [330-332] studies indicated that the incidence of dengue is 
dramatically increasing. 
In 2020, while no local transmission cases of dengue have been reported so far in Europe, 
several dengue epidemics from the Pacific to Latin America have been detected [333]. As of 
16 June 2020, according to the European Centre for Disease Prevention and Control (ECDC) 
[333], outbreaks of dengue fever are ongoing in: 
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− Americas and the Caribbean (Brazil, Paraguay, Bolivia, Argentina, French Caribbean 
islands), with 1,803,530 suspected and confirmed dengue cases and 655 deaths,  
− Asia (Vietnam, Cambodia, Thailand, China, Taiwan, India, Singapore, Philippines, Sri 
Lanka, Pakistan, Lao PDR, Malaysia, Bangladesh, Myanmar, Indonesia, and Maldives), 
with about 350,000 confirmed cases and 815 deaths 
− Africa (Réunion, Mayotte, Mali, Comoros, Mauritania), with about 42,000 cases and no 
reported deaths 
Asia-Pacific burden: Since the 1950s, dengue cases have been reported in several Pacific 
Islands. In the past 10 years, however, this has become the fastest and most serious emerging 
arbovirus epidemic in the region [215, 334-337]. In 2000 there were 50 registered 
notifications per 1,000 people in the Western Pacific Region (including Asia and Pacific sub-
regions), but by 2012 this had grown to 350 per 1,000 people [337]. Since 2007, dengue cases 
in the Western Pacific Region have substantially increased over the past 10 years, with more 
than 200,000 notifications consistently reported every year [337]. In 2010, for example, 24 
out of 38 countries and territories in the Western Pacific Region (13 and 11 countries in Asia 
and Pacific sub-region, respectively) registered a total of 353,907 dengue notifications 
(352,005 and 1,902 cases in Asia and Pacific sub-region, respectively). Of these, 1248 died, all 
of whom were from Asia sub-region except one case from Federated States of Micronesia. 
Many countries of the Pacific sub-region reported a consistently high notification rate of 
dengue cases in 2010. The Pacific experienced another high burden of dengue between 2014 
and 2018 where a total of 18 new dengue outbreaks and circulations were reported (Table 
2). 
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Dengue fever is not endemic in Australia. However, since the first notified cases during 1992–
1993, local transmission of dengue has been regularly reported in Queensland [338]. In spite 
of the implementation of improved surveillance systems and passive and active mosquito 
control activities, autochthonous cases are still occurring in Queensland [339]. Further, 
dengue infection has been increasingly observed in returned travellers, mainly from Asia and 
Papua New Guinea, from 2010 onwards. A respective increase of 298% and 155% in 2010 and 
2011 was recorded compared with the five-year mean, with an average of 144 notifications 
per month in the first half of 2012 [38, 340, 341]. As of 16 June 2020, outbreaks of dengue 
fever are ongoing in Australia, New Caledonia, Cook Islands, Marshall Islands, and French 
Polynesia, with about 7,000 cases and two deaths. 
51 
Table 2: Characteristics of new DENV infection outbreaks and circulations in Pacific Region, 23 May 2014 – 19 Feb 2018 (Source: author) 













DENV-1 As of 5 December, there have been 10 confirmed cases, of 
which 5 had dengue serotype-1 identified 
Dengue serotype-1 outbreak is ongoing 







DENV-2 Palau declared dengue serotype 2 outbreak in November 
2017 with a total of 329 cases by June 2017 
Dengue serotype-2 is in circulation with a 
decrease in the weekly number of cases 
[342, 344] 
Niue May 2017 18 June 
2017 
DENV-4 Niue reports five cases tested positive for dengue serotype 4 Dengue serotype-4 is in circulation with an 






DENV-2 Between 1 January and 30 March 2017 there were 901 
reported cases 
The outbreak continued through the end of 
April before tapering off 
[345] 




DENV-2 Between Nov. 2016–Oct 2018, 3,240 patients were tested for 
dengue. Of these, 1,081 (33.4%) were tested positive  
Dengue serotype-2 is in circulation with an 







DENV-2 In November 2016, an increase in the reported number of 
dengue fever cases was observed. On 30 December 2016, a 
dengue outbreak was declared. As of 31 May 2017, there 
have been 2,820 suspected cases 
Dengue serotype-2 outbreak appears to be 
ending. Dengue undetermined serotype is in 












DENV-4 On October 21st2016, a concurrent dengue outbreak in 
Kosrae was identified after routine testing of pregnant 
women. As of 30 November, there have been 98 suspected 
cases identified since the outbreak onset. 
The outbreak appears to be over [342, 348] 







As of 5 July 2017, there have been 4,467 cases since 
September 2016 (4,421 cases only in 2017). 
Dengue-serotype-1, 2 and 3 outbreaks are 
ongoing 
[342, 349] 




DENV-2 Between Aug 2016-Apr 2017, Solomon Islands had the 
longest and largest dengue epidemic on records, with 12,329 
cases, 16 deaths and 877 hospitalisations. 
Dengue serotype-2 is in circulation with a 






DENV-2 As of 4 August, in 2017, there have been 2,395 cases and 6 
deaths reported since January 2016 
Dengue serotype-2 is in circulation with an 







DENV-3 As of 24 January 2016, there have been 117 dengue-like 
illness cases seen since 3 January 2016 








DENV-2 A total of 170 cases were reported from 4th of November 
2015 to the 8th of January 2016 






DENV-1 As of 15 December 2015, there have been 152 confirmed 
cases of dengue since September 2015 
The outbreak appears to be over [342]  




As of 28 August 2017, there have been 1507 cases since 11 
June 2015 
Dengue-serotype 2 outbreak is ongoing 
with a decrease in the weekly number of 
cases 
[342, 343]  
American Samoa May 2015 22 
November 
2015 
DENV-3 As of 1 November there have been 463 cases with 146 
hospital admissions since May 2015 with 5 deaths 
The outbreak appears to be over [342, 353] 
Fiji January 
2015 
7 June 2015 DENV-2 & 
DENV-3 
As of 19 January 2015, Fiji declared a dengue outbreak, with 
17 laboratory confirmed cases. As of 29 April 2015, there 
have been 543 confirmed cases 




7 June 2015 DENV-3 As of 15 March 2015, Tonga reported an outbreak with 174 
dengue-like illness cases since 4/01/2015 
Dengue serotype-3 appears to be ending. 
Dengue undetermined serotype is in 
circulation with an increase in the number 
of weekly notifications 
[342, 343] 
French Polynesia February 
2013 
06 Feb 2018 DENV-1 & 
DENV-3 
As of 23 May 2014, about 2188 cases were tested positive 
since Feb. 2013. 2150, 1052 and 2093 notifications recorded 
in French Polynesia in 2014, 2015 and 2016, respectively 
Dengue-serotype 1 outbreak is ongoing 






Overview: Chikungunya is an acute febrile disease caused by CHIKV (Togaviridae, genus 
Alphavirus) and transmitted to humans by Aedes mosquitoes [356]. The name “chikungunya” 
is derived from Kimakonde language and translates to “that which bends up” in reference to 
the contorted posture of infected patients developed due to the rheumatologic 
manifestations of the disease [357-359]. The Kimakonde language is spoken in the Makonde 
Plateau, along the border between Tanganyika (the mainland part of modern-day Tanzania) 
and Mozambique [357, 359]. The area was where the first official outbreak of chikungunya 
was recorded in 1952 [357, 360]. 
CHIKV infection is characterized by a sudden onset of high-grade fever frequently 
accompanied by arthralgia or arthritis. Other signs and symptoms include rigors, headache, 
fatigue myalgia, a petechial or maculopapular rash, nausea and low back pain [361, 362]. No 
specific treatment or vaccine is currently available for CHIKV infection [363-365]. The 
symptoms are usually self-limiting and typically clear in 5–7 days. Asymptomatic infections 
are uncommon, being observed in about 15% of patients [366]. 
Mosquito vector: CHIKV has three distinct lineages (genotypes), depending on its 
phylogenetic origins: two original African lineages: (East Central South African and West 
African) and the Asian lineage [367, 368]. CHIKV exists in two primary transmission cycles: a 
sylvatic (or enzootic) cycle and an urban (mosquito–human–mosquito) cycle. The two cycles 
mainly involve primates and Aedes mosquitoes. In Asia, the virus is maintained primarily in an 
urban cycle, with the urban anthropophilic Ae. aegypti and Ae. albopictus being the primary 
transmission vectors. In Africa, the virus is largely maintained in a sylvatic cycle involving wild, 
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non-human primates (NHPs), such as macaques, and forest-dwelling Aedes mosquitoes such 
as Ae. camptorhynchites, Ae. furcifer, Ae. luteocephalus, Ae. vigilax, Ae. fulgens, Ae. vittatus, 
Ae. dalzieli [369-371], Ae. neoafricanus, Ae. africanus, Ae. taylori [368, 372] and Ae. cordellieri 
[373]. 
A range of Aedes species and other mosquito species have been implicated in transmission 
on field and/or laboratory grounds in different parts of the world. These include,  
− In Europe: Ae. caspius, Ae. detritus, Ae. vexans [374, 375], Ae. japonicus [376], Anopheles 
(A.) maculipennis [375], Cx. pipiens [374, 375],  
− In Africa: Cx. horridus, Cx. quinquefasciatus and Mansonia (Mn.) africana [369] 
− In the Asia-Pacific region, Ae. hensilli [377], Ae. Polynesiensis, Cx. Fatigans [378] and A. 
stephensi [379]. 
In New Zealand, three species have shown vector competence to become infected and to 
transmit CHIKV under laboratory conditions include Op. fuscus (highly competent), Ae. 
antipodeus and Ae. notoscriptus [27]. 
Reservoirs: During most of the epidemic periods, humans serve as CHIKV reservoir. Outside 
of these periods, the primary reservoirs are mainly monkeys, including African green monkeys 
(Chlorocebus sabaeus), Guinea baboons (Papio papio) and patas monkeys (Erythrocebus 
patas) [380, 381]. CHIKV and/or anti-CHIKV neutralizing antibodies have been detected in 
other wild caught vertebrates including sub-human primates (chimpanzee, gorilla, Baboon 
and orangutan) [382-384], rodents, galagos, squirrels, bates and birds [380]. Outbreaks may 
occur in monkeys; the animals develop viraemia but without physical symptoms [383, 384]. 
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Disease burden and distribution 
Global burden: During the 1960s and 1970s, CHIKV has been identified as the causative agent 
of sporadic outbreaks in Africa and Asia [385]. Localised activity has been recorded from the 
1980s until 2004 in Africa, when an outbreak took place in Kenya, spreading during 2005 to 
Comoros, La Reunion and to other islands in the Indian Ocean, causing about 500,000 cases 
[235, 386]. In 2006-2009, CHIKV expanded its geographic range to India with an epidemic 
causing an estimated 1.5 million human cases and subsequently spread through South-
eastern Asia to the Pacific region by 2011 [235, 387, 388]. Because of the serious expansion 
and re-emergences of CHIKV outbreaks, the virus is recognized as a major emerging, 
epidemic-prone pathogen by the public health community [387].  
In 2007, transmission was first reported in Europe in north-eastern Italy [389], followed by an 
outbreak in south-eastern France three years later [390]. These outbreaks suggest the 
considerable potential of the virus to spread to new areas, including Europe, Australia, New 
Zealand and the Western Hemisphere [235]. Only travel-related cases had been recorded in 
the Western Hemisphere [391-393], with no evidence of local transmission, until December 
2013 when the first known autochthonous transmission of CHIKV occurred on the island of 
Saint Martin. Within the next four months, numerous other Caribbean Islands reported more 
than 31,000 confirmed and probable locally acquired cases [235]. CHIKV was locally 
transmitted for the first time in the U.S (Florida). in 2014, with 11 cases [394]. 
To date, 103 countries and territories have reported Chikungunya cases (25 Africa, 20 Asia, 2 
Europe, 46 Americas, and 10 Pacific islands) [395] (Figure 7), with about more than 4 million 
cases only in the past 12 years [396]. In 2019 and 2020, no local transmitted cases of CHIKV 
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were reported in Europe. As of July 2020, while no updates were available for the outbreaks 
previously reported in Africa, ongoing autochthonous transmission has been detected in 
Americas and the Caribbean (Brazil, Venezuela, Costa Rica, Mexico, Peru, Colombia, Paraguay, 
El Salvador, Nicaragua, and Honduras) with more than 49,000 cases (99% in Brazil) and 13 
deaths; and in Asia (India, Malaysia, and Thailand), with about 5,500 cases and no deaths 
[397]. 
 
Figure 7: Global distribution of Chikungunya cases (Source: [395]) 
Pacific region burden: Local transmission of Chikungunya was not reported in the subtropical 
South Pacific region before 2011 [398], when it was identified in the Pacific in New Caledonia 
[398, 399]. In late 2014, widespread large outbreaks were reported in the Pacific Islands [24, 
25]. In 2012-2013, the African ECSA lineage of the virus was responsible for the largest 
epidemic in the Region in Papua New-Guinea, with estimated tens of thousands of cases [25]. 
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While the Asian lineage of the virus caused the outbreaks in New Caledonia in 2013 [25, 400] 
and the Yap State in 2013-14 [400]. To date, CHIKV is not endemic in Australia without any 
locally-acquired cases recorded [401]. However, a dramatic increase in imported cases of 
Chikungunya has been reported in the past 15 years, particularly among those who have 
visited South-east Asia and Pacific Islands [402, 403]. Since major outbreaks in the Cook and 
Marshall Islands during 2017 [404], the Pacific region, as of July 2020, has not reported any 
autochthonous transmission cases [397]. 
2.2.2.3 Zika  
Overview: ZIKV is a single-stranded RNA virus belonging to the Flaviviridae family (genus 
Flavivirus) [405, 406]. The majority of ZIKV infected cases are asymptomatic, with only 20% of 
the patients showing signs and symptoms similar to those of DENV and CHIKV infections [407, 
408]. Incubation typically ranges from 2-12 days after the Aedes mosquito bite before the first 
symptoms appear. Symptoms are generally mild and last for 2-7 days and commonly include, 
but are not limited to, a sudden onset fever, maculopapular rash, red/pink eyes (nonpurulent 
conjunctivitis), muscle and joint pain (arthralgia), headache and malaise [408-410]. Vertical 
transmission of ZIKV from an infected mother to a foetus or infant has also been reported. 
This can be either antenatal/congenital/intrauterine (transplacental transmission during 
pregnancy) or perinatal (weeks immediately before or after birth) [411]. Severe neurological 
malformations have been detected among infants born to infected mothers, including 
Guillain–Barré syndrome (GBS) [412, 413] and congenital microcephaly [414]. ZIKV has been 
detected in vaginal fluids, semen, breast milk, urine and saliva. ZIKV can be transmitted 
through vaginal and anal contact, as well as the sharing of sex toys [415]. In New Zealand, one 
case of Zika has been reported, with the infection locally acquired via sexual transmission 
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[416]. The risk of sexual mode of transmission can be reduced by using barrier methods 
(condoms). While the virus can be transmitted through oral sex, risk from deep kissing is very 
low [415]. 
Due to the non-specific presentation of its symptoms and its clinical resemblance to other 
Flaviviruses, ZIKV detection and diagnosis are complicated and challenging. Zika infection is 
best diagnosed serologically by the detection of ZIKV RNA in saliva, urine, serum or semen 
samples via PT-PCR (reverse transcriptase polymerase chain reaction) assay or by the 
detection of ZIKV IgM antibodies in serum samples of the patients [417, 418]. 
There are currently no specific treatments, antiviral therapy or licensed vaccine available for 
Zika infection. However, several vaccine candidates are currently in development and clinical 
trials. As symptoms are mostly self-limited (commonly resolve in 2–7 days), the management 
is generally supportive and can involve bed rest, increased intake of fluids, and use of 
analgesics and antipyretics for relief of pain and fever. The preventive measures include 
mosquito vector control (biological, chemical, environmental management), adopting 
personal precautionary measures and behaviours against mosquito bites and avoiding travel 
to endemic and epidemic areas.  
Vectors, reservoirs and transmission: ZIKV is maintained in two transmission cycles: (i) the 
sylvatic (wild) cycle between non-human primates (NHPs) and canopy-dwelling mosquitoes 
(e.g. Ae. luteocephalus , Ae. dalzieli, Ae. furcifer, , Ae. vittatus, Ae. hirsutus, Ae. taylori, Ae. 
unilineatus Ae. metalicus, , An. coustani, Ae. opok, Ae. africanus Ae. bromeliae, Mansonia 
uniformis and Cx. perfuscus), (ii) the urban cycle between human (as an amplification host 
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and reservoir) and predominantly anthropophagic urban Aedes mosquitoes (as vectors) 
(mainly Ae. aegypti and Ae. albopictus mosquitoes from all continents and Ae. polynesiensis 
and Ae. hensilli from the Pacific Islands) [377, 406, 409]. 
Phylogenetically, ZIKV has two geographically distinct lineages: Asian and African [419]. The 
African ZIKV is primarily maintained in sylvatic cycles with humans as occasional hosts, while 
in Asia the virus is predominantly maintained in the urban cycle including humans as the 
primary host [419]. ZIKV antibodies have been isolated from large mammals (e.g. orang-
outangs, elephants, zebras) and rodents [420]. The reservoir role of these animals and the 
competence of canopy-dwelling mosquitoes in transmitting ZIKV to humans are incompletely 
identified and need more research [406, 421]. 
Identification of Ae. aegypti and Ae. albopictus as the primary ZIKV vectors is confirmed by 
repeated virus isolation from field-collected mosquitoes [259, 422-429]. Ae. aegypti and Ae. 
albopictus also have the potential to retain ZIKV in their eggs via transovarial and trans-egg 
transmission [409, 422, 423]. ZIKV can also be transmitted horizontally from males which have 
(acquired the virus vertically) to non-infected females during mating [409]. Zika can also pass 
directly from human to human through sexual intercourse [430] [431], blood transfusion 
[432-434], breast feeding [435], saliva [436], and urine [431]. 
In the laboratory, the ZIKV transmission role of several mosquito species remains 
controversial. In the Americas, for example, many experimental infections have indicated that 
Cx. pipiens [437-439], Cx.quinquefasciatus [428, 439-442] and Cx. tarsalis [438] are not 
competent vectors for ZIKV. A study in Brazil, however, found that Cx. quinquefasciatus is able 
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to transmit ZIKV [429]. Furthermore, Ae. taeniorhynchus, Ae. triseriatus, An. stephensi and 
An. gambiae in the US were found not able to transmit ZIKV [437, 443]. Notably, despite their 
low transmission potential, Ae. vexans mosquitoes from Colorado are competent ZIKV vectors 
[444]. In Africa, Ae. luteocephalus, from Senegal, was shown to be susceptible to ZIKV, but 
only a small number of Ae. vittatus and Ae. luteocephalus mosquitoes were able to transmit 
the ZIKV [445]. In Asia, Cx. quinquefasciatus from China has been implicated as a ZIKV vector 
[276], but this unexpected result was not confirmed using the Singaporean strain [446].  
In Australia, using an African lineage of ZIKV, Ae. notoscriptus, Ae. vigilax and Ae. procax 
showed no transmission until day 14. Surprisingly, Ae. aegypti also showed a low ability to 
transmit the same ZIKV strain. However, Ae. albopictus and Ae. aegypti showed a high 
transmission rate of the Asian lineage of ZIKV, whereas Cx. quinquefasciatus, Cx. annulirostris, 
and the local Aedes species (Ae. notoscriptus and Ae. (Ochlerotatus) camptorhynchus 
(Thomson) ), as demonstrated by molecular methods, were identified as having low or no 
dissemination potential [260, 409]. 
Disease burden and distribution 
Global burden: ZIKV was first detected in 1947 in the blood of a Rhesus monkey during a YFV 
surveillance in the Zika Forest in Uganda. Zika translates to “overgrown” in the local language 
(Luganda) [447]. In 1948, the first isolate from a ZIKV vector was obtained from Ae. africanus 
collected from the same forest [448]. The first human cases of Zika were detected in 1952 in 
Tanzanian and Ugandan [449]. Two years later, the first human Zika virus isolate was obtained 
from a young girl in Nigeria [450]. Over the next 60 years, only a few naturally acquired human 
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cases were recorded worldwide, by virus isolation, all in a narrow belt of countries stretching 
across tropical Asia and Africa [451]. 
In Africa, ZIKV was detected in Burundi, Togo, Djibouti, Senegal Ethiopia, Nigeria Somalia, Mali 
Mozambique, Ivory Coast, Sudan, Uganda, Guinea Bissau, Kenya, Chad, Madagascar, 
Cameroon Seychelles, Burkina Faso, Angola, Tanzania, Zambia, Benin, Sierra Leone, Central 
African Republic, Gabon, Republic of Congo Liberia, Cabo Verde, and Niger [409].  
In Asia, it has been suspected that ZIKV had been circulating from 1954 in Vietnam, Thailand, 
Malaysia, and Philippines [452-454] and in the early 1980s in Indonesia [409, 455, 456]. Zika 
was not recognised as a major public health concern during this period. In 2007, however, 
this situation has been changed when the first outbreak outside Asia and Africa took place on 
the Yap Island (affecting about 73% of more than 11,000 residents) [457]. According to 
Shragai et al. “this key epidemiological event was viewed as an isolated oddity by many 
scientists at the time, but it was quickly followed by movement of ZIKV across the Pacific 
islands between 2013 and 2014” [458]. Zika was detected a one year later in Brazil [459]. 
On Feb 1, 2016, WHO declared Zika infection to be a “Public Health Emergency of 
International Concern”, due the rapid spread of the virus throughout the world [460, 461]. 
The WHO, CDC and the ECDC developed a classification scheme to classify the risk of exposure 
to ZIKV in known countries and areas [462]. Four categories of ZIKV transmission were defined 
[462] (Figure 8).  
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As of August 2020, there were no reports of ZIKV transmission by mosquitoes around the 
globe [463]. The most recent cases were reported in Brazil (June 11, 2020) [464], Peru, 
Colombia and Mexico (March 16, 2019) and Thailand (March 12, 2019) [465].  
 
Figure 8: Current Zika transmission worldwide ( Source: [466]) 
Pacific region burden: In 2007, Yap Island, Micronesia, in the North Pacific, experienced the 
first ZIKV outbreak outside Africa and Asia [238, 392, 457]. No further epidemics were 
reported in the Pacific until October 2013, when the Asian lineage of ZIKV caused a major 
outbreak in French Polynesia [238, 467]. This was followed by outbreaks in the Cook Islands 
Easter Island, and New Caledonia [24, 467]. There are many reported cases of ZIKV in 
Southeast Asian countries where the virus may have been present for several years at low 
levels [468]. In Australia, no cases of locally-acquired ZIKV virus have been recorded to date 
and the virus is not known to be present in local Aedes mosquitoes [469]. However, between 
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2013 and 2017, 568 confirmed infections were recorded in Australia, all acquired overseas 
[229]. 
ZIKV transmission in other Pacific countries is likely high. This is due to the mild clinical signs, 
poor diagnostic capacity, and overlapping symptoms of Zika, dengue, and chikungunya 
infections [467]. As of August 2020, there was no evidence of an ongoing ZIKV outbreak in the 
Pacific region [463]. The most recent confirmed cases in the region were reported in April 
2019 by the Australian health authorities among returning travellers from Fiji and Vanuatu 
[465]. 
 
Figure 9: Zika transmission in Asia-Pacific region as of October 2017 (Source: [470]) 
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2.2.2.4 Ross River virus infection 
Overview: RRV is an arthropod-borne virus of the Alphavirus genus (Togaviridae family) that 
is endemic in Australia and Papua New Guinea [287-291]. RRV disease is not fatal and 55-75% 
of cases are asymptomatic. However, it can cause considerable morbidity, debilitating joint 
pain and disability lasting for months [81, 286, 471]. Following a 3-21 day incubation period, 
the most common signs are arthralgia (usually of the peripheral joint) fatigue, fever, and a 
maculopapular (flat and raised lesions) rash. The majority of symptomatic cases undergo joint 
pain. Symptoms typically resolve within four weeks, but it may take over a period of 3-6 
months to return to full physical activity [286]. Ross River fever is most common in patients 
who are aged 20-60, and symptoms are relatively uncommon in children [240]. 
Initially, the syndrome caused by the RRV was called “epidemic polyarthritis” [286, 472], but 
this term was also used for Barmah Forest virus infection [473]. Later, “Ross River fever” has 
appeared and been used by the public [474]. More recently it has become known as “RRV 
disease” [291]. The latter term was introduced by Marshall and Miles [474], supported by 
[475] and is justified for the fact that not all symptomatic infected cases will have joint pain 
and fever; 83 to 98% of patients have the former, while 20 to 60% have the latter [475-479]. 
RRV disease has a considerable social and financial burden on patients and their families. An 
Australian epidemiological study estimated the direct cost burden of illness to be around 
AU$4000 per patient [480]. The annual cost of RRV infections in Australia alone in 2001 was 
conservatively estimated to be between about 3 and 6 million AUD [286]. However, this 
estimate does not account for mosquito control or public health surveillance or all diagnostic 
and medical costs [481]. Immunization, therefore, may provide a cost-effective intervention 
65 
[480], but no vaccine or treatment options are currently available [481, 482]. A candidate 
vaccine for RRV exists [481, 483, 484], but the cost of vaccine trials is difficult to justify for a 
non-fatal disease that is endemic in only two countries [286]. Therefore, current prevention 
actions rely primarily on mosquito-prevention and control practices, while treatment usually 
involves supportive care, general painkillers and anti-inflammatories -to reduce symptoms 
[286, 481].  
Mosquito vectors: RRV was first isolated in 1966 in Australia from Ae. vigilax mosquitoes 
collected in 1959 [485]. Since that time, the virus was isolated from about 41 Australian 
mosquito species belonging to six genera comprising of 23 Aedes, five Anopheles, six Culex, 
three Mansonia, three Verrallina and one Coquillettidia species. More than 30 species have 
also been implicated in RRV transmission on epidemiological grounds [240]. The main 
competent mosquito vectors in Australia are Ae. vigilax and Ae. camptorhynchus (in coastal 
regions), Cx. annulirostris (in tropical areas and temperate regions) and Ae. sagax (in arid 
areas) [472, 486, 487] and Ae. notoscriptus in tropical and subtropical regions [488]. In the 
Pacific Islands, various geographic strains of local Aedes mosquitoes were capable of 
transmitting RRV, including, Ae. aegypti, Ae. albopictus, Ae. pseudoscutellaris, Ae. 
polynesiensis, Ae. tabu and Ae. tongae [489, 490]. 
In New Zealand, six species have shown RRV vector competence under laboratory conditions: 
Cx. pervigilans, Cx. quinquefasciatus, Op. fuscus, Ae. antipodeus [27], Ae. australis [27, 264]) 
and Ae. notoscriptus [264]. 
66 
Vertebrate reservoir hosts: In Australia, macropod marsupials such as wallabies and 
kangaroos are thought to be most significant natural reservoir hosts for RRV [289, 473, 486]. 
However, other domestic and wild animals, including flying foxes (fruit bates) [81, 491, 492], 
horses [493] [81], rabbits [81, 492], possums [494], dogs and cats [495] have been implicated 
on serological and/or epidemiological grounds as urban reservoirs for human infection. 
Humans also are believed to be the vertebrate hosts and the distributors of the virus in 
epidemic periods across the Pacific Islands and other macropod free regions [286]. 
Australian brushtail possums (Trichosurus vulpecula) were introduced to New Zealand several 
times in the late 19th to establish a fur industry. However, they have no natural predators, 
parasites or competitors for food and shelter. This ideal habitat has made New Zealand land 
ecosystems significantly more productive than those in its home (Australia). New Zealand has 
more than 60 million animals occupy around 97% of its land area with about 10-12 
animals/hectare compared to less than 1 animal/hectare in Australia [13, 496]. Brushtail 
possums in New Zealand are a current reservoir for “bovine tuberculosis”, which is a major 
problem for the dairy export industry [497], and are a potential concern for human health as 
reservoir hosts for RRV [494, 498].  
The continuation of the endemic circulation of RRV in Fiji’s 1979-1980 major outbreak, despite 
the absence of major amplifying animal hosts, added to earlier implications that RRV can be 
maintained as a rural infection via domestic animals [499]. RRV has been identified in different 
mammalian hosts in Fiji [500], including bats [81, 491, 492], horses [81, 493], rabbits [81, 492], 
dogs and cats [241, 495]. 
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Disease burden and distribution 
Australian burden: The first reported outbreak of RRV was recorded in 1928 in Narrandera 
and Hay in New South Wales, Australia [501]. Fifteen years later, epidemics of arthralgia and 
arthritis were described during the Second World War among soldiers in the tropical regions 
of Northern Territory and Queensland [502-505]. The first isolate of the RRV from a human 
was reported in 1972 from a young boy from North Queensland, who had a febrile illness but 
no arthralgia or arthritis [506]. It was not until 1985 that RRV was isolated from a patient from 
Australia with typical symptoms of polyarthritis [507]. Outbreaks have since occurred 
intermittently in all Australian states and territories, including rural and urban areas. Rural 
areas included Griffith region [477], Bunbury region [508] and Gove region [509], while urban 
centres included Perth [508], Brisbane [510], Sydney, Melbourne, and Hobart [81, 511, 512] 
and Adelaide [513]. The disease transmission peaks in the warm months between December 
and May. 
From 1991 to 2014, more than 112,000 laboratory-notified cases were reported in Australia 
(Table 3). During this period, about 5000 notifications of RRV disease were reported annually, 
peaking at around 8,000 in the 1996 epidemic. The incidence of RRV disease in Australia varies 
regionally [479]. Most of the cases were reported by Queensland (55.5%), New South Wales 
(14.5%) and Western Australia (12%) [240, 514]. In general, the virus is endemic in all states, 
however Queensland has almost three-times more cases reported annually than any other 
state. While case notifications are generally thought to be an underestimate, those prior to 
1990 also involved less efficient diagnosis and reporting systems [240]. 
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Pacific Island burden: Outside Australia, RRV is also endemic in Papua New Guinea [287-291] 
and was recently discovered in American Samoa [241]. As there are no marsupials in American 
Samoa, this suggests that domestic and wild animals are capable to act as reservoir hosts and 
implies the RRV potentially circulates over a greater area than those currently recorded [241].  
Table 3: RRV cases reported by Australian states/territories*, 1991-2014 [240, 515] 
Year ACT NSW NT QLD  SA TAS VIC WA Total Ref. 
2013-14  5 509 434 1,845 111 19 161 1,485 4,569 [515] 
2012-13 5 502 211 1,683 177 6 190 1,081 3,855 
2011-12  8 556 219 1,788 222 19 272 1533 4,617 
2010-11  11 658 263 1,397 1,154 9 1,334 827 5,653 
2009-10  20 1139 323 2540 391 41 351 343 5,148 
2008-09 8 937 413 2,116 234 25 104 1,021 4,858 
2007-08 20 1,220 255 2,906 196 77 237 836 5,747 
2006-07 0 674 263 1753 28 0 21 397 3,136 
2005-06 10 1275 267 7561 773 46 594 3254 13,780 
2004-05 14 773 233 1717 271 11 375 236 3,630 
2003-04 4 441 180 1013 50 5 38 144 1,875 
2002-03 0 453 134 2391 20 2 14 146 3,160 
2001-02 0 217 71 944 57 120 43 130 1,582 
2000-01 14 773 233 1717 271 11 375 236 3,630 
Tot. (2001-2014) 119 10127 3499 31,371 3955 391 4109 11,669 65,240 
Average (case 
/year) 
8.5 723.36 249.92 2240.79 282.50 27.93 293.50 833.5 4660 
% 0.18 15.52 5.36 48.10 6.1 0.60 6.30 17.89 100 
2000 15 721 153 1421 375 8 316 1225 4234 [240] 
1999 7 1069 142 2279 48 67 265 530 4407 
1998 6 508 121 1950 61 9 112 327 3094 
1997 9 1642 223 2382 660 14 1057 699 6686 
1996 1 1041 131 4935 25 74 138 1478 7823 
1995 2 242 369 1681 23 28 35 302 2682 
1994 1 317 309 3035 26  N/A 58 95 3841 
1993 4 596 264 2367 774 N/A  1198 153 5356 
1992 1 317 238 4280 106 N/A  162 687 5791 
1991  N/A 402 482 1954 N/A  N/A  390 192 3420 
Tot. (1991-2000) 46 6855 2432 26,284 2098 200 3731 5,688 47,334 
Average (case 
/year) 
5.11 685.5 243.2 2628.4 233.11 33.33 373.1 568.8 4733.4 
% 0.097 14.482 5.137 55.52 4.43 0.422 7.88 12.01 100 
 
*Australian Capital Territory (ACT), New South Wales (NSW), Northern Territory (NT), Queensland (QLD), South Australia (SA), 
Tasmania (TAS), Victoria (VIC), Western Australia (WA) 
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The Pacific region experienced a large RRV outbreak in 1979-1980, affecting more than 
500,000 people. The epidemic involved the islands of Fiji (90% of population infected) [471], 
the Cook Islands (69% infected) [516], American Samoa (44% infected) [517], New Caledonia 
(33% infected) [518], and probably also Western Samoa, Kiribati and Tonga. The epidemic was 
initiated by a traveller from Australia to Fiji [240, 472, 474].The virus seems to have 
disappeared from the region, although there have been recent reports of infected New 
Zealanders [23] and Canadians returning from Fiji [519] and Germans who travelled to the 
South Pacific in 1999 [520].This is suggesting an ongoing transmission and a probable 
reintroduction of the virus to the Pacific region from the neighbouring endemic areas of 
Australia, Solomon Islands  and Papua New Guinea [19, 241, 521]. The identification of any 
new outbreaks in the Pacific region is likely to be delayed due to the limited public health 
capacities and laboratories facilities, as well as the misdiagnosis of RRV as Chikungunya, Zika, 
dengue, or other arbovirus diseases [23].  
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2.3 Review Three: Risk modelling of mosquito-borne diseases 
Anticipation and prevention of vector-borne disease epidemics depends on regular 
monitoring and analysing of the related entomological, epidemiological and environmental 
surveillance data [313]. However, this information alone does not constitute early prediction, 
but provides a means to detect outbreaks [29]. Arbovirus complex transmission dynamics, 
involving various intrinsic and extrinsic risk factors, pose challenges for predicting their 
emergence and re-emergence without using a multi-system approach within a quantitative 
framework, such as disease/risk modelling [522]. 
Disease modelling is a rigorous multi-system approach that seeks to predict location 
(geographical pattern) and/or timing (temporal pattern) of future course of disease outbreaks 
within a quantitative framework by linking infection dynamics (e.g. disease geographic range, 
vector/reservoir co-occurrence) with correlated surveillance covariates (i.e. predictors), such 
as epidemiological (e.g. disease notifications), entomological (e.g. mosquito occurrence), 
environmental (e.g. temperature records), and social (e.g. type of households) variables. 
Disease modelling economises resources, improves health outcomes, and designs and 
evaluates prevention and control strategies [34, 35], as well as provides the foundation to 
develop EWSs. The construction of precise validated models relies on the availability and 
quality of historical field records. 
Using mathematical language to describe infectious diseases dynamics started as early as 
1766, when Daniel Bernoulli described the effects of smallpox inoculation (a smallpox 
immunization technique) on life expectancy using mathematical life table analysis [523]. 
However, only by the 20th century, was the nonlinear nature of infectious diseases was 
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better understood [524]. In 1908, Sir Ronald Ross [525], the Nobel Prize winner for 
elucidating the malaria parasite life cycle, published his first malaria transmission model 
[134]. This was later extended by George Macdonald in the 1950s [526]. Since then, with 
increasing computing power and greater data accessibility by the 20th century, computer 
modelling has become an increasingly integral tool in in public health [527]. This includes 
designing and improving control strategies, understanding transmission mechanisms and 
forecasting disease outbreaks [92, 528]. For example, different modelling approaches were 
successfully used in surveillance, control and treatment programmes of the global AIDS 
pandemic in 1980-90s, the UK livestock foot-and-mouth infection in 2001 [529] and the global 
outbreak of SARS in 2002 [530]. 
2.3.1 Modelling approaches  
Models applied in epidemiology are frequently divided into two approaches, statistical (syn. 
correlative, empirical, phenomenological), which is based on deriving an occurrence 
probability from climatic/ecological variables [327] and mathematical (syn. mechanistic, 
process-based), which is based on the usage of a mechanistic approach to parameterize 
vector biology [531]. Recently, by combining mechanistic and correlative approaches, “hybrid 
models” have been developed to improve projections of species distributions [532]. 
2.3.1.1 Statistical approach 
a. Definition 
Vector distribution has been modelled based on correlative species-environment 
relationships [51]. This approach links environmental variables directly with species 
abundance or occurrence [532]. Occurrences records of a species suggest that this species 
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can develop, survive and successfully reproduce in that location under specific environmental 
conditions [533]. In addition to species occurrence in “geographical space” (plotted on a 
map), occurrence in “environmental space” should be considered. The concept of 
environmental space is well explained by the “ecological niche theory” [534]. According to 
Hutchinson (1957) [535], “fundamental niche” of a species is a conceptual space defined by 
all environmental conditions where a species is able to persist and survive”. 
“Occupied/realized niche”, however, is where the species actually lives. In other words, 
plotting the actual distribution in environmental space identifies the “occupied niche”, while 
plotting environmental conditions encapsulated within the fundamental niche identifies the 
“potential distribution”[51, 534]. Therefore, potential distribution and habitat preference 
(niche) of a species in unsampled areas can be identified by correlating species occurrences 
records (presence-absence or presence-only) statistically with georeferenced environmental 
[climatic (e.g. temperature, humidity, precipitation), and/or land surface (land use/land 
cover; LULC)] predictors associated with species occurrence. This can be done even if areas 
of actual occurrence (the occupied niche) of the species are very limited [536]. Depending on 
the perspective taken, these models are also commonly referred to as Species Distribution 
models (SDMs), Ecological Niche Models (ENMs), Habitat Suitability Models (HSMs), and 
when used only with climate variables, Climate Matching Models (CMMs) and Climate-
Envelope Models (CEMs) [50, 534, 537]. The main stages required to develop and validate a 
correlative SDM are outlined in Figure 10. 
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Figure 10: Major steps needed for developing and validating a correlative SDM (Source [534]
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The methodological approach can be summarized as follows: (i) at a specified resolution, the 
area of study is modelled as a  map of grid cells, (ii) collecting model inputs (occurrence and 
environmental data) to define the characteristics of each cell, (iii) the two inputs are fed into 
a statistical model to identify environmental factors associated with species occurrence 
(algorithms that are able to incorporate interaction among variables and integrate more than 
two variables are preferable [534]) (Equation 6), and (iv) a map can be constructed by showing 
the degree of suitability of each unoccupied location/cell either by predicting a continuous 
environmental suitability values from 0 to 1 or suitable/unsuitable binary prediction [534, 
538]. 
y = f1(x1) + f2(x2) + f3(x3)……………………Equation (6) 
Where y is the probability of occurrence of a specie and xn is the environmental variable (e.g. 
x1 is temperature, x2 is vegetation index, x3 is rainfall). 
The degree of equilibrium between species’ occurrences and environmental variables is a 
critical factor when considering the correlative approach to estimate the niche and potential 
distribution of a species. A species is considered to be at equilibrium with physical habitat if 
they occur in all abiotically suitable environments (niche), and are absent from all unsuitable 
ones [535]. Absence of species in regions of the potential distribution can be attributable to 
presence of biotic (e.g. absence of a food source or presence of a competitor) or geographic 
(e.g. mountain) barriers, insufficient time for dispersal or anthropogenic activities (e.g. 
landscape modifications, active control measurers).  
75 
On the other hand, individuals of a given species may occur outside its fundamental niche by 
a process known as “source-sink dynamics”. It refers to dispersal of a species from an area 
that supports a viable population (source/occupied niche) to a nearby area of unsuitable 
environmental conditions (sink) [539]. This situation is expected to occur most often in 
organisms with high dispersal rate. As correlative SDMs use actual occurrence data of species 
to estimate habitat suitability, inclusion records from sink populations is a source of potential 
error. However, this problem is commonly overlooked by assuming that records from source 
populations will be more frequent than records from sink populations [534]. 
As functional features (e.g. dispersal barriers) cannot be included in this approach, 
environmental suitability is difficult to convert to a probability of occurrence. However, 
correlative models could be used to represent the ability of a species to survive if it was 
introduced to a particular location [92]. Yet, correlative approaches have been applied in a 
wide range of contexts [540, 541], including biosecurity and epidemiology by predicting 
species distributions in new regions (e.g. predicting exotic species invasion/reintroduction 
[542-544]), or for another time period (e.g. predict impacts of climate change on a mosquito 
vector distribution [545-547]), forecasting glacial refugia (e.g.[548], [549]), delimiting species 
(e.g. [550], [551], [552], [552]), conservation planning (e.g. discovery of new population of a 
known species/natural colonisation [534]), detecting modes of speciation (e.g. [553]), and 
evaluating biodiversity (e.g. [554]), examining niche evolution (e.g. [555], [556]), and 
informing taxonomy (e.g. [557]). 
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b. Developing an SDM  
Data type and sources 
Correlative SDMs use two types of input data, they are biological data, which are species’ 
known occurrence records, and environmental data, which are the abiotic (climatic and LULC) 
components in which the species is found. Biological and environmental data used for SDMs 
are commonly stored, viewed and formatted in Geographic Information System (GIS). GIS is 
used to manipulate geographic reference systems (occurrence records and environmental 
variables at the site should be georeferenced to a mutual coordinate system), change the 
spatial resolution, interpolate point locality data to a grid and visualize model output [534, 
558]. 
According to Pearson (2007), the data can be stored in three forms: as point localities (called 
“point vector” data, such as known occurrence sites of a species, or weather station 
locations), as polygons representing an area (called “polygon vector” data, such as areas with 
different urban structures) or as a grid of cells (called “raster data”; such as LULC from remote 
sensing imagery). For use in a SDMs, it is usual to format/reformat all data to the same raster 
grid (e.g. spatial interpolation of daily weather records from weather stations [559]. This 
ensures that environmental data are available for all cells where biological data were 
recorded [534]. These cells (containing weather and biological data) are used to construct 
SDMs. After model construction, predictive performance of the model is evaluated (i.e. model 
validation). If the predictive ability is evaluated to be acceptable (i.e. outputs of the model 
have enough reliability to the real data-generating process) [560], species occurrence in cells 
containing only environmental data can be predicted. 
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Biological data: The known distribution records data of a mosquito species can be obtained 
from various sources, including scientific field studies, personal collection, national 
surveillance programmes, museum collections or online resources (example source: Global 
Biodiversity Information Facility: www.gbif.org) [534]. Species distribution data are either 
presence/absence (records of locations of confirmed negative and positive occurrence of the 
species) or presence-only (i.e. records of locations of only confirmed positive occurrence of 
the species) [561]. Absence data can enhance the prediction performance of the models 
[540]. However, confirmed absences are hard to obtain, especially for mobile species like 
mosquitoes, as they require intensive sampling effort to ensure their reliability [562]. Hence, 
presence-only models have been widely used to manage the lack of confirmed absences 
[563].  
In turn, two main types of presence-only models can be distinguished according to occurrence 
input data: 1) models that reply exclusively on truly ‘presence-only’ data (i.e. predicting 
without referring to any other sampling locations from the study area), and 2) models that 
use artificial absences, which often referred to as background or pseudo-absence data. 
Models that use presence/background data depend on relating locations where the species 
has been recorded (i.e. presences) to the rest of the study area (i.e. background); while 
models relying on presence/pseudo-absences aim to assess differences between localities of 
actual presence and other localities from the study area that are used as a substitute for 
actual absence data. This method is useful when the species was not recorded despite the 
positive suitability of the habitat, or when the species could not be identified although it was 
present [534].  
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In general, any presence/absence models can be applied using pseudo-absences. Pseudo-
absence records can be selected randomly (e.g. [564]) or systematically (e.g. [565], [566]). A 
key difference between the background method and the pseudo-absence method is that the 
latter do not comprise occurrence records within the pseudo-absence set. As using pseudo-
absences data may bias analyses, they should be used carefully [538]. Additional potential 
sources of error and bias may include incorrect mosquito species identification, imprecise 
geographical referencing of samples, and collecting larvae from easily accessible waterbodies 
(e.g. along rivers) [563]. When using records from online resources, personal or museum 
collections, the purpose of the collection should be considered (e.g. sampling for museum 
and herbarium collections is likely to be biased toward unknown and rare species rather than 
determining the species spatial distribution) [534]. 
Environmental data: Many environmental input variables have been used in SDMs, including 
climate [example sources: (WorldClim; https://www.worldclim.org), IPCC; 
https://www.ipcc.ch, NOAA), topography [example source: (United States Geological Survey; 
https://www.usgs.gov)], soil type [example source: United Nations Environment Programme; 
https://www.unep.org)] and LULC [(example source: (Global Land Cover Facility; https://un-
spider.org). Environmental variables can be either categorical or continuous data. Categorical 
data cannot be involved with many modelling algorithms. In these cases, it is possible to 
create a continuous scale from the categorical variables (e.g. [567]). 
Modern technologies, including GIS and remote sensing software have facilitated the 
dissemination of environmental variable inputs. Further, climate models have been used to 
simulate past climates (used to evaluate the predictive accuracy of models) and generate 
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scenarios of future climatic conditions (used to estimate the consequences of climate change 
on biodiversity) [534]. Considering the massive amounts of environmental data that can be 
collected, it is important to be critical in terms of the suitability of the variables that will be 
included in the model. While some studies have showed satisfactory predictive performance 
incorporating only three predictors (e.g. [568]), others have utilised many more predictors 
(e.g. Phillips et al. [569] used 14 environmental variables).  
Modelling algorithms:  
Many modelling algorithms are used to estimate the probability of occurrence of a given 
species as a function of given environmental variables. The model algorithm is the core of the 
SDM. However, it is one step among a broader modelling process [534]. According to species 
thresholds of occurrence (i.e. occurrence input data required by the algorithm), a number of 
different algorithms have been implemented. For example, Gower metric and climatic 
envelope require presence-only data, ecological niche factor analysis (ENFA) and MAXENT 
require presence/background data, and artificial neural networks (ANN) and generalized 
additive models (GAM) require presence/absence (or pseudo-absence) data. Similarly, model 
algorithms vary in their ability to incorporate categorical environmental data [534]. 
Further, model algorithms vary in the form of their output data. Output predictions are either 
continuous (e.g. a probability value between 0-1), which is most commonly used or binary 
(with 0 for unsuitable environment or species absence, and 1 for highly suitable environment 
or species presence). Further, the algorithms can be parametric (uses fixed number of pre-
defined parameters, simpler, computationally faster, but require more number of data 
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points) or non- parametric (computationally slower, but requires less data and, hence, takes 
fewer assumptions). 
Selection of “fittest” models 
Choice of model technique is mainly dictated by practical reasons, including knowledge of 
species biology and timetable, availability of field and laboratory information, project 
deadlines and availability of statistical/mathematical expertise [570]. Various studies have 
shown that conducting different modelling approaches will often result in substantial 
differences among predictions (e.g. [561, 571-576]). Many other factors are responsible for 
the varying predictions among alternative methods, including (i) availability of species 
occurrence data (presence-only, presence/absence, background or pseudo-absence data 
[561, 575, 576]), (ii) the approach for model calibration using model extrapolates [576], and 
(iii) if the model algorithm is parametric or non-parametric [573]. 
Elith et al. (2006) [575] compared 16 alternative modelling methods using 226 species from 
six regions of the world, making the most comprehensive comparison of models to date. The 
authors used presence‐only data for model calibration, while the presence/absence data 
were used to evaluate model performance. Although a significate difference between 
predictions was reported, some methods consistently performed better than others. In 
general, however, identifying models that are universally “best” or selection of the fittest 
model is both challenging and crucial. Model selection is influenced by many factors, most 
importantly the availability of environmental and biological (particularly actual absence) input 
data, and the purpose of the modelling [534]. For example, Elith et al. (2006) [575] evaluated 
predictive accuracy based on the ability of the model to estimate actual distributions. Pearson 
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et al. (2007) [536], on the other hand, assessed the fitness of the model by estimating 
observed presences, as the aim of the modelling was identifying potential distributions. In 
view of these factors, selection of the “best” method is not straightforward, and it is therefore 
difficult to favour one method over another. However, in general, models that were able to 
identify complex interactions among predictors (e.g. environmental and biological variables) 
are the models that evaluated as the best [534, 575]. Some authors consider this step (model 
selection) as the first part of model validation [577]. 
Model validation: 
Model validation is a crucial stage in model construction by which the accuracy of model’s 
predictions are evaluated and, therefore, the suitability of the model for a particular 
application is determined and compared with different modelling approaches [534, 560]. No 
particular validation approach has been widely preferred for use; rather, as in model 
selection, the choice of validation approach is affected by modelling aim, availability of the 
input data, and the modelling approach used [534]. Different strategies, however, can be used 
to assess predictive performance, including threshold-independent assessment, using 
suitable test statistics and strategies for obtaining test data. The latter is the simplest and 
most common method [534]. 
Test data (also called evaluation data) are data against which the model estimations are 
compared in order to assess the model predictive performance. Therefore, predictive 
performance can be evaluated based on the model’s ability to estimate the calibration data 
(data used to build the model; also called training data) [534]. Preferably, test data would be 
obtained independently from calibration data. Validation, therefore, can be undertaken using 
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independent test data set from different areas (e.g.[542, 578]), different time periods (e.g., 
[579]), data from surveys conducted by other researchers (e.g. [540]) or data at different 
spatial resolution (e.g., [580-582]). In practice, however, sometimes independent test data is 
not available. Therefore, partitioning available data into test and calibration datasets is 
common. A number of strategies are used for partitioning data. The simplest one is “one-time 
split” whereby the available data are divided either randomly (e.g. [583]) or spatially (e.g., 
[584]). The proportions of data included in each data set relatively vary depending on the 
total number of unique occurrence records available. Nevertheless, according to guidelines 
provided by Huberty (1994) [585], it is common to use 30% for testing and 70% for calibration. 
Another partitioning method is ‘bootstrapping’, in which the original occurrence records are 
repeatedly sampled with replacement. In other words, the same original occurrence data 
could be reused in the evaluation many times [534]. For example, by randomly selecting 150 
samples from 200 samples, and then return the selected samples before choosing another 
150 samples randomly. “Randomization” is another method similar to bootstrapping, 
however sampling is conducted without replacement (i.e. occurrence data are not reused in 
the evacuation more than one time) [586]. 
2.3.1.2 Mathematical approach 
a. Definition  
The mechanistic approach, on the other hand, uses biological/functional traits (physiological, 
behavioural and morphological) and associated life history (growth, development, 
reproduction, survival) of a vector species (derived from laboratory and field studies) to 
identify the range of environmental conditions that determine species’ distributions and/or 
infection patterns without relying on observed occurrence records [533, 537, 587]. Unlike the 
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correlative models, mechanistic models, according to Dormann et al., “formulate the ecology 
of a species as mathematical functions in a reductionist sense, defining causality; the species’ 
occurrence or abundance is an indirect, emergent consequence”. Important epidemiological 
parameters, such as vector development, survival rate, EIP, biting rates, mortality rates, 
strongly depend on temperature and rainfall [92]. This approach, therefore, is built on 
biophysical interactions between biotic (vector and pathogen) and abiotic (climatic and LULC) 
components [533, 588]. In other words, this approach is built on empirical data collected from 
laboratory and/or field studies to estimate vector proliferation (development, fitness and 
demography), and then combined with environmental, weather and/or socio-economic data. 
Hence, by using this dynamic approach, mosquito populations can be defined in spatio-
temporal patterns [589]. Mechanistic approaches, however, are subject to the same primary 
limitation as correlative models. They do not provide information on the actual areas 
occupied by the species, but identify areas with suitable environmental conditions, and 
hence, potential distribution [590]. Epidemiologically, this approach is mainly originated from 
the Ross–MacDonald model [283, 526]. 
In epidemiology, mathematical models can be stochastic (probabilistic) or deterministic. 
Stochastic epidemic models account for the mean trend, as well as the variance structure 
around it. As the population dynamics are ruled by a high level of uncertainty, stochastic 
modelling of an infection outbreak is important when the number of infectious individuals is 
small or when the variability in births, deaths, transmission, or recovery (demographic 
stochasticity), or the environment (environmental stochasticity) impacts the epidemic 
outcome [591-593]. Stochastic models are also used when knowledge of the risk factors 
influences on the disease risks are incomplete or imprecise, or if the ecological factors that 
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determine infection risks are difficult to be deterministic in nature [35]. While deterministic 
epidemic models are models with no element of uncertainty or chance. Accordingly, they only 
account for the mean trend of a process. [591, 594]. 
b. Developing a mechanistic model 
See Review One, Example 1, Section B. 
2.3.1.3 Hybrid approach 
While some SDMs are clearly located at the very ends of the “correlation–process 
continuum”, the majority can be placed somewhere in between, based on the extent to which 
they indicate processes explicitly (Figure 11) [532]. There is, as yet, no general agreement that 
defines “hybrid models”, in contrast with “integrated models”. However, the term “hybrid 
model” has been used to indicate the sequential application of different modelling 
approaches (i.e. adding dispersal data to the results of a correlative projection). In other 
words, the hybrid models use the mechanistic model (as a predictor) in the correlative model 
for predicting species’ habitat suitability [532, 533, 541]). This approach depends on the fact 
that species’ habitats are affected by complex interactions between physiological 
characteristics and climate factors [595] (e.g. [113]). Another example is the invasive Species 
Distribution Models (iSDMs). Invasive species, which are in a dynamic transition state within 
the invaded range, violate SDM's assumption that the species is in equilibrium with their 
environment [596, 597]. According to Srivastava et al. (2019) “fitting SDMs with existing 
biological/ecological knowledge of invasive species (i.e. hybrid models), would improve the 
accuracy of model outputs through linking species dispersal traits with predictions of species 
distributions” [598].  
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Figure 11: “The correlative–process model continuum”. In the ends, some correlative SDMs do not 
require any ecological knowledge to be used for species distribution maps (left). Hybrid SDMs use 
species distribution data for model calibration, but ecological knowledge are always included based 
on other studies. In the other extreme end, some process‐based SDMs can be applied without any 
data regarding species’ distribution as input data (Source: [532]). 
2.3.2 Strength and weaknesses of modelling approaches 
A common interrogation about quantitative models concerns their ability to be “right” or 
“true”. “All models are wrong, but some are useful” is the answer, stated by George P. Box 
[599] and it is now a motto among mathematical modellers [600]. All models are wrong 
because we never know the true state of nature. The relevant concern, therefore, is whether 
the model is useful. The pros and cons of models, especially correlative versus. mechanistic, 
are largely speculative [601].  
Correlative SDMs are faster and often easier to implement than the mechanistic ones, and 
more flexible in terms of data requirements. The model construction can be validated using 
a single and readily available dataset within a single analytical framework [533]. For instance, 
poorly studied taxa would be best modelled using a correlative approach as it requires little 
information on the biological links between organisms and their habitat [602, 603]. 
Correlative SDMs also convey more practical advantages because of their relative simplicity 
of use within open source packages (e.g. R-Package [604]) [533, 605]. With satellite imagery 
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and GIS-based descriptions, correlative approaches are ideal tools for producing habitat 
suitability maps (especially of large-scale patters) for species whose range is at equilibrium 
(e.g. well established species, species on an island), and for biosecurity, biogeography, 
biodiversity and conservation applications (e.g. [92, 605, 606]. Since they are correlative 
however, they are not good for extrapolation (i.e. prediction beyond the original observation 
range) and do not afford much data regarding causal mechanisms [533]. Further, statistical 
SDMs are limited in their inability to provide an explanation for predicted outcomes. In 
particular, they do not explain whether potential species range represents a direct 
relationship with the ecological variables, an indirect response medicated by a biotic 
interaction, or a confounding effect of another collinear variable absent from the model [533, 
587]. Another limitation for SDMs is that some models require, besides presence data, the 
knowledge of confirmed absence data, which can be difficult to obtain, and requires higher 
levels of surveillance [607, 608]. Instead, artificial absence data (usually called background 
data or pseudo‐absences) are commonly generated [608]. If the correlative data are limited 
over large areas, correlative SDM models suffer from under-reporting [589] and risk of 
observation and selection bias [547, 589]. Niche modelling is also influenced, indirectly, by 
socio-economic (e.g. urban status) and public health elements (e.g. vector control 
intervention), which in turn influence the occurrence (presence/absence) of mosquito vector 
(mainly Aedes sp.) [589]. Generally, estimations based on empirical models are restricted in 
their transferability to novel environments [532]. 
On the other hand, the mechanistic (process-based) approach is becoming more common 
[533], as it is potentially more accurate and robust in estimating species distributions than 
the more traditional correlative SDMs [609]. Since functional trait parameters are estimated 
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independently of the known (abundance/geographical range) data [533], process-based 
models can provide insights and understanding of proximate constraints limiting species 
abundance and distribution [602, 603]. For instance, this approach is useful for early warning 
of vector-borne diseases by assessment of recently introduced vectors (where occurrence 
data is limited) with actively expanding ranges (i.e. non‐equilibrium/novel circumstances), 
such as invasive species [533]. For more information about climate-based early warning 
systems for mosquito-borne diseases, see Appendix B. Complexity and input data-intensity 
are the main limitations for this approach [50]. Mechanistic models frequently need a large 
number of variables to be assessed, many demanding data of restricted availability at high 
spatial and temporal resolution. Errors in these parameters can compound causing poor 
accuracy in prediction. Further, these models, regarding species distribution, are typically 
designed to certain species, and hence need substantial revision before applying them to new 
species [541]. Therefore, correlative models are used for far more species than mechanistic 
models [532]. 
2.3.3 Challenges of modelling approaches:  
According to National Research Council (US) Committee on Climate, Ecosystems, Infectious 
Diseases and Human Health [610], there are several issues that should be considered 
regarding relating models to available data. These include:  
− Reporting bias occurs when the surveillance/reporting mechanism for a particular 
disease/vector depends on the direction or magnitude of the observed findings to 
avoid null outcomes or to increase the perceived efficacy. Reporting bias can be 
reduced either by mandating uniform criteria for data collection and reporting. 
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− Aggregation bias is confusing the units of analyses. For instance, in a study of risk 
factors associated with arbovirus infection death rates, data analyzed for urban areas 
showed a positive correlation between minority population and an arbovirus infection 
death rate, whereas the same data aggregated for remote areas showed a negative 
correlation. This shows the importance of considering spatial variability in diseases 
modelling. 
− Data availability and scale: While fine scales of resolution (e.g. spatial scale) are often 
preferable for feeding models (e.g. microclimatic variables of mosquito vector 
habitats), this high-resolution observational data is usually limited by the lack of data, 
or the practical difficulties in obtaining it. Coarse scales can greatly affect model fitting 
and validation. 
− Measurement errors: the difference between estimated findings and their actual 
values. For example, in a population dynamics model to assess the influence of 
ecological factors on mosquito abundances, feeding the model with the actual 
abundance of mosquitoes would be absurd. Instead, estimated population abundance 
is used. Substantial bias could be generated if the measurement errors associated with 
these estimates were not considered. 
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2.4 Review Four: Public health surveillance for mosquito-borne diseases in New Zealand 
2.4.1 Introduction 
Ongoing surveillance is essential for detecting and preventing or managing, as appropriate, 
the spread of emerging infectious diseases at local, national, and international levels [611]. 
Public health activities for detecting an outbreak of mosquito-borne infection ideally include 
case-based surveillance (i.e. clinical and laboratory-based surveillance), and mosquito vector 
surveillance, and monitoring of social and environmental risk factors (e.g. housing, income, 
education) [612]. The effectiveness of surveillance information in forecasting disease 
outbreak depends on the use of suitable indicators incorporated into an EWS [613]. Further 
details on the definition and framework for developing an EWS for infectious diseases are 
presented in Review Three. 
 Hence, risk prediction requires systematic collection of appropriate indicators and analysis of 
relevant data. The ability to create a risk-based model through various combinations of 
routine public health surveillance data can be expected to improve predictability and, 
therefore, timeliness of mitigation strategies. While the lack of these covariates, which could 
be due to poor surveillance systems, would potentially lead to poor predictive performance 
of the disease projections [614]. In this review, a cross-disciplinary approach was used to 1) 
review elements of existing local surveillance practices, with reference to existing 
international standards, that could be used to detect the establishment and local transmission 
of arboviruses, and 2) investigate organisational requirements for developing an EWS for 
arbovirus infections in New Zealand. 
90 
2.4.2 Public health surveillance systems  
A public health surveillance is the ongoing systematic collection, analysis, interpretation and 
dissemination of information on a particular disease for defined populations from different 
relevant sources for public health action to prevent or control this disease [615]. The main 
aim of public health surveillance is to detect (rather than predict) epidemic onset for early 
intervention. Disease surveillance also provides key inputs for early warning forecasting 
models for infectious disease prevention. Further, it monitors trends in the burden and 
distribution of diseases over time and space. Integrated public health surveillance activities 
for mosquito-borne disease should ideally include the case-based surveillance (i.e. clinical and 
laboratory-based surveillance), vector (i.e. entomological) surveillance, monitoring of 
ecological and social risk factors and Event-Based surveillance [612]. 
2.4.2.1  Disease (case-based) surveillance 
Background: Case-based or disease surveillance involves systematic monitoring of reported 
cases and associated clinical and laboratory information as available. This is used to establish 
local or national baseline levels so that any escalation of case numbers is cause for further 
investigation that will inform any public health response [313, 616]. The threshold for 
initiating a response will vary depending on local or national baselines – notably whether the 
infection is endemic in the area or a new arbovirus introduction. For example, at national 
level, in a country that has never experienced a local outbreak of a mosquito-borne disease, 
a single confirmed case of dengue with no prior travel history may be enough to indicate an 
outbreak and trigger actions [313]. 
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Case-based data collection process can utilise passive and active surveillance. Passive disease 
surveillance is the routine monitoring and reporting of notifiable diseases by health-care 
providers (e.g. hospitals, clinics, public health units) on a case-by-case basis. Passive 
surveillance is the most common type of case-based surveillance as it occurs continuously, 
and it requires few resources. However, medical professionals may underdiagnose or 
misdiagnose infected cases and/or fail to report cases routinely and quickly, with consequent 
underreporting. Further, data timeliness and quality are difficult to control as passive system 
rely on multiple institutions to provide data [617]. 
Whereas active disease surveillance is initiated by a health authority which systematically 
requests information about diseases of interest from health care providers. This involves 
outreach (e.g. regular visits or telephone calls) by public health authorities (e.g. local Public 
health units) to health care providers (e.g. clinics and laboratories) to promote recording and 
collection of data in a timely manner [313]. While this method requires more time and 
resources, it tends to provide a more complete reporting of disease occurrence. A more 
specific type of active surveillance is the sentinel case-based surveillance, which is an active 
surveillance undertaken in a specific cohort or geographic area where risk for a particular 
disease outbreak is high and cannot be detected by a passive system. Sentinel case-based 
surveillance is useful for detecting rare infections (e.g. introduced diseases) [618]. Sentinel 
surveillance systems require more resources and time, but can often produce more accurate 
data on cases of illness [619]. Sentinel surveillance is used to detect sporadic incidences of an 
arbovirus outbreak (e.g. sentinel influenza-like illness surveillance). Active laboratory-based 
disease surveillance programmes (using serological and virological diagnosis) are highly 
recommended by WHO for effective prevention and control of arbovirus infections. In 
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general, case-based surveillance provides more precise estimates of incidence and geographic 
spread and has potential to track the aetiology of an infection. However, the main limitation 
of this practice is the time lags between case occurrence and reporting [620]. 
Disease surveillance system in New Zealand: The case notification system forms the 
foundation of infectious disease control in New Zealand [621]. There are a number of other 
surveillance methods, including reporting (reports of diseases that are under surveillance but 
are not legally required to be notified), focus groups, interviews and other research tools used 
for particular studies [622]. The WHO defines notification as “the processes by which cases or 
outbreaks are brought to the knowledge of the health authorities”[623]. By Section 74 of the 
Health Act 1956, medical practitioners are required to report any suspected cases of a 
notifiable disease (i.e. infection that is required to be reported to government authorities by 
law) to Medical Officers of Health [i.e. senior physicians in charge of the Public Health Unit 
(PHUs) who work on healthcare of groups and communities rather than individuals] and 
territorial local authority for some diseases (Figure 12) [40]. PHUs are in charge of contacting 
positively-identified infected cases and promoting follow-up sample collections, investigating 
of travel histories, and relevant epidemiological data [611]. Including arbovirus diseases, 
there are 49 diseases and conditions on the notifiable disease list of New Zealand [624]. 
According to the New Zealand Ministry of Health, the broad purpose of this notification 
system is to provide updated information to public health officials responsible for early 
detection of epidemics and initiating an appropriate public health action [625]. Public health 
action refers to the response taken by PHUs to investigate confirmed cases and outbreaks. 
Although all notifications add to disease surveillance and analysis, most of reported cases 
require a minimal public health action. Notification system also makes it possible to identify 
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areas and population groups with a higher infection risk and understand of trends in disease 
rates over time [616]. 
 
Figure 12: Notifiable disease surveillance system (Source: Ministry of Health [40]) 
For more comprehensive and faster overall reporting of communicable diseases and to 
support reporting by clinicians, the Health Amendment Act 2006 introduced the requirement 
for laboratories to directly notify Medical Officers of Health of notifiable disease results 
(LabSurv; Figure 12) [626]. Further, since 2017, nurse practitioners have been required to 
share the notification responsibility with medical practitioners and laboratories. If health 
practitioners or laboratories fail to notify in accordance with the Health Act 1956 
requirements, they might be prosecuted, and must pay a fine on conviction [616]. 
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Serum samples from patients with suspected arbovirus infection are referred to Institute of 
Environmental Science and Research (ESR) for serological [627] and virological (e.g. 
molecular) analyses (Figure 12) [611, 628]. ESR has provided serological testing of DENV 
IgM/IgG ELISA, anti-CHIKV indirect Anti Chikv Indirect Immunofluorescence Assay (IFA) and 
ZIKV ELISA since 2008, 2015 and 2016, respectively. A molecular RT-rtPCR diagnostic platform 
was implemented for ZIKV in 2014, and DENV 1–4 and CHIKV in 2015 due to more frequent 
outbreaks of these arbovirus infections in the Pacific and a subsequent increase in imported 
cases, combined with extensive cross reactivity of serological diagnosis between related 
arboviruses (e.g. ZIKV, DENV, West Nile virus, Yellow Fever virus, Japanese Encephalitis virus 
and St Louis Encephalitis virus) [627, 628]. In 2017, ESR introduced the Centers for Disease 
Control and Prevention (CDC) Trioplex RT-rtPCR as a multiplex assay for CHIKV, DENV, and 
ZIKV screening [611]. 
Under contract with the Ministry of Health, ESR also undertakes surveillance of notifiable 
diseases in New Zealand and operates the national notifiable disease database (EpiSurv; 
Figure 12) [629]. EpiSurv collects data on notifiable diseases on real-time bases from the 
Medical Officers of Health. Data collected depends on the disease, but in general includes 
case demographics, risk factors and clinical features. EpiSurv also incorporates notification 
algorithms (trigger points) that enables cases to be linked. Output data are published in 
regular surveillance reports and maps [626]. For each disease, breakdowns are provided by 
the number of cases and the rate per 100,000, age, sex and ethnicity [40]. 
In New Zealand most disease outbreaks are detected by Medical Officers of Health through 
one of three methods:  
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i. Identifying anomalies among sporadic cases collected via another formal surveillance 
system, such as EpiSurv or tools that detect unusual patterns in EpiSurv data such as the 
CDC Early Aberration Reporting System (EARS; a surveillance system applied to New 
Zealand EpiSurv notifiable disease data that uses models to detect deviations in recent 
data when linked to a historic mean [630]). Beside the Medical Officers of health, ESR 
may detect disease outbreaks via EARS or from laboratory surveillance. Another formal 
surveillance systems used to detect sporadic incidences of an arbovirus outbreak is 
sentinel influenza-like illness surveillance [626]. 
ii. Detecting aberrations among cases collected through informal surveillance such as self-
reported cases (cases of illness that are directly reported by a member of the public to 
the Medical Officers of Health) 
iii. Informally reported (e.g. phone calls) suspected outbreaks. This involves detection of a 
considerable number of cases of a particular disease of a common source by health care 
providers, members of the public, health care workers, service providers or institutions. 
According to ESR, this method accounts for the majority of outbreaks recorded in New 
Zealand [626].   
2.4.2.2  Mosquito surveillance  
Background: Entomological surveillance is the systematic and ongoing process of collecting 
data on insect vectors of diseases (e.g. mosquitoes) and their environment, to determine 
defined ecological parameters, such as temporal and spatial distribution of species, weather 
and habitat features, seasonal abundance and dynamics, and resistance to insecticides. This 
information is essential to identify high risk conditions for virus transmission and guide 
suitable and timely public health interventions for preventing vector introduction, 
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establishment and spread [631, 632]. There are several standard methods available for the 
surveillance of adult and juvenile stage [633]. Sampling method selection depends on the 
surveillance aims, levels of infestation, skills of personnel and funding [634]. 
Globally, entomological surveillance, as a tool for monitoring arbovirus diseases, has been 
mainly conducted by local mosquito control districts and public health agencies [635]. 
According to Article 22 and 34 of the WHO International Health Regulations (2005), especially 
in countries free of major arbovirus mosquito vectors, as far as practical, facilities used by 
traveller arrivals at ports of entry, containers and container loading areas are required to be 
kept in a sanitary condition and maintain free of sources of contamination or infection, 
including vectors and reservoirs. This can be achieved by monitoring for the 
arrival/establishment of unwanted mosquitoes of public health significance, identifying 
potential breeding sites, especially around the ports of entry, and planning to eliminate or 
subject these sites of active control activities, and determining the distribution and habitat 
niche of local mosquito vectors [44]. 
Mosquito surveillance in New Zealand: Under part four, the Biosecurity Act 1993 “provides for 
the continuous monitoring of New Zealand’s status in regards to pests and unwanted organisms”, 
such as exotic mosquitoes [636]. There are four components of a programme to monitor and 
exclude exotic mosquitoes in New Zealand [44]:  
i. Pre-border clearance of risk goods conducted by MPI Quarantine Service (MQS) staff at 
offshore sites. Under section 24A of the Biosecurity Act 1993, MPI has also biosecurity import 
health standards that biosecurity risk goods (e.g. tyres, vehicles, wet-footed plants) must 
meet before biosecurity clearance can be given and imported into New Zealand [637].  
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ii. Inspection and disinsection (use of insecticide on international flights) of vessels, aircraft and 
their high-risk cargo before and after arriving at New Zealand ports (including devanning at 
transitional facilities, also conducted by MPI [638]. Whenever a live mosquito is found, 
international shipping containers are treated (e.g. fumigated) according to 
MPI/international standard operating procedures for mosquito control [26].  
iii. In response to a previous incursion 1998-2010, an ongoing routine saltmarsh mosquito 
surveillance across more than 780 catalogued saltmarsh habitat locations around high-risk 
entry points, conducted by Mosquito Consulting Services and fund by the MPI, which includes 
larval sampling (dipping) and adult trapping (CO2 baited light traps) [639]. 
iv. A response programme and routine surveillance of mosquitoes at New Zealand international 
ports of entry, conducted by Health Protections Officers and founded by the Ministry of 
Health. This surveillance ensures that unwanted exotic mosquito species are intercepted 
before they become established. 
For more details on vessel, aircraft, and cargo inspection and clearance and response programme 
and routine surveillance of mosquitoes, see “import risk analysis: vehicle and machinery”, a 
report released by Biosecurity New Zealand, Ministry of Agriculture and Forestry, Wellington 
[640]. 
New Zealand is a signatory to the International Health Regulations (2005) which includes 
obligations on implementing vector surveillance and control at designated points of entry to 
detect any new incursion of non-resident species [641]. The programme is overseen by the 
Ministry of Health, delivered by the District Health Boards (DHBs) public health units with 
entomology support from Southern Monitoring Services Ltd (trade as New Zealand BioSecure) 
[642].  
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In Wellington, for example, for the last decade, Regional Public Health has been operating a 
surveillance programme targeting exotic mosquitoes, mainly, Ae. albopictus and Ae. aegypti at 
Wellington Airport and CentrePort Wellington [26]. The programme includes adult trapping (using 
BG sentinel traps, GAT sentinel traps and CO2 baited light traps), and larval trapping (using tyre 
traps) and sampling (using dipping and other techniques) [44]. In Auckland, Regional Public Health 
Service (ARPHS) conducts audit surveys and “mega surveys” once or twice a year at Auckland 
International Airport. During a mega survey, Health Protection Officers sample, map and mitigate 
any potential mosquito habitat around the Point of Entry. ARPHS also maintains larval and adult 
trapping programmes at Ports of Auckland (using tyre traps, CO2 baited light traps and BG sentinel 
traps). Auckland International Airport and Ports of Auckland, however, have also contractors 
conducting mosquito surveillance. Auckland International Airport is conducted by SMS Ltd and 
the Ports of Auckland is conducted by Bioscientific Solutions.  
2.4.2.3 Monitoring environmental and social risks 
Background: In addition to mosquito surveillance, other interrelated environmental and 
social parameters that influence a community’s vulnerability to epidemics should be 
periodically assessed for integrated vector management strategies. This includes 
socioeconomic status, income and/or education [643-645], knowledge about the targeted 
disease [646], household crowding (number of people per room) [647, 648], housing status 
(e.g. sewage, solid waste disposal services) [648], household density [643], type of household 
[647, 648], conditions of land tenure, surrounding land use types, human movements, 
proportions of immigrants [649]  and domestic water storage practices [211, 313]. This type 
of data, obtained by various New Zealand social and government agencies, helps in planning 
and assessing disease risks (e.g. establishing socio-ecological profiles that can be of value for 
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targeting source reduction). Weekly or monthly analyses of meteorological data are usually 
required if the data are to be used in early warning forecasting models [313].  
Environmental and social monitoring in New Zealand: Under the Resource Management Act 
1991, crown research institutes, central government agencies, and local government in New 
Zealand are legislatively responsible for environmental monitoring. NIWA, Ministry for the 
Environment (MfE) and MetService are responsible for monitoring and managing the 
weather, climate and atmosphere domains. The Ministry for Primary Industries, NIWA, 
Department of Conservation, and regional councils are responsible for monitoring and 
managing the freshwater and marine domains [650]. Further, The Environmental Reporting 
Act 2015 requires Stats NZ and the Ministry for the Environment to produce a biennial report 
on a different environmental domains such as fresh water, weather and climate [651]. 
Under the Statistics Act 1975, Statistics New Zealand is legislatively responsible for collecting 
information from New Zealanders and businesses, government agencies and other 
institutions through Stats NZ censuses and surveys, government agencies, and non-
government organisations [652]. The information includes social measures that affect 
transmission dynamics of arboviruses such as housing, income, household demographics, 
population density, employment, education and population movement [653]. De-identified 
linked data can be accessed through the online Integrated Data Infrastructure (IDI) [654]. 
2.4.2.4  Event-based surveillance 
Background: Classical case-based surveillance relies mainly on routine reporting of notifiable 
diseases, which bases on patients seeking medical consultation [23]. However, cases are 
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repeatedly missed by the surveillance system due to mild presentations, under-diagnosis, lack 
of access to health care, or misreporting. Further, traditional surveillance-based data 
constrained by time, staffing and bureaucracy, with a 2 week lag for the best platforms [25]. 
This might result in underestimation of the true disease burden [22] and consequently, 
challenge preparedness and delay real-time interventions. Complementary surveillance 
systems are required to provide earlier insight on potential infectious disease epidemics for 
an appropriate public health response. For earlier insight on potential infectious disease 
epidemics in general, and vector borne diseases in particular, complementary surveillance 
systems have been developed, such as Event-Based Surveillance (EBS).  
In contrast to the traditional surveillance that is based on the ongoing collection of 
information and automated thresholds for response, EBS is the organized and rapid capture 
of free or low-cost sources of unstructured data about events of potential risks to public 
health to characterize disease epidemiological patterns [655]. Under the concept of “digital 
epidemiology” [656], this information includes rumours or other ad hoc stories and reports 
spread through internet news outlets, digital and social media, health expert mailing lists, 
queries to online search engines [655, 657, 658], freely accessible information from Twitter, 
Wikipedia, Google (e.g. Google Health Trends performance, Google Flu Trends) [656], 
nongovernmental organizations reports [655] and electronic information systems (e.g. 
ProMED, GPHIN HealthMap and BioCaster) [313, 620, 655, 657]. This modern approach, 
promoted since the mid-90’s, is designed to rapidly detect signals of unexpected or unusual 
public health events such as unexplained disease trends [27]. In conjunction with classical 
case reporting system, EBS is able to provide detailed near real-time information on disease 
outbreaks [655, 657], as well as an accurate estimate of changes in the spatial patterns of 
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infectious diseases [657]. Several studies highlighted the event-based disease surveillance as 
an effective approach to complement traditional disease surveillance [655, 657]. EBS requires 
few human and financial resources to be established. For example, during the 2009 influenza 
pandemic, National Department of Health of Papua New Guinea established an EBS system 
of two members (a surveillance and an administrative officer). Nevertheless, the Papua New 
Guinean EBS system has effectively helped to detect several urgent public health threats and 
instigated rapid responses [659]. 
Event-based surveillance in New Zealand: There is no reference to the existence of an event-
based surveillance among New Zealand’s national surveillance systems. 
2.4.3 Towards an Early Warning System for arbovirus infections in New Zealand  
It can be concluded that New Zealand has an effective monitoring (i.e. disease notification, 
environmental, socioeconomic, entomological surveillance systems) and, therefore, risk 
assessment systems and the potential to construct predictive models through various 
combinations of the monitored predictors. However, surveillance systems work 
independently. This would limit the leverage of its maximum potential as a predictive tool for 
epidemic preparedness. For instance, although it has been described by the ESR as “the best 
known surveillance system” [660], analysing data of the notifiable disease system 
independently would detect rather than predict the onset of a disease outbreak (there is 
therefore no lead-time as such). Yet, by linking surveillance systems in a holistic integrated 
framework, an EWS will allow stakeholders and health-care services to plan and enact 
effective evidence-based public health practices and mitigation strategies and respond to 
epidemics in timely and cost-efficient manner. For example, in dengue outbreaks in Australia 
102 
in 2003 and 2009, with the presence of an accurate integrated EWS, the total responding 
costs were $115,000 and $1.1 million, respectively. A delayed response of 4–6 weeks (i.e. a 
scenario without integrated surveillance framework) would result in a projected cost of $13 
million (i.e. 86 times higher) in 2003 and $382 million (i.e. 346 times higher) [661-663]. In New 
Zealand, the latest modelling study on mosquito vector distribution or arbovirus transmission 
in New Zealand was conducted in 2001 [28]. The study used an integrated framework of 
climatic, entomological, topographical, trade and travel, and demographic data to describe 
the areas of potential dengue vector distribution and transmission risk in New Zealand for 
current and projected climatic conditions. This work can be used as an example of what can 
be achieved by putting together all the information is currently recorded by different 
institutions and agencies. Recommendations on the national public health surveillance and 
risk assessment strategies for arbovirus diseases are provided in Appendix C. 
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Chapter 3 : Imported arbovirus infections in New Zealand, 2001-2017 
3.1 Abstract 
Background/aims: Over the last decade and following international trends, cases of 
mosquito-borne arbovirus infections, notably dengue fever, chikungunya and Zika, have 
increased among travellers arriving in New Zealand, but no locally acquired cases have been 
identified. Imported cases are described and examined to identify trends and features that 
might assist in reducing transmission risk from travellers and recommendations made to 
reduce risks of local transmission from infected travellers. 
Methods: Information on traveller arrivals, notified cases and risk factors for disease 
acquisition were obtained from national sources. Trends in importation rates, seasonality are 
described and relationships of notifications with traveller arrivals were examined with a 
negative binomial regression model. 
Results: There was a significant increase in dengue notifications combined with the 
emergence of Zika and chikungunya. Most notifications were from arrivals in Auckland from 
Pacific Islands during summer and early autumn who reported making little effort to avoid 
mosquito bites even during high-risk periods. 
Conclusion/implications: Overseas travel from New Zealand, particularly to the Pacific Islands 
and Southeast Asia, involves increasing risk of arbovirus infection. Measures are needed to 
increase awareness and protective behaviours among travellers. The repeated introduction 
of arboviruses to New Zealand also increases the risk of local transmission in a country that 
has vector capable and vector potential mosquitoes, as well as an increasingly suitable climate 
for new vectors to establish.  
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3.2 Background 
Unprecedented growth in world travel and international trade over the past 50 years, 
combined with global warming, are facilitating the global expansion of both pathogens, 
mainly arboviruses, and their vectors [4-7]. Travellers, particularly asymptomatic and pre-
symptomatic, contribute substantially to the introduction of arboviruses, notably DENV, 
CHIKV and ZIKV [4, 8, 9], to new areas where suitable vectors are present and populations 
largely unexposed [4, 38]. Since most arbovirus infections have an intrinsic incubation period 
of 3-14 days, and travelling to any part of the world is possible within this timeframe, the 
potential for rapid geographical expansion is apparent [664]. Over the last decade, there has 
been accelerated emergence of travel-associated epidemics of arbovirus diseases in non-
endemic, but vector-established, areas by local transmission. This includes dengue in 
Australia [229], southern Europe [230-232], United States [233] and China [234], chikungunya 
(CHIK) in the Caribbean Islands and the Americas [235, 236], Zika illnesses in United States 
[237], Pacific Islands [238] and southeast Asia [239], and Ross River virus (RRV) infection in 
the Pacific Islands [12, 240, 241]. 
Following the international trend [4, 37-39], arbovirus infections in returning travellers have 
been increasingly reported in New Zealand over the past 10 years [40]. About half of the 
international travellers arriving in New Zealand are from Australia and the Pacific Islands 
[285]. Since 2012 various Pacific Islands have experienced epidemics of dengue, chikungunya 
and Zika infections, with over 120,000 notified cases [24]. In the same region, RRV infection 
is endemic in Australia, Papua New Guinea [287-291] and Solomon Islands [286]. RRV 
infection is the most common and widespread arbovirus disease in Australia [175, 665]. 
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To date, no locally acquired cases of human arbovirus infections have been reported in New 
Zealand [10]. All reported cases have been diagnosed in returning travellers from endemic 
regions, mainly Australia and the Pacific Island. DENV, CHIKV, RRV, and more recently ZIKV, 
were the most commonly imported arboviruses [40]. New Zealand has vector capable (Ae. 
(Halaedes) australis (Erichson), Ae. (Finlaya) notoscriptus (Skuse), and Cx. (Cx.) 
quinquefasciatus (Say)) [27] and vector potential [e.g. Ae. (Ochlerotatus) antipodeus 
(Edwards) and Cx. (Cx.) pervigilans Bergroth] species [12] for human disease, as well as 
suitable climate for the establishment of major vectors (e.g. Ae. albopictus) [28]. The repeated 
introduction of these viruses to the New Zealand immune-naïve population through viraemic 
travellers represents a risk for local transmission [666]. 
This study examines notifications of imported arbovirus disease cases, in particular dengue, 
CHIK, Zika and RRV infection as a risk factor for local transmission of arbovirus diseases, as 
well as providing a baseline for future evaluation of measures taken to reduce this. This study 
has five objectives: i) review and characterize imported arbovirus disease cases reported in 
New Zealand from January 2001 to December 2017, ii) compare trends in notifications with 
those in international travel iii) assess the risk of local transmission of these infections in New 
Zealand by way of infected travellers, and iv) assess mosquito avoidance precautions taken 
by the cases during their visit to risk areas. 
3.3 Methods 
3.3.1 Data sources and elements  
Notifiable travel related infectious diseases are reported by clinicians to their local public 
health unit by web-based applications. Data are held by the Institute of Environmental 
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Science and Research Ltd. (ESR) [660, 667], which runs the national notifiable disease 
surveillance database, EpiSurv, for the Ministry of Health [667]. Data on imported cases of 
arbovirus disease were obtained from Episurv for notifications 2001 to 2017. The de-
identified data elements of disease notifications included demographic data (age, sex, 
territorial authority and ethnicity) laboratory confirmation, hospitalization details and risk 
factors for the disease acquisition (e.g. country of acquisition, travel history). Data on arrivals 
to New Zealand by residents, long term migrants and international visitors in the same period 
of time were obtained from Statistics New Zealand, although it was not possible to link these 
with specific case notifications. 
3.3.2 Data analysis  
Confidence intervals for the proportions of interception records were estimated using the 
Clopper-Pearson exact method. This focussed on the four most commonly notified imported 
arboviruses in New Zealand; DENV, CHIKV, ZIKV and RRV. The monthly number and rate of 
notification among traveller arrival numbers were analysed with a negative binomial 
regression model with a continuous term for year and dummy terms for month. Adjustment 
for multiple comparisons between the months was made with the Holm–Bonferroni method. 
For Zika and RRV infections, there were months with no notifications. The analysis for these 
infections used pairs of months (e.g. Jan and Feb, March and April, etc). For ZIKV the analyses 
for yearly trends did not include month terms and the analyses for monthly differences was 
restricted to 2014-2017. The glimmix procedure of statistical package SAS 9.4 (SAS Institute 
Inc, Cary NC) was used to examine trends over time with differences between the months as 
a surrogate for seasonal conditions. We fitted a generalized linear model to the number of 
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notifications, with a negative binomial distribution, a log link and overdispersion with the log 
of the number of traveller arrivals was included as an offset. 
3.3.3 Ethical approval 
The study protocol was deemed as a “minimal risk health research – audit and audit related 
studies” by University of Otago Human Research Ethics Committee and the Ministry of Health. 
The study was approved as being consistent with Rule 11(2) (c) of the New Zealand Health 
Information Privacy Code 1994. 
3.4 Results 
3.4.1 Disease incidence 
A total of 1912 overseas-acquired cases of six arbovirus diseases were reported in New 
Zealand between 2001 and 2017 (Table 4). Most of these (81.1 % of cases) were dengue, 
followed by Zika (9.3%), chikungunya (7.0%) and RRV infection (2.4%). Five cases of Barmah 
Forest virus (BFV) infection and one case of Japanese encephalitis (JE) were also reported. 
More than half of all the arbovirus cases reported occurred in the final four years (2014-2017), 
with an average notification rate of 244 case per year. Most cases (93%) were confirmed by 
laboratory test. However, the infecting viral serotype was unknown for 90% of confirmed 
dengue cases. Of the 10% of cases with known serotype, dengue serotype 2 (DEN-2) virus was 
the most common (5.7%) then DEN-3 (1.5%) of cases. The overall notification rate was 2.7 per 
100,000 population (Table 4) and 2.4 per 100,000 traveller arrivals (Table 5). Hospitalisation 
status was recorded for 88% of cases while only 37% of these reported seeking hospital-based 
care (Table 4). 
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Dengue 1550 2.2 1474 95.1 1303 84.1 547 42.0 35.3 
Zika 178 0.2 148 83.1 166 93.3 19 11.4 10.7 
Chikungunya 133 0.2 113 85.0 166 124.8 45 27.1 33.8 
RRV infection 45 0.1 35 77.8 43 95.6 6 14.0 13.3 
BFV infection 5 0.0 5 100.0 3 60.0 0 0.0 0.0 
JE 1 0.0 1 100.0 1 100.0 1 100.0 100.0 
Total 1912 2.7 1776 92.9 1682 88.0 618 36.7 32.3 
 
Table 5: New Zealand arbovirus disease case notifications by year and per 100,000 traveller arrivals, 
2001-2017* 








Notifications per 100,000 
traveller arrivals 
2001 93 1 0 3 0 0 97 3,293,714 2.9 
2002 69 0 0 1 0 0 70 3,444,369 2.0 
2003 55 0 0 1 0 0 56 3,580,789 1.6 
2004 8 0 0 5 1 1 15 4,166,878 0.4 
2005 11 0 0 1 2 0 14 4,341,672 0.3 
2006 19 0 0 2 0 0 21 4,381,585 0.5 
2007 114 0 1 0 0 0 115 4,531,789 2.5 
2008 113 0 1 1 0 0 115 4,530,764 2.5 
2009 139 0 1 3 2 0 145 4,480,439 3.2 
2010 50 0 0 5 0 0 55 4,630,313 1.2 
2011 42 0 1 3 0 0 46 4,776,163 1.0 
2012 76 0 0 1 0 0 77 4,829,582 1.6 
2013 106 0 1 3 0 0 110 5,037,189 2.2 
2014 178 57 44 1 0 0 280 5,289,611 5.3 
2015 125 9 
 
4 0 0 186 5,722,763 3.3 
2016 191 100 28 4 0 0 323 6,268,441 5.2 
2017 161 11 8 7 0 0 187 6,715,042 2.8 





1.9 0.2 0.2 0.1 0.0 0.0 2.4   
          
*Underlined = Notification peak  
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3.4.2 Secular trend and seasonality 
There were significant increases in dengue, Zika and chikungunya notifications over the 17-
year period (Table 6). Dengue notifications increased by about 8% per year in this time. The 
overall trend included the recent emergence of chikungunya and Zika cases (for which the 
increase mainly occurred 2014-17, with only occasional cases before 2013), along with a 
continuing low notification rate of RRV cases (Figure 13). 
Table 6: Annual and seasonal trends in the number of arbovirus infections notified in New Zealand, 
January 2001 to December 2017 (NS= Not Significant) 
Imported 
diseases 
Annual trend Seasonal trend 
Estimated change 
(95% CI) 






Dengue 1.08 (1.05-11.1) 1-191 26.22 <0.0001 1-1191 1.11  0.36 (NS) - - 
Zika* 1.51 (1.09-2.10) 1-15 7.30  0.016 5-17 3.89 0.016 Jan/Feb Jul/Aug 
Nov/Dec 
CHIK 1.76 (1.52-2.03) 1-191 59.85 <0.0001 11-191 1.10 0.37 (NS) - - 
RRV 
infection 
1.06 (1.00-1.13) 1-95 3.75 0.056 (NS) 3-95 2.96 0.016 Mar/Apr Jul/Dec 
*Annual trend for Zika without a month term, seasonal trend for Zika refers to the emergence period 2014-2017 only 
The rate of notifications among total traveller arrivals also increased for dengue, Zika, 
chikungunya by 4% (95%CI 1%-7%, F=9.07 df 1-191 p=0.009), 45% (95%CI 4%-103%; F=5.78 
df=1-15 p=0.030, without a month term) and 69% (95%CI 47%-94%; F=54.20 df=1-191 
p<0.0001) times per year, respectively (Figure 13). Zika and RRV infections also showed a clear 
seasonal pattern of notification with peaks in January-February and March-April, respectively 
(Table 6, Figure 14). 
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Figure 13: Annual notifications of arbovirus diseases, New Zealand, 2001 to 2017 
 
Figure 14: Monthly notifications of arbovirus diseases and totals of international travellers, New 
Zealand, 2001-2017 
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An average of 160 cases were notified per year (range 14-323) reaching a peak in 2016, with 
5.3 cases per 100,000 traveller arrivals. The monthly totals ranged from 93 in September to 
291 in February (average about nine per month). In general, although there were no 
significant relationships between notifications received neither on a monthly nor a seasonal 
basis and the numbers of arrivals (Table 7), higher proportions of cases were notified during 
summer and early autumn (mainly, January, February and April; Figure 15). Short-term 
international visitor arrivals show a pattern with regular annual peaks (  
Figure ). Observed peaks of dengue in New Zealand tend to follow one of these. Traveller 
arrivals increased over the entire period by 4% per year (1.04 95%CI 1.04, 1.04; F=1609.71, 
df=1,191 p<0.0001), which is about half the rate of the notifications. 
Table 7: Preliminary tests for association between the number of dengue fever notifications the 
number of traveller arrivals by month and season 
Traveller arrivals No. of notifications from next month No. of notifications from next season 
NZ resident arrivals 0.35 (0.09-1.40), p=0.14 0.14 (0.01-1.52), p=0.1 
Permanent/long term 
immigration 
1.16 (0.38-3.55), p=0.80 2.16 (0.57-8.21), p=2.6 





Figure 15: Monthly arbovirus disease notifications and international arrivals in New Zealand, 2001 to 2017 
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3.4.3 Country of acquisition 
Except for one case of Zika which was acquired locally via sexual transmission, all cases of 
arbovirus infection had travelled overseas during the incubation period for the diseases or 
had a prior travel history that could account for their infection. Overall, travel history was 
recorded for 98.5% (n=1883) of cases. Some cases reported travelling to two (261 cases, 
13.7%) or three (77 cases, 4.0%) countries. More than 65 countries were visited or lived in by 
the infected individuals. The countries commonly visited or lived in were Samoa (323 cases, 
16.9%), Cook Islands (236 cases, 12.3%), Fiji (225 cases, 11.8%) and Tonga (215 cases, 11.2%) 
(Figure 16). Cook Islands, Samoa, Indonesia, and Tonga, however, had the highest notification 
rate per 100,000 traveller arrivals (Table 8). About 90% of the RRV infection cases had been 
in Australia during the incubation period for the disease. However, its notification rate was 
only 0.2 per 100,000 traveller arrivals.  
 
Figure 16: Total notifications of arbovirus diseases, New Zealand, 2001 to 2017, by countries 
commonly visited or lived in during the incubation period for the disease 
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cases of  
arboviral 
diseases 
2001 19,002 1 0 0 1 2 10.5 21,457 5 0 0 5 23.3 642,735 1 0 1 0 2 0.3 2,565,450 21 0 0 0 21 3,293,714 95 2.9
2002 17,916 5 0 0 0 5 27.9 25,544 5 0 0 5 19.6 645,488 1 0 1 0 2 0.3 2,711,493 13 0 0 0 13 3,444,369 71 2.1
2003 18,257 35 0 0 0 35 191.7 19,498 5 0 0 5 25.6 716,506 0 0 1 0 1 0.1 2,780,817 7 0 0 0 7 3,580,789 56 1.6
2004 18,965 2 0 0 1 3 15.8 21,103 0 0 0 0 0.0 870,149 0 0 4 1 5 0.6 3,210,468 2 0 0 1 3 4,166,878 15 0.4
2005 23,317 0 0 0 0 0 0.0 19,707 1 0 0 1 5.1 888,127 0 0 1 2 3 0.3 3,361,778 8 0 0 0 8 4,341,672 14 0.3
2006 25,170 2 0 0 0 2 7.9 18,952 3 0 0 3 15.8 916,810 0 0 2 0 2 0.2 3,369,304 5 0 0 0 5 4,381,585 21 0.5
2007 23,228 2 0 0 0 2 8.6 21,353 1 0 0 1 4.7 963,842 1 0 0 0 1 0.1 3,468,496 20 0 1 0 21 4,531,789 115 2.5
2008 25,621 18 0 0 0 18 70.3 19,189 6 0 0 6 31.3 989,257 3 0 1 0 4 0.4 3,438,166 23 0 1 0 24 4,530,764 115 2.5
2009 26,376 17 0 0 1 18 68.2 20,602 6 0 1 7 34.0 1,097,473 2 0 2 2 6 0.5 3,277,101 21 0 0 0 21 4,480,439 145 3.2
2010 22,166 0 0 0 0 0 0.0 22,257 5 0 0 5 22.5 1,135,721 4 5 0 9 0.8 3,394,080 19 0 0 0 19 4,630,313 55 1.2
2011 22,752 1 0 0 0 1 4.4 18,356 6 0 0 6 32.7 1,170,612 2 0 2 0 4 0.3 3,504,319 23 0 0 0 23 4,776,163 45 0.9
2012 23,660 13 0 0 0 13 54.9 17,844 18 0 0 18 100.9 1,170,672 0 0 1 0 1 0.1 3,558,150 29 0 0 0 29 4,829,582 77 1.6
2013 25,322 5 0 0 0 5 19.7 21,521 14 0 0 14 65.1 1,237,565 3 0 3 0 6 0.5 3,690,390 57 0 0 0 57 5,037,189 110 2.2
2014 25,185 60 0 0 0 60 238.2 22,521 11 0 0 11 48.8 1,271,035 4 0 1 0 5 0.4 3,902,488 49 2 7 0 58 5,289,611 280 5.3
2015 27,828 2 0 3 0 5 18.0 22,785 7 1 0 8 35.1 1,352,073 0 0 4 0 4 0.3 4,245,099 32 1 6 0 39 5,722,763 186 3.3
2016 30,239 9 9 14 1 33 109.1 28,340 5 0 0 5 17.6 1,434,983 4 1 3 0 8 0.6 4,691,059 47 9 13 0 69 6,268,441 323 5.2
2017 30,750 30 7 2 0 39 126.8 28,710 15 2 0 17 59.2 1,497,110 1 0 6 0 7 0.5 5,067,884 44 2 4 0 50 6,715,042 187 2.8





















































Imported cases of  
arboviral diseases 
Cont. Table 8: The countries commonly visited or lived in by imported cases of arbovirus infections and their notification rates, New Zealand, 2001-2017 
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3.4.4 Case characterisation 
The notifications were recorded in 19 of the 20 New Zealand DHBs (Appendix D). About 60% 
of the cases (1112 cases) were notified in the Auckland region, with an annual rate of 4.6 per 
100,000 population (Figure 17). Auckland DHB had the highest annual rate, with 5.8 (CI 5.4-
6.5) per 100,000 population, followed by Counties Manukau DHB with 4.5 (CI 4.2-5.1) per 
100,000 population (Appendix D). Ethnicity was recorded for 92% (1759/1912) of cases. 
Overall, the highest annual rate was reported in the Pacific Peoples [11.4 per 100,000 
population (CI 10.4-12.4), 520 cases], followed by Asian [3.1 per 100,000 population (CI 2.7-
3.5), 232 cases] and European and other [1.9 per 100,000 (1.8-2.0), 940 cases] ethnic groups. 
Pacific People’s ethnic group had also the highest annual rate in dengue [8.2 per 100,000 
population (CI 7.4-9.1), 373 case], Zika [1.8 per 100,000 population (CI 1.4-2.2), 81 cases] and 
Chikungunya [1.4 per 100,000 population (CI 1.1-1.8), 66 cases]. While European and other 
ethnic group had the highest average annual rate in RRV infection [0.08 per 100,000 
population (CI 0.06-0.1), 40 cases]. (Figure 18). The average age was 41 years and ranged from 
0-82. The age group with the highest notifications rate was 51-60 years [4.00 per 100,000 
population (CI 3.6-4.4), 365 cases], followed by 21-30 years [3.8 per 100,000 population (CI 
3.4-4.2), 311 cases] (Figure 19). Approximately 78% of cases were of age between 21-60 years. 
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Figure 18: Annual notification rates of arbovirus diseases, New Zealand, 2001 to 2017, by ethnicity 
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Figure 19: Notifications rates of arbovirus diseases, New Zealand, 2001 to 2017, by age 
3.4.5 Precautionary measures 
Usage of bite‐avoidance measures given in Table 9 was recorded for 52.2% (n=1004) of cases. 
Of these, 32% (n=229) of cases always used repellent, 32% (n= 321) stayed in screened/air-
conditioned accommodation, 6% (n=65) wore long sleeved shirts and trousers, and 13% 
(n=133) used bed nets. Only 4.8% (n=48) of cases always used all of the listed precautionary 
behaviour measures. 
During the New Zealand peaks of arbovirus disease notifications (Table 8), the usage of bite‐
avoidance measures was recorded for 263 (54%) cases out of a total of 568 notifications. Of 
these, 96 cases (37%) always used repellent, 109 (41%) stayed in screened/air-conditioned 
accommodation, 14 (5%) wore long sleeved shirts and trousers, and 44 (17%) used bed nets. 
Only five cases (2%) always used all of the precautionary behaviour measures during visiting 



































 Dengue Zika Chikungunya RRV infection
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Table 9: Usage of bite‐avoidance measures by notified cases during peaks of arbovirus diseases,  
New Zealand, 2001-2017 
*No. of notifications from the county commonly visited or lived in during the NZ peak/ no. of notifications from all countries during the NZ 
peak in the associated year 
**U= Unknown N= Never  R= Rarely O= Occasionally                           A= Always 
Disease Date of the peak County 
commonly visited 
or lived in during 
the NZ peak 




year months bed nets (n) Clothing (n) Repellent (n) Screened 
place (n) 








































































































































































































































































3.5.1 Imported arboviruses in New Zealand 
Notification and characterisation of arbovirus disease cases provides a baseline for evaluating 
trends and preventive measures although the data only represent those who experience 
symptoms and seek medical assistance in New Zealand. Nevertheless, a noticeable increase 
above background number of cases should trigger an alert for further investigation [313]. 
From 2001 to 2017, with the exception of one case of Zika being locally sexually transmitted, 
all (n=1912) recorded cases of the six arboviruses (DENV, CHIKV, ZIKV, RRV, BFV and JEV) were 
notified following overseas travel. An overall rate of 2.4 cases per 100,000 traveller arrivals 
per year is low by some standards (or might be due to disease underreporting) but confirms 
travel as an import pathway for pathogens and risk factor for local disease transmission. 
Following the global trend [3, 226, 668], dengue notifications, and recently chikungunya and 
ZIK, have increased significantly in New Zealand, and appear linked to outbreaks occurring 
elsewhere in the Pacific region. 
Between 1980-2000, the annual average of dengue and RRV infection notifications were 5.5 
and 0.25, respectively [669]. Before 2014, only one case of Zika and five cases of chikungunya 
had been notified [10]. In the final four years of the 17-year study period (2014-2017), 
however, more than half of all the arbovirus cases (976 cases) were recorded, with an annual 
average of 244 cases. This increase accompanied an increase in the number of traveller 
arrivals, especially from the Pacific region, where some countries have experienced a high 
burden of mosquito-borne diseases, including the emergence of Zika and chikungunya 
infections, since January 2012 [24]. This finding is consistent with earlier epidemiological 
121 
studies described in other countries that showed a strong correlation between international 
travel volume and the emergence or re-emergence of infectious diseases (e.g. [38, 670-672]). 
Reported cases of viraemic travellers entering New Zealand are probably a considerable 
under-representation for several reasons. For example, one recent estimate indicates 390 
million dengue cases per year globally, of which only 25% manifest clinically [3]. The 
underreporting is usually because a large proportion of symptomatic cases have mild, self-
limiting, non-specific symptoms, and might not seek medical treatment. In a recent study in 
Australia [673], only 40% of hospitalised dengue-infected patients met the WHO criteria for 
dengue with warning signs [313]. Underdiagnosis in New Zealand is also likely because both 
medical staff and victims may have limited experience with these infections. In Florida, for 
example, until 2010, local physicians tended to lack awareness of dengue, and the 
underreporting led to delayed detection of DENV introduction and outbreak. Medical 
practitioners attributed initial cases to nonspecific viral infection without consideration of 
DENV [661]. Additionally, as laboratory tests are often unavailable at the time of care, 
decision-making process frequently has to be made solely on the clinical features [674]. 
Hence, medical professionals should be aware of the presentation of arbovirus diseases, their 
geographical distribution, and maintain a high level of suspicion with regard to travellers 
returning from high-risk areas. As the annual number of overseas visitor arrivals in New 
Zealand is consistently higher than the New Zealand resident arrivals, visitors who show 
symptoms of illness during their stay may not seek medical advice until they return to their 
home country [23]. 
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Although most notified cases are laboratory confirmed (93%), few DENV serotypes (10%) are 
recorded. Serotype determination should become routine since sequential infection by more 
than one serotype of DENV is a major contributing factor to the serious medical conditions of 
Dengue Haemorrhagic Fever and Dengue Shock Syndrome, although these have not been 
recorded in New Zealand to date. Early detection of serotypes circulating in an area could 
therefore be a means to reduce the incidence of serious cases during outbreaks by predicting 
the health support needed for early diagnoses and treatment. 
3.5.2 Seasonality of travel-associated infectious diseases 
Although there were no significant relationships between notifications received on a monthly 
basis, and the numbers of arrivals, the majority of notifications were recorded in the summer 
and autumn months (January, February and April). These findings are in agreement with 
previous studies (e.g. [670, 675-678]). 
The pattern of arbovirus disease notifications in New Zealand probably reflects several 
factors. First, it may reflect the high burden of arbovirus diseases in the Asia-Pacific region, 
combined with an increasing number of New Zealanders traveling to these destinations [38]. 
Numbers of visitor arrivals in New Zealand from the Pacific Islands grew by 3.7% in 2016. 
Australia and New Zealand were also the major source of visitors to the Pacific Islands 
representing 52% of the total travellers in 2016 [679]. Second, the seasonality observed in 
this study is likely to reflect a preference for visitors from New Zealand to travel during 
Christmas and holiday season (December, January, and February), which coincides with 
warmer months in the Southern Hemisphere. Third, these periodic trends are determined by 
variations in transmission risk during the disease outbreaks in the Pacific region, which peak 
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during the rainy season [38]. However, rainy seasons vary widely from country to another, 
and also vary locally within countries. Because of these geographic variations, the relationship 
between rainfall and dengue is complex [675]. 
In this study, during all New Zealand peaks of arbovirus disease notifications, the major source 
countries for the notified cases were experiencing an ongoing outbreak of the peak disease, 
mostly during their rainy seasons. The epidemiological status of these is provided in Appendix 
F. Dengue, Zika and chikungunya infections can thus be considered as diseases which pre-
travel advice should include data on disease risks according to season. Further, the seasonality 
and annual trends can aid the medical practitioners in evaluating the relative likelihood of 
arbovirus diseases in travellers returning with a nonspecific febrile illness [675]. 
The most commonly reported countries of travel among cases in this study were Cook Islands 
followed by Samoa. Studies of arbovirus infections in Australian [680], American [681] Dutch 
[682] Israeli [683] Swedish [678] travellers report that the majority reported a history of travel 
to South Asian and/or pacific destinations. Travel to Pacific Islands and Australia by New 
Zealand travellers has shown the strongest growth in the last decade and are the first most 
common source and destination countries of the notified cases [285]. About 50% of the 
international travellers arriving in and leaving New Zealand are from Oceania [285]. With 
regard to arbovirus infections, the high-risk destinations in Asia Pacific region for New Zealand 
travellers are presented in Appendix G. 
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3.5.3 Risk factors for local arbovirus transmission 
In New Zealand, the most likely source of virus importation is travellers arriving from endemic 
tropical and sub-tropical regions, mainly the Pacific Islands. However, according to Weinstein 
et al. (1995), “the number of circulating virus particles in people in a large cosmopolitan 
population such as that of Auckland is therefore likely to be sufficient to initiate an outbreak, 
assuming that a competent mosquito vector is present” [11]. With the marked increase in 
global travel and trade in the meantime, travel-associated locally-transmitted infections have 
been recorded in non-endemic, but vector-established, areas including Australia (DENV) 
[229], Europe (DENV and CHIKV) [230-232], the Americas (DENV, CHIKV and ZIKV) [233, 235-
238] and Pacific Islands (DENV, CHIKV, ZIKV and RRV) [12, 23, 239-241]. Another possible 
source of the virus importation is by way of infected mosquitoes arriving on aircraft or 
shipping [666]. However, it has been suggested that mosquitoes as a source of infection are 
probably overestimated [684]. It is possible that biosecurity measures make this route of 
arbovirus importation less likely than that of viraemic travellers which may be asymptomatic 
and pre-symptomatic are not subject to scrutiny. If so, when assessing the risk of introducing 
infectious disease viruses to non-endemic countries with a population that is predominantly 
immunologically naive, like New Zealand [17, 20], the main surveillance effort, besides 
evaluation of local competent vector status, should be in the evaluation of the extent of 
imported disease notified by via travellers. 
Primary Aedes vectors [e.g. Ae. (Stegomyia) aegypti (Linnaeus)and Ae. (Stegomyia) albopictus 
(Skuse)] for human arbovirus transmission are regularly intercepted at Auckland’s 
international ports [12, 666]. Under the current weather conditions, Auckland and the 
Northland regions are suitable for the establishment of Ae albopictus, and with projected rise 
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in temperature, these areas also could be accessible for Ae aegypti [28]. In the current study, 
about 60% of the arbovirus cases were notified in the Auckland region. These factors increase 
the risk of local transmission in northern New Zealand. 
3.5.4 Mosquito bite‐avoidance measures  
The majority of cases reviewed for this study made little effort to avoid mosquito bites even 
during high-risk periods and outbreaks. Of all cases recorded as using at least one of the 
avoidance measures (including use of bed nets, mosquito repellent, wearing of protective 
clothing, screened or air-conditioned accommodation), only 4.8% (n=1004 cases) always used 
all of these measures. During the nine New Zealand peaks of notifications, the most 
commonly visited countries (Samoa, Cook Islands, Tonga, Fiji and Indonesia) were 
experiencing outbreaks of similar infections. Although information was available of ongoing 
outbreaks in these countries on the official websites of New Zealand Ministry of Foreign 
Affairs and Trade (safetravel.govt.nz) [685], the CDC [686] and the WHO, only 2% (n=263) New 
Zealand infected visitors always used all of the precautionary behaviour measures. This 
suggests that most of New Zealand travellers underestimate or are not aware of the risk of 
travel-related mosquito borne infections. 
Although it is the responsibility of travellers to collect information and to be aware of 
associated risks and methods of prevention, the medical and the travel professions can 
provide a great deal of advice [687]. According to WHO (2018) [688], “risk communication” is 
a key pillar of response to national or international epidemics. It refers to “the real-time 
exchange of information (e.g. advices) on risk between health experts (communicators) and 
people who face a threat/hazard (audience) to their health and well-being” [688]. New 
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Zealand travellers to endemic or epidemic areas, mainly, Asia Pacific region, should be 
informed about ongoing risks and updated on the latest disease situation and new trends, 
particularly during high-risk periods and peak travel times. As most travellers now buy airline 
tickets, accommodation, and travel insurance online, securing advertising space with links to 
“safetravel.govt.nz” or a reminder to check the epidemiological status of destination 
countries on flight, accommodation and travel insurance websites should be considered. 
Public health awareness campaigns and pre-travel advices should be promoted not only 
through websites, but also via media, mobile phone-based short messaging service (SMS), 
travel agents, tour operators, hospitals and clinics, airline and shipping companies. Aircrew 
members can have an important role by advising travellers to endemic and epidemic 
countries during the pre-flight safety briefings. Pre-travel advice should include information 
about destinations and seasons associated with high risk, access to medical facilities in foreign 
countries, reciprocal health-care agreements between New Zealand and the destination 
country, health insurance, quality of accommodation and the use of certain medications 
[689]. Travellers who seek health consultation from a health professional before traveling 
showed better awareness of infectious disease risk, more precise risk assistants and a greater 
level of planned risk-reducing behaviours [690-694]. Travellers should also be advised to 
urgently seek medical care if they develop flu-like fever, chills and muscle aches after 
travelling, particularly to high-risk areas. Of all hospitalized cases recorded in this study, only 
37% reported seeking hospital-based care. 
Until awareness of the risks associated with travel to arbovirus-endemic countries among 
travellers improved, cases of arbovirus infections will continue to escalate, unless a cost-
effective vaccine is developed or Aedes mosquitoes can be effectively controlled. Therefore, 
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clinicians in New Zealand, especially in Auckland, will counter increasing caseload of travellers 
returning from endemic or epidemic areas, especially Oceania. 
3.6 Study limitation 
A limitation of this analysis was the inability to determine “residency status” of individuals 
with notified cases since this is not recorded in the Case Report Forms (CRF). This information 
would help to identify the extent to which the infection risk during travel and associated risk 
for establishing local transmission could be reduced through the New Zealand travel 
industry/authorities or by targeting traveller arrivals directly. 
Further, travelling to high-risk destinations for holidays and the little effort reported by the 
majority of infected travellers to avoid mosquito bites (even during high-risk periods and 
outbreaks) could not be attributed to inadequate awareness or not taking adequate or 
suitable precautions. Therefore, an assessment of patient prior knowledge of the disease 
status of their travel destinations should also be added to the CRF. This will help to identify 
whether the responsibility for risk of infection during travelling rests with the New Zealand 
travel industry/authority or the travellers themselves. 
3.7 Conclusion 
Between 2001 and 2017, New Zealand experienced a significant increase in imported cases of 
arbovirus infections, with more than half of the cases occurring in the final four years. This 
involved a substantial increase in the number of dengue notifications, and the emergence of 
CIHK and ZIK. The notifications of these diseases showed seasonality, with the highest 
incidence in returned travellers from arrivals in Auckland from Pacific Islands during summer 
and early autumn. Therefore, information on relative risk according to season and epidemic 
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activity at the destination should be considered in pre-travel health consultations. The 
majority of notified cases reported taking little efforts to avoid mosquito bites even during 
high-risk periods and outbreaks. This suggests that most of New Zealand travellers 
underestimate, or are unaware of, the travel-associated risk for mosquito borne disease. 
Improved education and awareness of the risk related to travel to endemic destinations 
(mainly Asia-Pacific region) is required to encourage travellers to seek pre-travel medical 
advice and adopt personal protective measures against mosquito bites. This, combined with 
awareness among local clinicians and appropriate laboratory diagnostic facilities, is crucial for 
the early detection of travel-related infections and for the subsequent prevention of 
transmission in New Zealand in general, and in the Auckland region in particular, if competent 
vectors become established. The development of a case-based reporting system to provide 
early warning of new or spreading infections to appropriate authorities highlights a need for 




Chapter 4 : Intercepted mosquitoes at New Zealand ports of entry, 
2001-2018 
4.1 Abstract 
Background: Important vector of mosquito-borne diseases are extending their range via 
international travel and trade. Climate change makes New Zealand an increasingly suitable 
environment for less tropically adapted exotic mosquito vectors to become established. This 
shift will add a multiplier effect to existing risks of both the establishment of new species and 
of resident exotic species extending into new areas.  
Methods/aims: Information on mosquito interception records and air and sea freight 
imports, and international passenger flight arrivals to New Zealand between June 2001 and 
March 2018 were obtained from national sources. Trends in the border interceptions of exotic 
mosquitoes were described and the role of imported goods as a mean of transport was 
evaluated. 
Results: Ae. (Stegomyia) albopictus (Skuse) and Ae. (Stegomyia) aegypti (Linnaeus), the two 
most commonly intercepted species, were only intercepted in Auckland. Used tyres and 
machinery were the main mode of entry for both species. The majority of Ae. albopictus were 
transported as larvae by sea, while most Ae. aegypti were transported as adults by air. 
Continuing introductions of these mosquitoes, mainly arriving via Japan or Australia, increase 
the risk of the local transmission of mosquito-borne diseases in New Zealand in general and 
in the Auckland region in particular.  
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Conclusion/implications These findings reinforce the need for a high performing and 
adequately resourced national biosecurity system, particularly port surveillance and 
inspection. Recommended biosecurity improvements are described. 
4.2 Background 
The rate of introduction of exotic mosquito species in new geographic areas has increased 
notably in parallel with global trade and travel [41-43, 695]. The spread of the container-
breeding species Ae. (Stegomyia) albopictus (Skuse) and Ae. (Stegomyia) aegypti 
(Linnaeus)beyond their native range has been facilitated by trade of goods, significantly in 
used tyres and machinery [696-698]. These two species are of major public health concern, 
as they are the main vectors of the most important arbovirus diseases, including yellow fever, 
dengue, chikungunya, and Zika [699]. Despite the widespread distribution of these 
arboviruses, the majority are found in tropical and subtropical climate zones where Aedes 
mosquitoes are prevalent [74]. 
Ae. albopictus was initially considered native to humid tropics of Southeast Asia. However, 
during the last four decades, it has expanded geographically [78, 160] to mid-latitude 
temperate areas of all continents [223, 700], making it the most invasive mosquito species in 
the world [700]. The main factor contributing to the aggressive colonizing capacity of Ae. 
albopictus seems to be its ability to adapt to different climates through the production of 
diapausing cold-resistant eggs, with temperate strains surviving cold winters in mid-latitudes 
[160, 223]. 
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Ae. aegypti is distributed predominantly in the tropical regions of all continents, as well as 
some subtropical regions such as the south-eastern United States, northern Australia and 
northern India [701]. Up to the beginning of the 20th century, this invasive species was 
established in temperate countries in Europe as far north as Belarus and Ukraine [702]. It has 
recently re-established on the island of Madeira (south-west of Portugal) [703], around the 
Black Sea [704], and in Netherlands [705]. Unlike Ae. albopictus, Ae. aegypti does not 
overwinter in the egg stage. Instead, the active stages minimize exposure to unsuitable 
environmental conditions by utilising sheltered sites in urban settings (e.g. water tanks) [706]. 
Reiter [702], however, claims that there are no climatic reasons why Ae. aegypti could not 
become widely established in other temperate regions, if introduced or reintroduced. 
The transport of immature stages of Aedes species via the used tyre trade appears to account 
for the establishment of Ae. japonicus in France [707] and the United States [42, 708]; Ae. 
albopictus in Albania, France and Italy in Europe [223, 709]; the United States, 10 other 
countries in the Americas [710] and elsewhere [42, 708, 711]. The establishment of Ae. 
albopictus in the United States for the first time in 1985 followed a substantial increase in 
used tyre imports shipped from Japan after 1980. Subsequently, Ae. albopictus was recorded 
in 26 states [712]. By the late 1990s, the United States CDC stopped tyre inspections because 
Ae. albopictus had already invaded most of the country [225]. Used tyre transportation may 
not have played such a major role in recent invasions of Ae. aegypti [42]. However, used tyre 
shipments [223, 709] from the United States were the major source of Ae. aegypti mosquitoes 
transported to South America [713] and the Netherlands [714]. 
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There are also concerns over the introduction and establishment of exotic mosquito vectors 
by aircraft into countries where they are not indigenous [41]. Aircraft were probably 
responsible for the introduction of the Ae. aegypti into Trinidad and Tobago [715], Bermuda 
[716], Bolivia and Colombia[41]. Further, dengue and Ross River Virus (RRV) infection 
outbreaks followed the introduction of Ae. albopictus by aircraft into the Solomon Islands 
[41], Ae. vigilax into Fiji [717], and most of the Western Pacific region [41, 717]. The 
establishment of mosquitoes depends on suitable ecological conditions. Despite the 
predominantly temperate climate (subarctic in the north and subtropical in the south) [718], 
Ae. albopictus is widespread in Japan, with northward expansion (to latitude 38 degrees 
north; annual mean temperature of 11°C) [719]. For the first time since World War II, Tokyo 
recorded an outbreak of dengue in early autumn 2014 [545]. Dengue epidemics in Japan are 
likely to increase over the next decades, facilitated by the continuing geographic expansion 
of Ae. albopictus and favourable climatic conditions [720]. Increasing temperature has been 
also implicated as a major factor in the establishment and re-establishment of Aedes species 
and their associated diseases in Europe [43, 545]. 
Global climate change is projected to have a marked effect on larval development, female 
feeding behaviour, arbovirus replication and transmission [18, 181, 721, 722]. Global climate 
models project a rise in mean temperatures of 1.5°C by sometime between 2030 and 2052 
[723]. This change would create new ecological niches for mosquito vectors, altering the 
global spatio-temporal distribution of mosquito-borne diseases [724, 725]. Consideration of 
adaptability and dispersal ability, combined with climate change projections and current risk 
mapping, suggest that new introductions and establishment of at least one of the two Aedes 
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species are very likely to occur in new geographic areas [78, 160] including those countries 
with rigorous biosecurity systems such as France, Australia and New Zealand [726]. 
New Zealand has only 12 documented native mosquito species, despite its temperate climate 
and suitable environments for mosquitoes to establish [44, 249]. New Zealand’s peculiar 
indigenous fauna (notably a lack of land mammals as hosts), high level of anthropogenic 
environmental change [18], and increasing global trade (mainly shipping) and tourism make 
it vulnerable to invasion by exotic mosquitoes. All three resident mosquito species that are 
known vectors of human disease are introduced: Ae. (Finlaya) notoscriptus (Skuse), Ae. 
(Halaedes) australis (Erichson) and Cx. (Cx.) quinquefasciatus (Say) [44]. The establishment of 
Ae. notoscriptus and its southward expansion may serve as a blueprint for the establishment 
of other cold-hardy exotic mosquitoes in New Zealand, especially Ae. albopictus [45, 46]. Laird 
et al. [45] first alerted authorities that used tyres were a source of imports and potential 
infestation by known vector species. He reported about a hundred Ae. albopictus larvae in a 
used tyre shipment from Japan. Derraik [12] found in 2004 that used tyres and machinery 
comprised about 75% of all mosquito interceptions arriving by ships in New Zealand. 
According to Kramer et al. [39], at least two endemic species [Cx. (Cx.) pervigilans Bergroth 
and Ae. (Ochlerotatus) antipodeus (Edwards)] are also potential arbovirus vectors. 
The aim of this study is to describe trends in border interceptions of exotic mosquitoes and 
evaluate the role of used tyre and vehicle imports as means of transport. The present study 
updates and expands on the review of Derraik [12] on mosquitoes intercepted in New Zealand 
to 2004. The study objectives are to: 
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1. Examine New Zealand exotic mosquito interception data, pathways and ports of entry for 
the period July 2001 to March 2018. 
2. Examine New Zealand import data for potential water receptacles (used tyres and used 
machinery) in the same period of time. 
3. Evaluate the role of used tyres and vehicles imports as a contributor to exotic mosquito 
introductions, especially for the container-breeding species, Ae. albopictus and Ae. 
aegypti. 
4. Examine interceptions of new vector mosquitoes as a risk factor for local transmission of 
arbovirus disease in New Zealand, and to consider implications of identified trends for 
present and projected climate conditions and for biosecurity practices. 
4.3 Methods  
4.3.1 The interception records 
Mosquito interception data were provided by the New Zealand Ministry of Health from 
records obtained between June 2001 and March 2018. The data were categorised according 
to mosquito species, country of origin, mode of entry, port of entry, and date of interception. 
The New Zealand Ministry of Health [727] defines an interception event as the confirmation 
that adult mosquitoes or larvae of public health significance are detected at or before the 
New Zealand border, or in association with recently arrived travellers or goods. Considering 
the impact of current biosecurity import practices on preventing the arrival of mosquitoes 
from overseas, an even wider definition has been adopted. This study considered an 
interception event to be the detection of any mosquito, dead or alive, of foreign or unknown 
country of origin, irrespective of whether the species is already present in New Zealand 
(established). If more than one mosquito species were intercepted at the same time, each 
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species (regardless of numbers of specimens) was considered as a separate interception 
event. Vessels, mainly ships, stop at one or more ports prior to arriving in New Zealand. This 
makes it difficult to confirm the origin of an invading species. The present study followed 
Derraik [12] in assigning origin to the last overseas port of call but appreciate that this does 
include an element of uncertainty. According to the Ministry of Health [281], the exotic 
mosquitoes listed on the “Unwanted Organisms Register” in New Zealand include all 
mosquitoes of the genus Anopheles plus 13 other species. 
According to New Zealand BioSecure [44], there are three lines of defence to prevent the 
establishment of exotic mosquitoes in New Zealand. These lines are: (i) pre-border clearance 
of risk goods conducted by Ministry for Primary Industries Quarantine Service staff at offshore 
sites; (ii) inspection and disinsection, undertaken by public health units and port companies, 
of ships (first port of international call vessels), aircraft, and their high-risk cargo arriving at 
New Zealand ports; and (iii) mosquito surveillance at seaports and airports conducted by 
Public Health Units and the Ministry of Health, including handovers from Ministry for Primary 
Industries, from customs, or transitional facilities. Most of the interception data used in this 
study were obtained from activities of the inspection and disinsection of ships and shipment. 
4.3.2 Interception sites: airports, seaports and their transitional facilities 
Data were examined from seven airports, six seaports, and their transitional facilities (Figure 
20; Appendix H). These are the major commercial ports of entry to New Zealand out of a total 
of 35 air and seaports where biosecurity surveillance is undertaken. The transitional facilities 
are approved to receive containers and goods that pose a potential biosecurity risk, especially 
plants, animals, and related products. At these facilities, the goods or containers are inspected 
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or treated before they can be cleared for entry into the country [44]. There are about 7000 
transitional facilities throughout New Zealand [728]. The entrance pathways of mosquitoes 
intercepted in transitional facilities were assigned to the nearest port and the means of 
invasion (e.g., fruit containers, used tyres, and used machinery) in relation to its origin of 
transport. 
 
Figure 20: Ports of entry of mosquito interceptions in New Zealand, July 2001–March 2018  
137 
4.3.3 Trade data imports and international flights 
Data on air and sea freight imports (including used tyres and vehicles), and international 
passenger flight arrivals to New Zealand (2001 to 2017), were obtained from Statistics New 
Zealand. Used vehicles included motor cars, heavy vehicles, and all special purpose vehicles 
or transporters. Interception data were examined in relation to date, origin, and size of trade 
imports to assess the risk of exotic mosquitoes arriving in New Zealand and their pathways of 
entry. 
4.3.4 Statistical analysis 
Confidence intervals for the proportions of interception records were estimated using the 
Clopper-Pearson exact method. The seasonality for Ae. aegypti and for Ae. albopictus 
interception records were estimated using the Poisson regression model of Stolwijk et. al. 
[729]. Time trends in interception counts were modelled with negative binomial regression 
with overdispersion using the Genmod procedure in the statistical package SAS 9.4 (SAS 
Institute Inc., Cary, NC, USA). For all mosquito interception counts, a model with the year was 
used. For Ae. albopictus and Ae. aegypti, differences in time trends were tested with a model 
with the year, species, and species by year interaction terms. 
4.4 Results 
4.4.1 The interception records 
Interception events: District Health Board officers and New Zealand BioSecure responded to 
over 650 suspected interceptions in the assessment period (Figure 21). Of these, 244 were 
considered interception events and used in the analysis. About 90% of these events had an 
identified foreign country of origin. However, more than 13.5% of the suspected interceptions 
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were flies other than mosquitoes (mainly Chironomids). Of the 44 mosquito species 
intercepted, 18 were on the “Unwanted Organisms Register” (Table 10). These made up 75% 
of exotic interceptions. Ae. aegypti was the most commonly intercepted of the registered 
species, with more than 32% of the total, followed by Ae. albopictus, (22%). The number of 
Ae. aegypti and Ae. albopictus interceptions is likely to be higher, since 49 out of 244 records 
were taxonomically unidentifiable or identified to genus level only (Figure 21). The 
established species (Ae. camptorhynchus, Cx. quinquefasciatus and Ae. notoscriptus) of 
presumed foreign origin were intercepted 56 times. Although Ae. (Ochlerotatus) 
camptorhynchus (Thomson) was declared to be eradicated from New Zealand in June 2010, 
it remains a high-risk species on the register [730]. 
 
Figure 21: New Zealand Interception records, July 2001—March 2018  
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Table 10: Species and development stages of mosquito interception events in New Zealand, July 
2001—March 2018 
Species No. of Events (Larvae) 
Culex 107 (14) 
Cx. quinquefasciatus 60 (11) 
Cx. sitiens * 8 (1) 
Cx. australicus 6 (0) 
Cx. pervigilans 5 (0) 
Cx. pipiens * 2 (0) 
Cx. gelidus * 2 (0) 
Cx. nigripalpus 1 (0) 
Cx. annulirostris* 1(0) 
Cx. ocossa  1 (0) 
Cx. tritaeniorhynchus 1 (0) 
Cx. fuscocephala 1 (0) 
Cx. sp. 19 (2) 
Aedes 108 (47) 
Ae aegypti * 29 (11) 
Ae. albopictus * 20 (15) 
Ae. notoscriptus  14 (6) 
Ae. vexans  8 (0) 
Ae. camptorhynchus* 6 (3) 
Ae. japonicus * 6 (4) 
Ae. vigilax * 6 (1) 
Ae. taeniorhynchus  3 (0) 
Ae. polynesiensis* 2 (2) 
Ae. vittiger 2 (0) 
Ae. alternans 2 (0) 
Ae. tremulus  1 (1) 
Ae. cinereus 1 (0) 
Ae. infirmatus 1 (0) 
Ae. sollicitans  1 (0) 
Ae. cooki 1 (1) 
Ae. togoi * 1 (1) 
Ae. sierrensis * 1 (1) 
Ae. sp. 3 (1) 
Anopheles 6 (1) 
A. siniensis* 1 (0) 
A. subpictus * 1 (0) 
A. stephensi* 1 (0) 
A. crucians* 1 (0) 
A. culicifacies* 1 (1) 
A. albimanus* 1 (0) 
Other 9 (3) 
Mansonia humeralis  1 (0) 
Culiseta annulata 1 (0) 
Coquillettidia nigricans  1 (0) 
Uranotaenia sp. 1 (0) 
Verralina funerea 1 (0) 
Mansonia titillans 1 (0) 
Toxorhynchites speciosus 1 (1) 
Tripteroides bambusa 1 (1) 
Uranotaenia novobscura 1 (1) 
Mosquito spp.  14 (1) 
Total 244 (66) 
* On Ministry of Health “Unwanted Organisms Register”. 
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Origin of interception: Twenty-eight interceptions were of unknown origin (Figure 21). The 
balance of 179 interceptions came from 33 different countries (Table 11), of which Asia-Pacific 
countries were the major contributors, with more than 75% of the reported interceptions.  
Table 11: Countries of origin and development stages of mosquito interception events in 
New Zealand, July 2001—March 2018 
Origin of Transport  No. Events (Larvae) % by Total 
South Pacific 95 (29) 38.9 
Australia  48 (9) 19.7 
Fiji 12 (0) 4.9 
Vanuatu 7 (6) 2.9 
Samoa 6 (4) 2.5 
New Caledonia 6 (0) 2.5 
Cook Islands 5 (5) 2.0 
Tonga 5 (0) 2.0 
Wallis and Futuna 2 (2) 0.8 
Niue 1 (1) 0.4 
Papua New Guinea 1 (1) 0.4 
Guam 1 (0) 0.4 
Noumea 1 (0) 0.4 
Asia 52 (19) 21.3 
Japan 23 (15) 9.4 
India 4 (1) 1.6 
Philippines 4 (0) 1.6 
China 4 (0) 1.6 
Thailand 3 (0) 1.2 
Hong Kong 3 (0) 1.2 
Malaysia 2 (1) 0.8 
Korea 2 (1) 0.8 
Taiwan 2 (0) 0.8 
Vietnam 2 (0) 0.8 
Singapore 2 (1) 0.8 
Cambodia 1 (0) 0.4 
Americas 46 (4) 18.9 
Ecuador 21 (0) 8.6 
USA 17 (4) 7.0 
Chile 3 (0) 1.2 
Canada 2 (0) 0.8 
Panama  1 (0) 0.4 
Argentina 1 (0) 0.4 
Colombia 1 (0) 0.4 
Europe 4 (0) 1.6 
Netherlands 2 (0) 0.8 
Germany 2 (0) 0.8 
Unknown 47 (15) 19.3 
Total 244 (66) 100 
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Predictably, Australia, as the closest to New Zealand and the main destination and source for 
tourists and trade, appears to be, by far, the most common source of interceptions, 
accounting for 19.7% of the total interceptions of known origin. Since Cx. pervigilans is 
endemic, it is likely that specimens intercepted are from a local source. Japan was the second 
source of interceptions of a known origin, with 11.7%, followed by Ecuador, the major source 
of fruit imports (mainly bananas) to New Zealand. 
Entrance pathway: The major pathway of entrance for mosquito interceptions to date has 
been by sea. More than 66% of known interceptions were at six New Zealand seaports (Table 
12). Of these, 83% were at Ports of Auckland. The remaining 34% were in seven airports. 
Auckland International Airport was by far the main entry point, accounting for more than 81% 
of air pathway interceptions. Auckland was the main city of entry, with 201 records (134 Ports 
of Auckland and 67 Auckland International Airport), accounting for more than 82.5% of all 
interceptions (Table 4). 
Table 12: Entrance pathway and development stages of mosquito interception events in 
New Zealand, July 2001—March 2018. 
Pathway Port No. of Events 
(Larvae) 
% by Entrance 
Pathway 




Ports of Auckland 134 (52) 83.2 54.9 
Lyttelton Port 11 (5) 6.8  4.5 
CentrePort Wellington 7 (1) 4.4  2.9 
Port of Tauranga 7 (0) 4.4  2.9 
Port of Whangarei 1 (0) 0.6  0.4 
Port Otago 1 (0) 0.6  0.4 




Auckland International Airport 67 (6) 80.7 27.5 
Christchurch International Airport 9 (0) 10.8 4.4 
Wellington Airport 3 (0) 3.6 1.2  
Tauranga Airport 1 (0) 1.2 0.4 
Hamilton Airport 1 (1) 1.2 0.4 
Hastings airport 1 (0) 1.2 0.4 
Marlborough Airport 1 (1) 1.2 0.4 
Total interceptions by air 83 (8) 100 34 
Total interceptions 244 (66) 100 100 
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Stages of development: About 73% of the mosquito interceptions were recorded as adults 
(Table 13). The major pathway for both adults and larvae has been by sea, 58% and 88%, 
respectively (Table 13). Ae. aegypti, Ae. albopictus, and Cx. quinquefasciatus made up 56% of 
the intercepted larvae (Table 10). Most larvae (48/66) originated from the South Pacific 
(29/66) and Asia (19/66) (Table 11). Used tyres and machinery accounted for about 60% of all 
larval interceptions and about 91% of larval interceptions with known modes of transport 
(Table 14). 
Table 13: Development stages and pathways of mosquito interception events in New 
Zealand, July 2001—March 2018. 
Stage Entrance Pathway No. of Events % by Stage % by Total 
Adult By air 75 42 31 
By sea 103 58 42 
Total adult interceptions 178 100 73 
Larvae By air 8 12 3 
By sea 58 88 24 
Total larvae interceptions 66 100 27 
Total interceptions 244 100 100 
 
Table 14: Mosquito interception events in New Zealand, July 2001—March 2018. 






By air Air 
Containers  
Roses, fresh fruits, and vegetables 11 (0) 13.3 4.5 
Unspecified 9 (0) 10.8 3.7 
Luggage 7 (1) 8.4 2.9 
Unknown  Inspection at and around 
ports/transitional facilities  
35 (1) 42.2 14.3 
Aircrafts inspection 14 (2) 16.9 5.7 
Surveillance traps 7 (4) 8.4 2.9 
Total interceptions by air 83 (8) 100 34  
By sea Used tyres 25 (19) 15.5 10.2 
Used machinery 29 (20) 18 11.9 
Containers Fresh fruits and vegetables 30 (1) 18.6 12.3 
Manufactured goods 9 (0) 5.6 3.7 
Empty 5 (0) 3.1 2 
Unspecified 20 (2) 12.4 8.2 
Unknown Ports/ transitional facilities inspection 14 (3) 8.7 5.7 
On ships- inspection 25 (12) 15.5 10.2 
Surveillance traps 4 (1) 2.5 1.6 
Total interceptions by sea 161 (58) 100 66  
Total interceptions 244 (66) 100 100 
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Means of transport: This was unknown in 99 cases (≈41%; Table 14). These were intercepted 
at seaports, airports, and their transitional facilities during mosquito port inspection and 
associated surveillance. Mosquitoes entered by ship in fresh fruit and vegetable containers 
(30/244), used machinery (29/244), and used tyres (25/244). Mosquitoes entered by 
airfreight in fruit and vegetable containers, personal luggage, and unspecified good 
containers, collectively accounting for 11% (27/244) of the cases. 
Years of interception: Between 2001 and 2015, the records of mosquito interceptions in New 
Zealand varied between 6 and 21 records per year. However, an increase to 30 and 36 
interceptions was recorded in 2016 and 2017, respectively (Figure 22). Overall, there was a 
significant mean annual increase of 7% (mean estimate 1.07, CI 1.03–1.12; p = 0.0009). 
 
Figure 22: Ae. aegypti, Ae. Albopictus, and total foreign mosquito interception records in 
New Zealand, July 2001—December 2017. 
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Ae. aegypti and Ae. albopictus: To date, Ae. aegypti and Ae. albopictus were only intercepted 
in Auckland. Most Ae. aegypti were intercepted as adults arriving by aircraft. In contrast, most 
Ae. albopictus entered the country as larvae by sea (Table 15). Ae. aegypti was intercepted 
19 times at Auckland International Airport and 10 times at Ports of Auckland, while Ae. 
albopictus was intercepted 19 times at Ports of Auckland and only once at Auckland 
International Airport. Most Ae. albopictus arrived in used machinery (40%) and used tyres 
(20%). Ae. aegypti arrived mainly in used tyres and machinery (60%) (Table 15). While the 
country of origin of more than half of the Ae. aegypti intercepted was unknown (51.7%), Japan 
was the most common source of Ae. albopictus (40%) (Table 15). 
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For Ae. aegypti, an annual increase of 20% (mean estimate 1.20, CI 1.08–1.34) was significant 
(p = 0.0009) and for Ae. Albopictus, there was no significant change (mean estimate 0.93, CI 
0.84–1.03; p = 0.15). Considerable yearly variation was found and the main increase in Ae. 
aegypti occurred over the last four years (Figure 22). The monthly interception records of 
both species peaked in summer between December and February (Figure 23). This indicates 
a significant seasonality for Ae. aegypti (p = 0.003) and for Ae. albopictus (p = 0.047). 
Since exotic mosquitoes in general, and Ae. albopictus and Ae. aegypti in particular, mainly 
arrived in used tyres and machinery, trends in import data for used tyres and machinery were 
also examined to be compared with the interception data. 
 
Figure 23: Monthly records of Ae. aegypti and Ae. albopictus intercepted in New Zealand, 
July 2001—December 2017. 
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4.4.2 Trade data imports and international flights 
Sea and air freight: Between 2001 and 2017, the total gross weight of New Zealand’s sea and 
air freight imports increased by 60% (Figure 24) and 14% (Figure 25a), respectively. 
 
Figure 24: New Zealand total gross weight of sea imports, total number of used tyre 




Figure 25: (a) Left axis: Total number of passenger flights to New Zealand from all overseas 
ports and from ports where Ae. aegypti is established. Right axis: New Zealand total gross 
weight of airfreight imports. (b) Total number of passenger flights to New Zealand from 
major overseas ports where Ae. aegypti is established. 
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International passenger flight arrivals: The total number of international flights to New 
Zealand during the period of the study increased by more than 71% (from 22,180 to 38,027) 
(Figure 25a). The most frequent international flights to New Zealand during the study period 
were from Sydney (146,082), Melbourne (78,497), and Brisbane (75,322). There was a ten-
fold increase in the number of flights from Coolangatta airport (a tourist destination, 
Queensland Gold Coast) over the 17-year period. This makes Coolangatta the fourth highest 
source of international flights to New Zealand from airports where Ae. aegypti was 
established (after Brisbane, Los Angeles and Nadi) (Figure 25b). 
Used tyres: From 2001–2017, New Zealand imported about 5.5 million used tyres from 35 
countries (Table 16). About five million (≈91%) were from 21 countries where Ae. albopictus 
is established, and only about 300,000 (≈5%) were from 16 countries with Ae. aegypti. Japan, 
where Ae. albopictus is indigenous, supplied about 88% of the total number of used tyres. 
Although the total gross weight of New Zealand’s sea imports increased by more than 60% 
(Figure 24), there was an 86% decline in the quantity of imported used tyres from its peak in 
2003 (from around 607,000 to 85,000). During 2001–2003, New Zealand's annual used tyre 
imports averaged more than a half of a million. However, in 2017, this number significantly 
declined to about 85,000 (Figure 24) [44]. 
Used vehicles: In the past 17 years, New Zealand has imported a total of about 2.3 million 
used vehicles from 107 countries. Japan was by far the largest source, with more than 1.95 
million used vehicles, representing about 88% of the total vehicle imports (Table 16). New 
Zealand imported around 133,000 used vehicles per year from 2001 to 2017. However, 
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concurrently with the global financial crisis, the average number of vehicle imports dropped 
to approximately 70,000 vehicles per year between 2007 and 2012 (Figure 24). 
Table 16: Imports of used tyres by New Zealand, 2001—2017 showing countries where Ae. 
aegypti and Ae. albopictus are present 
Country of origin Used tyres Used vehicles Presence or absence  
Quantity % Quantity % Ae. aegypti Ae.albopictus 
Japan 4,703,435 87.7 1,959,112 86.61 - + 
Germany 264,294 4.9 184,852 8.17 - + 
Australia 147,414 2.7 16,832 0.74 + - 
Taiwan 41,680 0.8 24 0.00 + + 
S. Korea 39,811 0.7 5,725 0.25 - + 
Singapore 34,107 0.6 679 0.03 + + 
Netherlands 24,055 0.4 162 0.01 - - 
China 22,538 0.4 276 0.01 + + 
USA 17,388 0.3 36,555 1.62 + + 
UK 13,958 0.3 30,269 1.34 - - 
UAE 12,029 0.2 29 0.00 - - 
Italy 11,529 0.2 3,353 0.15 - + 
Thailand 9,394 0.2 686 0.03 + + 
Malaysia 5,403 0.1 103 0.00 - + 
Hong Kong 4,401 0.1 146 0.01 - + 
Belgium 3,283 0.1 671 0.03 - + 
France 3,207 0.1 8,903 0.39 - + 
Spain 1,588 0 519 0.02 - + 
Switzerland 1,106 0 35 0.00 - + 
Brazil 714 0 9 0.00 + + 
Jordan 559 0 105 0.00 - + 
Finland 89 0 7 0.00 - - 
Argentina 75 0 8 0.00 + - 
Indonesia 46 0 11 0.00 + + 
Fiji 34 0 36 0.00 + + 
Sweden 32 0 11,075 0.49 - - 
South Africa 16 0 661 0.03 + - 
Canada 7 0 220 0.01 - - 
Papua New Guinea 6 0 9 0.00 + + 
Botswana 5 0 0 0.00 - - 
Luxembourg 4 0 1 0.00 - - 
Slovakia 4 0 46 0.00 - + 
India 2 0 104 0.00 - + 
Philippines 1 0 5 0.00 - + 
Zimbabwe 1 0 0 0.00 - - 
Other 0 0 731 0.03  ________  __________ 
Total 5,362,215 100 2,261,959 100          17            22 
Present +   
      
Absent - 
     
150 
4.5 Discussion 
4.5.1 Main findings 
Our findings add to earlier observations that Aedes mosquito vectors, especially Ae. 
albopictus, have extended their range via international travel and trade, especially via used 
tyres and machinery [696-698]. To date, Ae. aegypti and Ae. albopictus have been the two 
most commonly intercepted foreign vector mosquitoes. The Ports of Auckland and Auckland 
Airport were the main ports of arrival into New Zealand and the only points of entry for both 
Ae. aegypti and Ae. albopictus. Most of the interceptions probably originated from Japan or 
arrived via Australia. Japan, where Ae. albopictus is indigenous, was by far New Zealand’s 
largest supplier of both used tyres and vehicles and was also the largest source of Ae. 
albopictus. 
Most Ae. albopictus interceptions have been larvae, imported by sea, and most likely 
originating from Japan. The majority of Ae. aegypti have been intercepted as adults 
transported by air, potentially from endemic neighboring countries with direct and frequent 
flights to New Zealand (e.g. Queensland, Australia). These findings are consistent with the 
biological features of Ae. aegypti and Ae. albopictus, whose eggs are deposited in natural and 
artificial habitats where water levels fluctuate [731]. These eggs are stimulated to hatch by 
rising water levels, often many months later [708]. Larvae of many container-breeding 
mosquitoes are also able to survive food scarcity for several weeks, or even months, longer 
than any immature stages of other mosquito species (e.g., ground water mosquitoes) ) [732]. 
With suboptimal food, larvae of Ae. albopictus can survive between 58 and 80 days [733]. 
However, with enough food, they may develop to adults within two weeks. Another 
physiological adaptation of Ae. albopictus larvae that facilitates their survival in tyres is their 
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superior tolerance to contaminants in tyre leachate compared with other mosquito species 
[734]. Furthermore, Ae. albopictus eggs are thermal and desiccation tolerant and may remain 
viable for several months [161]. 
Sailing time from Japan to Auckland, which is New Zealand's main gateway for international 
trade and the main city of entry for foreign mosquitoes, is between 10–12.5 days [735]. The 
journey time is between 12–17 days from Munich [736], 15 days from San Francisco and three 
days from Australia [640, 735]. Therefore, Ae. albopictus can survive a journey from Japan, 
Germany, or USA to New Zealand in larval and egg stages, possibly under extreme weather 
and food shortage conditions. The adults, however, cannot survive starvation for more than 
seven days [737]. It is, therefore, possible for a female mosquito locked in a vehicle to survive 
a journey from Australia, but this is unlikely to occur from more distant countries like the USA, 
Germany, and Japan [640]. 
It is clear that both Aedes species can travel to New Zealand via shipping and airplanes. 
However, the number of interceptions is relatively small (29 Ae. aegypti and 20 Ae. albopictus 
in 17 years). On the other hand, there were 39 detections of Ae. aegypti at Perth International 
Airport, Australia alone in a six month period (October 2015–April 2016) [738]. In the year 
ending June 2018, more than 10 million international passengers passed though Auckland 
Airport [739]. In the same period, about 4.4 million international passengers travelled through 
Perth International Airport [740]. Both airports receive frequent direct flights from Ae. 
aegypti endemic countries, such as Singapore, Indonesia, Thailand, and many Pacific Islands 
[739, 740]. This comparison provides some support for the effectiveness of current New 
Zealand pre-border biosecurity measures to reduce mosquito introductions and prevent their 
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establishment. Information about the National concerns and development of responses for 
mosquito interceptions is provided in Appendix I. Information about the current programme 
to monitor and exclude exotic mosquitoes in New Zealand is provided in Review Four, Section 
2.4.2.2. 
4.5.2 Current risk status for arbovirus infections 
The New Zealand population is considered to have the highest per capita rate of international 
travel in the world, especially within the Asia Pacific region [284, 741], where epidemics of 
arbovirus disease are an ongoing feature. Imported cases of arbovirus infections are reported 
every year among travellers to New Zealand arriving from endemic or epidemic regions, 
mainly Pacific Islands and Australia [40] Travel and trade conditions, combined with the 
presence of exotic mosquito vectors and global climate change, increase the risk of the local 
transmission of mosquito-borne diseases in New Zealand [284]. A warmer climate will also 
facilitate latitudinal and altitudinal range expansion [28, 181, 725]. This situation is 
compounded by the recent unaccredited cruise ships that have arrived on New Zealand 
shores without being checked by the Ministry for Primary Industries [742]. This concern is 
exemplified by the finding of Cx sitiens larvae by Biosecurity NZ near the Kaipara in March 
2018 .[282] Cx. sitiens is widespread in the Pacific, Australia and Southeast Asia and is a 
competent vector for several arboviruses, such as RRV [283]. 
Furthermore, according to a recent study carried out in Australia, intercepted Ae. aegypti 
mosquitoes detected at international ports in New Zealand and Australia had point mutations 
that confer strong resistance to synthetic pyrethroids, the only insecticide class used for 
aircraft disinsection validated by the WHO [738]. 
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4.5.3 Climatic suitability for Aedes mosquitoes’ establishment in New Zealand 
Establishment and dispersal of exotic mosquitoes after introduction is only possible under 
suitable climatic conditions [545]. According to de Wet et al. [28], and under the current 
temperature and rainfall conditions, Auckland and the Northland regions are the most 
suitable areas in New Zealand for the establishment of Ae. albopictus [306]. However, 
projected increases in temperature, rainfall, and humidity could make these areas suitable 
for Ae. aegypti and extend the geographic distribution of Ae. albopictus to the south [28, 
306].. Using a mid-range climate projection, Pearce et al. [743] reported that Auckland’s 
temperature is expected to increase by 0.5 to 4.2 °C by 2040–2110, depending on future 
concentrations of greenhouse gases in the atmosphere [743]. 
Ae. aegypti and Ae. albopictus, the most commonly intercepted “unwanted” species, were 
only intercepted in Auckland. Moreover, the majority of used tyres and machinery enters New 
Zealand at the Ports of Auckland. Arriving exotic mosquitoes in general, and Ae. albopictus in 
particular, are likely to find a suitable habitat around the ports of entry, while climate warming 
will facilitate their establishment and spread [17]. This local situation illustrates a global 
concern and one of the future human costs of globalizing travel and trade. 
4.6 Implications and recommendations 
The first line of defence against climatic influences on the establishment and spread of 
arbovirus diseases should be to prevent the entry of exotic mosquito vectors. This approach 
is likely to be far more cost-effective than attempting to contain and eradicate exotic 
mosquitoes after their establishment in New Zealand. A particular focus on biosecurity 
practices is recommend, as follows: 
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1. Regularly review mosquito interception practices as part of an integrated vector-
borne disease surveillance system. Consider a surveillance sector approach [744] and 
advice from targeted research –based surveillance to identify potential 
improvements. Such surveillance will be essential to anticipate projected climatic 
influences 
2. As a component of regular reviews of mosquito surveillance and interception 
responses, there should be particular attention given to mosquito surveillance at 
major ports of entry, notably at the Ports of Auckland and Auckland Airport. As the 
present study recognize that interception data are, at least partially, relative to effort, 
this review should include improved standardization of port surveillance procedures, 
recording, and schedules (e.g., install permanent traps and yearlong rather than 
seasonal operation) to provide a reliable baseline for future evaluation. This was a key 
limitation in the quality of data available for this present analysis and review. 
3. Increase the use of molecular methods to enhance mosquito interception 
surveillance. Effective biosecurity surveillance of mosquitoes will depend on having a 
high level of confidence in identifying mosquito species and origins. For example, only 
a third of interceptions linked to aircraft have a specified port of origin. Molecular 
identification (e.g. [745] and [746]) of unknown specimens and genetic origin analysis 
for unknown sources (e.g. [747]) are currently undertaken by an Australian laboratory 
[738]. It is essential to facilitate direct access to New Zealand and international 
molecular expertise and global reference material for this purpose. 
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4. In addition to existing biosecurity practices, new regulations and requirements should 
be adopted for the discarding of waste tyres where they are within the 1600 meter-
zone around ports (the dispersal distance of Aedes mosquitoes [748]). 
5. Review aircraft disinsection procedures for New Zealand. This review should pay 
particular attention to Auckland Airport and the recent increase in interceptions of Ae. 
aegypti [749] in view of the resistance to the pyrethroid pesticides [738] identified in 
specimens intercepted at New Zealand and Australian ports [738].  
6. Use research-based surveillance to regularly evaluate effectiveness and identify any 
specific gaps with regard to current biosecurity measures. 
4.7 Conclusions 
Continuing introductions of Ae. aegypti and Ae. albopictus, and their potential establishment, 
raise concerns about the initiation of locally transmitted mosquito-borne diseases in New 
Zealand in general and in the Auckland region in particular. In 1998, when Italy and Albania 
were the only European countries colonized by Ae. albopictus, Reiter [710] stated that “there 
is no reason to believe that the European countries will be more successful than the United 
States in blocking the importation of cargos infested with Ae. albopictus. In short, it seems we 
must accept the establishment of exotic species as an inevitable consequence of modern 
transportation technology”. Ae. albopictus has now been reported in at least 27 countries in 
Europe. This expansion was facilitated by human activities, in particular the trade of used 
tyres [709]. If New Zealand can learn any lesson from this experience with invasive 
mosquitoes, it is that there should be no complacency. Continued vigilance and investment 
in port surveillance are well justified by existing concerns, while future risks will be 
exacerbated by climatic factors.  
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Chapter 5 : Mapping the potential spatial distribution of Aedes 
(Finlaya) notoscriptus in New Zealand 
5.1 Abstract  
Background: The Australian vector mosquito Ae. (Finlaya) notoscriptus (Skuse)has been 
identified as a potential vector of several arboviruses in New Zealand. Mosquito surveillance 
in New Zealand is mainly limited to international ports and airports for biosecurity purposes. 
Detecting local spatial distribution of Ae. notoscriptus is a key consideration in assessing and 
managing risks of locally transmitted arbovirus diseases, particularly RRV, and might also be 
a good proxy for the potential distribution of Ae. albopictus, assuming their establishment in 
New Zealand and considering the coexistence of the two species in north Australia. 
Aim: Map the potential spatial distribution of Ae. notoscriptus in New Zealand under present 
climate conditions and consider how this might assist the assessment of current and future 
risks of local arbovirus transmission. 
Methods: A multiple logistic regression model was developed by statistically relating Ae. 
notoscriptus occurrence records obtained from three biosecurity surveillance programmes 
with georeferenced environmental predictors. Pooled records of Ae. notoscriptus from all 
three programmes were used initially to test fit with the model, then occurrence records from 
the routine port surveillance programme (comprising the main part of the entire database) 
extracted and retested. 
Results: The model built using routine port surveillance records had better fit (pseudo R2 = 
48%) and predictive accuracy (sensitivity = 67.03, specificity = 96.11) than the combined 
records. The model indicated that mean annual temperature, induration and particular 
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urban/rural profile categories were predictors of the distribution of Ae. notoscriptus. The 
Northland Public Health Unit (PHU), with the highest mean annual temperatures in New 
Zealand, also had mosquito counts that were 40 times greater than those obtained from all 
other PHUs. Although this PHU accounted for only 6.1% of the total occurrence (i.e 
presence/absence), records of Ae. notoscriptus was 14 times more likely to be present in 
“other rural areas” than “major urban areas” (the baseline category). 
Conclusion/implications: The predicted high probability of Ae. notoscriptus in rural areas, 
corresponds with the widespread presence of Australian brushtail possums which could 
provide a marsupial wildlife reservoir for RRV. This suggests that RRV in New Zealand is 
possibly to be maintained in a sylvatic transmission cycle. Considering the coexistence of Ae. 
notoscriptus and Ae. (Stegomyia) albopictus (Skuse) recorded in northern Australia, the 
predicted distribution of Ae. notoscriptus in New Zealand suggests that Ae. albopictus is likely 
to find a suitable habitat around New Zealand ports of entry in the warmer areas of northern 
North Island, particularly Port of Tauranga, Ports of Auckland and Auckland International 
Airport. The predicted absence of Ae. notoscriptus in some urban areas can be explained by 
the restricted geographical representation of the training dataset. Further spatio-temporal 
analyses are required with standardized and more representative occurrence records to 
improve appreciation of where and when potential mosquito-borne diseases may occur. 
Identifying the present species range in New Zealand provides a baseline for comparison with 
future change, when more available habitat is likely to suit the vector and the reservoir host. 
The ability to recognize the coincidence of circumstances leading to local buildup of numbers 
in a particular area will be crucial to anticipate and implement local control of both biting 
nuisance and pathogen transmission. 
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5.2 Background 
The Australian native mosquito Ae. notoscriptus is one of two resident mosquitoes in New 
Zealand which transmit human disease in other countries [47]. Several Australian studies have 
indicated that Ae. notoscriptus is a competent vector of RRV [240, 255, 258, 510], ZIKV [259, 
260] and MVEV [252]. Further details on the public health significance of Ae. notoscriptus are 
provided in Review Two, Section 2.2.1.1. 
This species entered New Zealand from Australia, via shipping in the 1920s [47, 249]. It is 
abundant and widespread mainly in the North Island and at coastal to mid-altitudes [47, 249] 
and appears to be expanding its range southwards [47, 253, 254] (due to its biological and 
ecological flexibility; e.g. overwintering). It has increased cold tolerance in New Zealand and 
recently be been reported south of Timaru on the eastern side of the South Island and in the 
MacKenzie Country [750]. Ae. notoscriptus is also found throughout the Asia Pacific area (e.g. 
Indonesia, New Caledonia, New Guinea and the Solomon Islands) [249], and is now also 
present in the United States, particularly in California [751]. 
In countries where arboviruses are endemic, it is feasible to examine the impact of 
environmental factors on arbovirus disease risk directly from infectious mosquito data (e.g. 
assessing the entomological inoculation rate) [125]. This approach is not possible in New 
Zealand due to the absence of local transmission. Theoretically, in this case, risk can be 
assessed by estimating the vectorial capacity and viewing this in conjunction with other risk 
factors. However, there would be major uncertainties in estimating parameter values and also 
testing would involve biosecurity and ethical constraints [752]. For example, the only vector 
competence study that used local field collected mosquito species from New Zealand was 
159 
conducted in New York, USA because of New Zealand biosecurity reasons [27]. An alternative 
approach, taken in this study, is to focus on vector distribution/abundance as a partial 
indicator of risk. This has the advantage of simplicity, but it should be considered that vector 
distribution/abundance is only one of many factors contributing to risk assessment. Further 
details on factors affecting arbovirus transmission are provided in Review One, Section 0. 
Field records provide information on species distribution and relative abundance at sampling 
sites [49]. This does not provide information on areas that have not been surveyed [753] or a 
baseline for predicting potential distributions or invasions following climate change [754]. 
However, these records provide information on seasonal and daily timing of mosquito activity 
in relation to environmental variables and, therefore, can be used for making predictions of 
species occurrences derived from species distribution modelling (SDM) [50]. SDMs 
statistically predict the distribution of species in unsampled areas or different time periods by 
relating species occurrence data (presence-absence, presence-only or abundance) to 
geographically referenced climatic (e.g. temperature, humidity, precipitation), and/or 
environmental (e.g. land use/land cover; LULC) data [51]. Furthermore, SDMs provide a useful 
tool for predicting spatial patterns and dispersal potential of biological introductions (invasive 
vector species and exotic pathogens), and hence also potential for vector-borne disease 
transmission [755, 756].  
In New Zealand, mosquito surveillance by the Public Health Units (PHUs) and Ministry of 
Health is undertaken primarily for biosecurity purposes, and is limited to relatively small 
sampling areas (mainly airports and seaports) [44]. This is estimated to be <0.002% of the 
total area of the country and includes mainly built and coastal environments. SDMs and 
160 
mapping can describe the New Zealand distribution of potential arbovirus vectors in general, 
and Ae. notoscriptus in particular [11, 12, 17, 18, 20, 28, 666]. 
Several studies have indicated significant concerns about the risk of an arbovirus outbreak in 
New Zealand under the current environmental conditions [11-15, 17-22, 270]. This risk will be 
compounded by climate change, which is expected to make New Zealand an increasingly 
suitable environment for less cool-adapted mosquito vector species to become established 
[28]. To estimate changes in mosquito vector distribution and abundance as the result of 
environmental change, it is first essential to indicate the degree to which current distributions 
can be described by environmental factors [757]. Using an SDM and by developing county-
scale environmental suitability maps, this study 1) estimates the current and potential spatial 
distribution of adult Ae. notoscriptus in areas of New Zealand not covered by the existing 
surveillance systems, and 2) explains how this might be helpful in assessing the present and 
future risk of arbovirus transmission. 
5.3 Methods 
5.3.1 Model selection 
For this study an SDM was used with a logistic regression approach. Logistic regression is an 
ideal candidate model to describe the relationship between one dependent 
binary/dichotomous variable (e.g. present/absent, yes/no, dead/alive, 0 or 1) and one or 
more continuous or categorical predictor variables [758]. Mosquito presence/absence was 
used as the dependent binary variable and environmental variables as predictors. This is a 
standard approach for low dimensional (i.e. large sample size compared to the number of 
covariates) binary outcomes [759], as in this study. 
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Other advantages of logistic regression approach include simplicity and interoperability as it 
does not require computational resources, input features to be scaled or tuning (customizing 
the model to generate the most accurate prediction outcomes) [759]. This occasionally leads 
to outperforming other complicated nonlinear models such as decision trees or other non-
parametric algorithms [760]. Therefore, logistic regression is widely applied by applied 
research practitioners (e.g. ecologist and physicians) and researchers with non-computational 
background for several reasons including lack of expertise, lack of time due to the associated 
practical applications (e.g. field work), and the applied journal requirement to keep data 
analysis simple [759, 760]. However, complex biological processes, such as interactions 
between components of disease cycles, are not readily explained by these models. 
Furthermore, logistic regression models do not perform well for binary predictions where the 
target variable is drawn from a small sample size or not linearly separated (see Appendix J for 
further details) [761]. 
5.3.2 Mosquito occurrence data 
Mosquito occurrence records were obtained from the national mosquito surveillance 
database collected for biosecurity purposes, which includes i) records from routine 
surveillance at international ports of entry, ii) the National Saltmarsh Mosquito Surveillance 
Programme, and iii) findings from inspection and disinsection of vessels by Public Health Units 
and the Ministry of Health. The records are collated by the New Zealand Biosecure 
Entomology Laboratory (NZBEL) for biosecurity purposes, although mostly comprise records 
of resident species, which are the focus present modelling projections. Further details on the 
components, provider and methods of each programme are provided in Review Four, Section 
2.4.2.2. 
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The database contains more than 125,000 adult and larval occurrence records from multiple 
sites with repeat sampling at a few locations, mainly ports and/or airports throughout the 
New Zealand's 12 PHUs between April 2004 and December 2018 (Appendix K). Two sets of 
mosquito occurrence records were used to examine the predictive accuracy and goodness-
of-fit of the model: “all biosecurity dataset” comprised occurrence records from all three 
surveillance programmes, and “routine port surveillance dataset” comprising records 
obtained only from the routine surveillance at New Zealand international ports of entry. The 
latter was investigated further because it comprised most of the national mosquito 
surveillance database (70%) and was likely to be of more consistent scientific quality. Repeat 
records of Ae. notoscriptus from this programme also indicate that this species can develop 
and breed in the environment around ports of entry, which, in turn, would be a suitable 
habitat for arriving exotic mosquitoes. 
Associations between larval indices and arbovirus transmission are not considered to be 
satisfactorily predictive of disease epidemics [762], as only adult female mosquitoes are 
responsible for disease transmission [763]. Further, considering that the data used to build 
the model is records from routine surveillance at international ports of entry, larval breeding 
sites are treated regularly. Hence, many of the occurrence records were negative and 
therefore, might give false negative occurrence. Accordingly, only adult occurrence records 
of Ae. notoscriptus were used in modelling analysis [763, 764]. Binary variables were 
generated to code for presence or absence of adult Ae. notoscriptus at each unique trapping 
site. Presence and absence were defined with respect to the entire period of observation 
(2004 – 2018). 
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5.3.3 Environmental data 
An urban rural classification was obtained from Statistics NZ as a GIS shapefile at census area 
unit scale [765]. Climate, landform, and soil variables were obtained from Land Environments 
of New Zealand (LENZ) [766]. Fifteen environmental predictors widely used in SDMs [767-
769] were examined (Appendix L). The set of predictor variables used in the final model were 
selected using a stepwise procedure (see “model development” below). These were annual 
mean annual temperature (MAT), vapour pressure deficit (VPD), induration (defined as 
continuous variables), and urban rural classification (defined as a categorical variable). 
According to Statistics New Zealand’s 2018 Statistical Standard for Geographic Areas [770], 
the urban/rural profile categorises areas in New Zealand into urban, rural or water areas 
(Table 17). The classes and subclasses are classified based on population size (Figure 26) [771]. 
Demographically, the term urbanization denotes “the redistribution of populations from rural 
to urban settlements over time” [772]. Hence, population size would represent the economic, 
social and environmental characteristics [773]. 
Table 17: Characteristics of urban/rural classes in New Zealand (Source: [770]) 
Urban/Rural Profile Class Characteristics 
Urban areas Major urban areas Areas with more than 100,000 or more inhabitants 
large urban areas Areas with 30,000-100,000 inhabitants 
Medium urban areas Areas with a 10,000 to 30,000 inhabitants 
Small urban areas Areas with 1,000 to 10,000 inhabitants 
Rural areas Rural settlements Areas with 300-1000 inhabitants and at least one public 
or community building (e.g. School, church). 
Other rural Include agriculture and forestry lands, conservation 
areas, and regional and national parks 
Water areas Inland water non-contiguous, demarcated by territorial authority 
(also includes harbours and tidal areas) 
Inlets Non-contiguous, demarcated by territorial authority 
Oceanic Non-contiguous, demarcated by regional council 
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Urban areas are characterised by densely populated centres with heavily clustered built 
environment features for residential, trade, and social purposes. Urban areas are categorised 
into four classes (Table 17). “Major urban areas” was used as the baseline category. According 
to several studies [54, 774-776], mosquito abundance and diversity are usually low in major 
urban areas (e.g. central business districts) due to control efforts, disturbance, and lack of 
waterbodies and vegetation. Rural areas defined as being outside urban clusters. They are 
classified as “rural settlements” or “other rural” (Table 17). To ensure that the urban rural 
profile covers all New Zealand’ geographic areas, water bodies are categorised separately into 
“inland water”,” inlets” and “oceanic” (Table 17). These include inland water bodies larger 
than 50 km2, major ports and harbours larger than 40 km2. 
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Figure 26: Population density by territorial authority, 2013, people per km2 (Source [777])   
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5.3.4 Model development 
Data management and logistic regression analyses were performed in Stata version 15 [778]. 
Using ArcView Geographical Information System (GIS) version 10.4.1, environmental variables 
were spatially matched (georeferenced) to mosquito occurrence records. Data were exported 
from the GIS as a text file. Forward stepwise selection was used to fit the model by selecting 
environmental predictors most strongly associated with mosquito occurrence and remove all 
non-significant variables (P>0.05). The probability cut-off for a prediction of presence was set 
to 0.5. The outcome metric of the model was the probability of mosquito presence (between 
zero and one). Environmental suitability maps of the predicted Ae. notoscriptus distributions 
were then made in the GIS. 
5.3.5 Model evaluation 
The accuracy of the model was assessed by comparing the results with Ae. notoscriptus 
occurrence records obtained from the preliminary surveillance trapping of adult mosquitoes 
conducted in Chapter 6, as well as records collected by Snell in 2005 [254]. The fit of model 
predictions was tested against the observed dataset using specificity (correct prediction of 
absence proportion) and sensitivity (correct prediction of presence proportion).  
5.4 Results 
5.4.1 Model built using all biosecurity records 
Observed dataset: Of a total of 125,573 occurrence records, 20,935 (16.7%) were adults 
(Table 18). Of which, 5,762 (27.5%) sites were positive (i.e. 72.5% confirmed absences), with 
a total number of 124,578 adult mosquitoes collected from 12 PHUs (Table 18). Although 
about 80% of the total occurrence records were in Auckland Regional Public Health Service, 
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Toi Te Ora and Community and Public Health, only 37% of the total mosquito count were 
collected from these PHUs. However, about 54% of the total mosquito count were collected 
from Northland and Hawke’s Bay PHUs, although only 10% of the total occurrence records 
were in these PHUs (Figure 27, Table 18). 
















Auckland Regional Public Health 
Service 
7,197 (34.4) 1,593 (22.1) 20,456 (16.4)  201 (2.8) 2,481 (4.3) 
Toi Te Ora (Bay of Plenty, Lakes) 6,588 (31.5) 1,456 (22.1) 19,254 (15.5)  234 (3.6) 1,527 (2.7) 
Community and Public Health 
(Canterbury, West Coast) 
2,829 (13.5) 396 (14.0) 6428 (5.2)  61 (2.2) 503 (0.9) 
Northland 1,637 (7.5) 1,094 (66.8) 47,216 (37.9)  776 (47.4) 33,705 (58.6) 
Hawke’s Bay 544 (2.6) 313 (57.5) 20,544 (16.5)  101 (18.6) 1,5352 (26.7) 
MidCentral (Lower North island) 531 (2.5) 215 (40.5) 1023 (0.8)  13 (2.4) 89 (0.2) 
Nelson Marlborough 497 (2.4) 319 (64.2) 2,892 (2.3)  66 (13.3) 195 (0.3) 
Waikato 470 (2.2) 64 (13.6) 1,009 (0.8)  24 (5.1) 415 (0.7) 
Public Health South 216 (1.0) 46 (46.2) 407 (0.3)  0 (0.0) 0 (0.0) 
Tairāwhiti 216 (1.0) 155 (71.8) 2,700 (2.2)  76 (35.2) 1,364 (2.4) 
Regional Public Health  
(Wellington and Wairarapa) 
186 (0.9) 100 (53.7) 2605 (2.1)  56 (30.1) 1,852 (3.2) 
Taranaki 24 (0.0) 11 (45.8) 44 (0.04)  4 (16.7) 27 (0.05) 
Total 20,935 (100) 5,762 (27.5) 124,578 (100)  1,612 (7.7) 57,510 (100) 
* Total trap inspections = -ve and +ve trapping events  
** +ve occurrence records/ total occurrence records  
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Figure 27: Public Health Units of New Zealand  
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For Ae. notoscriptus, of the 20,936 adult occurrence records, 1,613 (7.7%) were positive, with 
a total mosquito count of 57,510. About 60% of total Ae. notoscriptus count were collected 
from Northland PHU, although this PHU reported only 7.5% of the total occurrence records. 
On the other hand, Public Health South did not report any presence of adult Ae. notoscriptus 
in 216 trapping occasions during the 13-year period of the surveillance. Surprisingly, of 7,197 
trapping occasions, Auckland Regional Public Health Service reported Ae. notoscriptus in only 
201 (3%; Table 18). 
Model outputs: Table 19 shows the results from multiple logistic regression analyses, which 
evaluate possible associations between mosquito occurrence and urban/rural land areas, 
MAT, VPD and induration. Urban (large and small) areas, rural and “other rural” settlements 
were significant independent predictors for Ae. notoscriptus occurrence, while no association 
was found with medium urban areas and inlets (Table 19). The presence of Ae. notoscriptus 
was weakly correlated with MAT (OR 1.004, 95% CI 1.001-1.007, P = 0.007), VPD (OR 0.997, 
95% CI 0.995-0.998, p= 0.000), and induration (OR 1.200, 95% CI 1.104-1.299, P = 0.00). The 




Table 19: Results of multiple logistic regression model using all biosecurity records predicting spatial 
distribution of adult Ae. notoscriptus in New Zealand (N=20,935). 
 
*Significant predictors in the model (P < 0.05) 
5.4.2 Model built using routine port surveillance records 
Observed dataset: The routine surveillance at international ports of entry reported adult 
mosquito occurrence records from 14,326 different trapping sites in the 12 PHUs (Table 20). 
Of these, 2,778 (19.4%) records were positive, with a count total 44,816 mosquitoes (Table 
20). Toi Te Ora, Auckland Regional Public Health Service and Community and Public Health 
PHUs accounted for 85.5% of the total occurrence records. However, only 2% (n = 276) of the 
total female Ae. notoscriptus recorded in these three PHUs. In contrast, Northland recorded 
about 14,000 Ae. notoscriptus mosquitoes from 870 occurrence records. This comprises 
97.6% of all adult Ae. notoscriptus collected by the routine surveillance at international ports 
of entry in the study period (2004-2017). Further, more than 62.5% (536/870) of trapping 
sites were positive for Ae. notoscriptus in Northland PHU, compared to 11% (118/5,203) in 
Toi Te Ora, 0.4% (17/4,845) in Auckland Regional Public Health Service and 0.5% (10/2,203) 
in Community and Public Health. 
Predictor OR (95% CI) P 
Major urban Reference  
Large urban areas  1.741 (1.224-2.474) 0.002* 
Medium urban areas 1.390 (0.637-3.033) 0.408 
Small urban areas 1.790 (1.143-2.801) 0.011* 
Rural settlements 2.241 (1.420-3.540) 0.001* 
Other rural 0.531 (0.402-0.700) 0.001* 
Inlets 1.128 (0.705-1.803) 0.615 
MAT 1.004 (1.001-1.007) 0.007* 
VPD 0.997 (0.995-0.998) 0.000* 
Induration 1.200 (1.104-1.299) 0.000* 
Model Pseudo R2 0.0621  
Model P 0.000  
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Toi Te Ora 5,203 (36.3) 1074 (20.6) 13,969 (31.2)  118 (2.3) 237 (1.7) 
Auckland Regional Public 
Health Service 
4,845 (33.8) 664 (13.7) 4,982 (11.1)  17 (0.4) 24 (0.2) 
Community and Public Health 2,203 (15.4) 108 (4.9) 186 (0.4)  10 (0.5) 15 (0.1) 
Northland 870 (6.1) 602 (69.2) 21,029 (46.9)  536 (61.6) 13,889 (97.6) 
Hawke’s Bay 327 (2.3) 163 (49.8) 4227 (9.4)  26 (8.0) 34 (0.2) 
MidCentral 301 (2.1) 88 (29.2) 193 (0.4)  6 (2.0) 9 (0.1) 
Waikato 288 (2.01) 15 (5.2) 37 (0.1)  0 (0.0) 0 (0.0) 
Public Health South 123 (0.9) 14 (11.4) 38 (0.1)  0 (0.0) 0 (0.0) 
Nelson Marlborough 118 (0.8) 41 (34.7) 132 (0.3)  9 (7.6) 12 (0.1) 
Regional Public Health 30 (0.2) 2 (6.7) 2 (0.0)  0 (0.0) (0.0) 
Taranaki 13 (0.1) 6 (46.2) 16 (0.04)  1 (7.7) 5 (0.0) 
Tairāwhiti 5 (0.03) 1 (20.0) 5 (0.01)  0 (0.0) 0 (0.0) 
Total 14,326 (100) 2,778 (19.4) 44,816 (100)  723 (5.0) 14,225 (100) 
* Total trap inspections = -ve and +ve trapping events  
** +ve occurrence records/ total occurrence records 
Model outputs: The model built using routine port surveillance records explains about half of 
the variability in the Ae. notoscriptus occurrence (Pseudo R2 = 0.48). Table 21 shows that 
medium urban areas were negatively associated with Ae. notoscriptus occurrence. In 
contrast, “other rural” areas were positively associated with Ae. notoscriptus occurrence. The 
presence of Ae. notoscriptus was positively associated with MAT (OR 1.106, 95% CI 1.050-
1.164, P = 0.000) and induration (OR 1.776, 95% CI 1.320-2.391, P = 0.000), while no 
associated was found with VPD. The sensitivity and specificity of the predictions of mosquito 
presence/absence were 67.03 % and 96.11%, respectively. Since the model built using routine 
port surveillance records had the best fit (R2 = 0.479) and predictive accuracy (sensitivity = 
67.03% and specificity = 96.11%), distribution maps were constructed based on the outputs 
of this model. 
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Table 21: Logistic regression model using routine port surveillance records predicting spatial 
distribution of adult Ae. notoscriptus in New Zealand (N=14,326) 
Predictor OR (95% CI) P 
Major urban Reference  
Large urban areas  2.000 (0.407-9.492) 0.400 
Medium urban areas 0.091 (0.019-0.426) 0.002* 
Small urban areas 0.000 (0.000-1.000) 0.980 
Rural settlements 0.362 (0.064-2.044) 0.250 
Other rural 14.275 (1.611-126.493) 0.017* 
Inland water 4.194 (0.605-29.056) 0.147 
MAT 1.106 (1.050-1.164) 0.000* 
VPD 1.000 (0.986-1.005) 0.376 
Induration 1.776 (1.320-2.391) 0.000* 
Model Pseudo R2 0.479  
Model P 0.000  
 
Environmental suitability maps: Using the outputs of the model built using routine port 
surveillance records, maps predicted distributions of Ae. notoscriptus were developed (Figure 
28). The values represent the probabilities of ‘presence’ of Ae. notoscriptus females, with 
relative probability values ranging from 0 (white) to 1 (brown). This is consistent with the 
relationship between the proportions of sampling locations positive for Ae. notoscriptus and 
MATs (Figure 29). 
Maps indicate that the highest probability of Ae. notoscriptus female presence is in northern 
Northland PHU (50-70%; Figure 30). Ae. notoscriptus presence was also predicted throughout 
Northland (Figure 31) and Auckland Regional Public Health Service PHUs (Figure 31). The 
probability of presence of this mosquito was higher in some locations than others, including: 
along the coasts of Waikato (from the east and west), Toi Te Ora, Tairāwhiti and Hawke’s Bay 
PHUs (Figure 32). It is also potentially present, with a somewhat patchy distribution, along 
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the Regional Public Health PHU in southern North Island (Figure 33). In the South Island, 
however, except minor patches in the north and Christchurch city (Figure 34), the probability 
of presence of Ae. notoscriptus is very low. Most of the predictions correspond with the 
observed distribution of Ae. notoscriptus of the training dataset.  
 
Figure 28: Predicted distribution of Ae. notoscriptus in New Zealand   
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Figure 29: Mean annual temperature of New Zealand, 1981-2010 (Source [779]) 
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Figure 30: Predicted distribution of Ae. notoscriptus in Northland PHU 
 
Figure 31: Predicted distribution of Ae. notoscriptus in Auckland Regional Public Health Service PHU 
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Figure 32: Predicted distribution of Ae. notoscriptus in Waikato, Toi Te Ora, Tairāwhiti and Hawke’s Bay  
 
Figure 33: Predicted distribution of Ae. notoscriptus in Regional Public Health PHU  
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Figure 34: Predicted distribution of Ae. notoscriptus in Community and Public Health PHU  
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5.5 Discussion 
Two different datasets of Ae. notoscriptus occurrence records (all biosecurity vs. routine port 
surveillance records) were used to develop estimates of the potential spatial distribution of 
adult Ae. notoscriptus in New Zealand under present environmental conditions. As it was 
likely to be of more homogeneity and consistent scientific quality, the model built using 
routine port surveillance records had better goodness-of-fit (pseudo R2= 48%), predictive 
accuracy (sensitivity = 67.03, specificity = 96.11) and, therefore, explained more variation in 
Ae. notoscriptus presence. The findings of this model will be discussed. 
Induration, MAT and “medium urban areas” and “other rural areas” urban/rural profile 
categories were statistically significant predictors of the distribution of Ae. notoscriptus. 
Except induration, these predictors, particularly MAT, are in agreement with current 
biological knowledge and habitat preferences of Ae. notoscriptus in New Zealand. It is not 
clear if the positive association with soil induration is direct or a proxy for a factor, such 
environmental moisture (e.g. [254]). 
Routine surveillance at international ports of entry showed that, between 2004 and 2017, out 
of 870 trapping events (6.1% of the total occurrence records), number of adult Ae. 
notoscriptus mosquitoes collected from Northland PHU (n = 13,889) is 40 times more than 
that collected from all other PHUs surveyed (n = 336). Further, in Northland, more than 62.5% 
(536/870) of trapping sites were positive for Ae. notoscriptus. However, Toi Te Ora, Auckland 
Regional Public Health Service and Community and Public Health, PHUs that had highest total 
occurrence records, collectively recorded Ae. notoscriptus in only 1.2% (145/12,251) of their 
trapping sites. Besides Hawke’s Bay, these four PHUs also had the lowest latitudes, and 
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highest MATs and Ae. notoscriptus occurrence percentages. While Waikato, Public Health 
South, Taranaki and Tairawhiti PHUs, which had mid-high latitudes and lowest MATs, never 
reported presence of Ae. notoscriptus. These findings were consistent with the predicted 
distributions of Ae. notoscriptus. Hence, MAT was a predictor of the distribution of Ae. 
notoscriptus in New Zealand. A study which modelled the global potential distribution of Ae. 
notoscriptus, based on an SDM derived from its occurrence records in its Australian native 
range. This study reported that MAT was not “informative” and was not included in the model 
[751]. The model, however, classified the sites where the species has been reported (in 
California) as “sparsely suitable region for this species”. Mosquito development and growth 
rates are temperature dependent (e.g. [42, 148, 779]). Knowledge of how mosquito 
distribution and development varies with temperature, is necessary for development of SDMs 
and mechanistic population modelling with respect to climate change, and current and future 
risk of mosquito-borne disease transmission [779]. 
Establishment and dispersal of exotic mosquitoes after introduction is only possible under 
suitable environmental and climatic conditions, mainly temperature [545]. Ae(Stegomyia) 
aegypti (Linnaeus)and Ae. (Stegomyia) albopictus (Skuse) are the two most commonly 
intercepted species at the New Zealand border [666]. However, Ae. albopictus, the most 
invasive mosquito species in the world [700], seems to be posing the greatest threat to New 
Zealand [17, 666], due to its ability to adapt to different climates through the production of 
diapausing or cold-resistant eggs and temperate strains surviving cold winters in mid-latitudes 
[160, 223]. Considering the coexistence and cohabitation of Ae. notoscriptus and Ae. 
albopictus in the islands of the Torres Strait, Australia [780], the predicted distribution of Ae. 
notoscriptus suggests that Ae. albopictus is likely to find a suitable habitat around New 
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Zealand ports of entry, particularly Port of Tauranga (New Zealand's largest port in terms of 
total cargo volume and container throughput) in the coastal Toi Te Ora PHU, Ports of Auckland 
(New Zealand's 2nd largest port) and Auckland International Airport (the country's largest and 
busiest airport). Therefore, the establishment Ae. notoscriptus in New Zealand might serve as 
a blueprint for the establishment of Ae. albopictus. This hypothesis is supported by an 
Australian study that indicated that the cohabitation of Ae. albopictus with the endemic Ae. 
notoscriptus will probably not prevent the establishment of the former in Australia. 
Considering that Ae. albopictus was only intercepted in Auckland (95% were in Ports of 
Auckland) [666]. This situation is compounded by the intentions of the New Zealand 
government to move ports of Auckland to the Northland [781], the country’s highest MATs 
area, and where about 98% of all adult Ae. notoscriptus collected by the routine surveillance 
at international ports of entry. These findings are in agreement with a national correlative 
modelling study by de Wet et al. [28], who reported that under the current temperatures, the 
Northland and Auckland regions are the most suitable areas in New Zealand for the 
establishment of exotic Ae. albopictus. In addition, projected increases in temperature, 
rainfall, and humidity could make these areas suitable for Ae. aegypti and extend the 
geographic distribution of Ae. albopictus to the south [28, 306]. Information on the 
distribution and abundance of Ae. notoscriptus in New Zealand are key elements for assessing 
and managing the present and future risk of arbovirus transmission, particularly RRV, and 
planning effective prevention and control strategies against introduced arbovirus infections, 
particularly dengue, and their invasive Aedes mosquito vectors, particularly Ae. albopictus. 
Assuming the establishment or introduction of the latter, Ae. notoscriptus, might also have 
the capacity to sustain the transmission cycle of some arbovirus infections, such as dengue, 
in synergy with the introduced/established competent vectors. 
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The model also predicted that Ae. notoscriptus is 14 times more likely to be present in “other 
rural areas” than “major urban areas” (the baseline category). This suggests the abundance 
and wide distribution of this species in rural and forest habitats in New Zealand as this profile 
category represents agriculture and forestry, conservation areas, and regional and national 
parks. These finding are consistent with several literature that reported the presence of Ae. 
notoscriptus in New Zealand’s forests as a sylvan container breeder [250]. Derraik [782] 
(2003), for example, reported that, Ae. notoscriptus in New Zealand are commonly found in 
rot-holes and leaf-axials. Leisnham et al. [783] found that Ae. notoscriptus in Kapiti are 
restricted to native forests. According to Graham (1939), Ae. notoscriptus is naturally more 
abundant and utilizing natural containers such as water bodies held by plants in forest 
habitats. In Australia, a mark-release-recapture study reported that Ae. notoscriptus has 
limited dispersal in urban centres of Brisbane [784]. In South-East Queensland, the prevalence 
and abundance of this species contemporary urban habitats have not been established [785].  
Ae. notoscriptus is an important RRV vector in Australia [240, 255, 258, 510]. In its native 
Australia, RRV circulates among several species of mosquitoes and marsupial reservoir hosts 
with spillover to humans [256, 286, 289, 473, 486]. Historically, in Australia, RRV is considered 
to be a rural disease [240, 508, 510, 512], with the highest incidence rate in rural and remote 
regions of Queensland [786]. In these areas, marsupial mammals (especially macropods and 
possums) are abundant and widespread, with “hot spots” in peri-urban areas with a mix of 
agricultural, residential and remnant natural ecosystems.[787]. In New Zealand more than 60 
million brushtail possums are estimated to occupy 97% of the land area [16, 788], with two-
thirds in the North Island, which has more of their preferred habitat (especially in rural areas 
and where remnant forest borders farmland) [789]. This is also where the constructed model 
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indicated high probability of Ae. notoscriptus presence. The potential of the occurrence the 
Australian rural RRV transmission in New Zealand is supported by serological evidence of 
brushtail possum feeding from engorged Ae. notoscriptus females [790]. To develop early 
warning and management strategies of arbovirus infections, entomological drivers for 
potential RRV local transmission across rural and peri-urban landscapes should be prioritised 
for further investigation, including identification of spatial and temporal distribution, blood 
feeding preferences and source blood meals [791], and vector competence [255, 258] of the 
New Zealand strain of Ae. notoscriptus. The framework for developing an EWS for infectious 
diseases is reviewed in Review Three. 
The model, however, indicated no association between Ae. notoscriptus occurrence with 
large urban areas and a small, but significant, negative association with medium urban areas. 
The low probability of occurrence of Ae. notoscriptus in urban environments predicted by the 
model is inconsistent with the occurrence records of the validation dataset (the preliminary 
surveillance of Chapter 6), as well as several ecological studies reported the well-
establishment of this species in domestic and/or semi-domestic areas in and New Zealand 
and Australia (e.g. [262, 265, 278, 784, 785, 792, 793]).  
The model also predicted the absence of Ae. notoscriptus in most of the Wellington region, 
which is also inconsistent with records of this species in the southern North Island since 1968 
[794]. Since then, Ae. notoscriptus has become abundant, widespread and regularly reported 
in the Wellington region and other urban surrounding urban centres (e.g. [15, 18, 45, 46, 48, 
254, 268, 278, 782, 794]). The predicted absence of Ae. notoscriptus in large urban areas, as 
well as in Wellington regions, can be explained by the restricted geographical representation 
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of the training dataset. As the mosquito records used in this study have been collected for 
biosecurity purposes, PHUs with busy international ports and/or airports were clearly more 
represented than others. While the poor representation of Ae. notoscriptus occurrence in 
urban profile categories can be explained by the location of ports and airports at the edge of 
urban areas (rural-urban fringe or peri-urban area). Given the recent geographic range 
expansion of Ae. notoscriptus into urban and outer metropolitan areas of New Zealand, it is 
conceivable that modification of natural habitat and urban expansion might have implications 
for arbovirus infection risk. Country-scale sentinel surveillance programmes for mosquitoes, 
particularly potential disease vectors, are needed and highly recommended. Precise 
identification of the potential distribution and seasonal dynamics of Ae. notoscriptus, and the 
relative importance of specific drivers to RRV epidemics would have implications during 
potential local RRV outbreaks and might have further benefits for prevention of other 
arbovirus infections in New Zealand. 
5.6 Conclusion 
Using a multiple logistic regression model, this study has indicated that mean annual 
temperatures, urban/rural landscape and soil induration are key correlates of the distribution 
of adult Ae. notoscriptus in New Zealand. Areas in northern New Zealand with the highest 
MATs had the highest presence probabilities. The number of Ae. notoscriptus collected from 
Northland PHU was 40 times more than that collected from all other PHUs combined, 
although this PHU accounted for only 6.1% of the total occurrence records. The model also 
has indicted that “other rural area” have the highest association with Ae. notoscriptus 
occurrence. This finding suggests that Ae. notoscriptus is abundant and widely distributed in 
rural habitat in New Zealand. However, the predicted absence of Ae. notoscriptus from urban 
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areas (where the activity of this species has been recorded) can be explained by the restricted 
geographical and habitat representation of the mosquito occurrence records, which are 
originally collated for biosecurity purposes. Considering the coexistence of Ae. notoscriptus 
and Ae. albopictus in north Australia [780], estimating the potential spatial distribution of Ae. 
notoscriptus has important implications for demonstrating the risk of establishment of Ae. 
albopictus in northern North Island where there may be suitable environmental conditions 
around the ports of entry. The ability to identify the coincidence of circumstances leading to 
local buildup of numbers of mosquito vectors in general, and Ae. notoscriptus in particular, in 
a particular area will be crucial to anticipate and implement local control of both biting 
nuisance and pathogen transmission.  
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Chapter 6 : Surveillance case study: mosquito activity and 
environmental variables in selected built environments 
6.1 Abstract 
Background/aim: Identifying the local environmental factors that affect mosquito seasonal 
abundance and distribution can facilitate prediction of disease transmission and timely 
responses. This chapter aims to identify the ecological and meteorological conditions 
favourable for mosquito biting activity and, therefore, disease transmission from a 
surveillance case study in three urban areas (Kapiti, Palmerston North and Wellington north) 
in the south-west North Island of New Zealand. 
Methods: Light trap surveillance mosquito counts were examined for association with 
selected ecological (vegetation cover and distance to nearest inhabited dwelling), and on-site 
and remotely recorded meteorological factors (temperature, relative humidity and rainfall) 
using negative binomial regressions. 
Results: More than 17,000 female mosquitoes were trapped over a 17-month period. Five 
species belonging to three genera were recorded overall. Ae. (Finlaya) notoscriptus 
(Skuse)was the most widespread (in all three study areas) and most abundant (in Palmerston 
North and Wellington north) species. Cx. (Cx.) pervigilans Bergroth, however, represented 
83% of the total catch, 79% of which came from only two trapping sites at a nature reserve 
with caged birds in Kapiti. Apart from clear seasonality in catch numbers, there was no 
significant correlation identified of Ae. notoscriptus trap catch over the summer (biting) 
period with weather variables or ecological categories tested. Ae. notoscriptus were most 
numerous in trap samples from most of the year. Cx. pervigilans was more likely to be found 
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in greater numbers during warmer but less humid conditions following rainfall, and in areas 
near human habitation and with mature tree canopy coverage. While Cx. (Cx.) 
quinquefasciatus (Say) was present but not abundant in the surveillance habitats (1% of total 
numbers), and occurrence associated with mature trees (mainly native), further away from 
the nearest inhabited dwelling. It also showed distinct seasonality (warmer months), and 
stronger association with warm and drier weather conditions than Ae. notoscriptus. 
Conclusion/implications: The predominance and distribution of the introduced Ae. 
notoscriptus in this study support the view that this species has adapted to built environments 
in New Zealand. It has been suggested that, since European settlement, urbanisation has 
created new anthropic habitats that are underutilised by native species, while they provide 
opportunities for more domesticated exotic species, as appears to be the case for Ae. 
notoscriptus. In particular this involves the availability of artificial and often temporary, water 
containers as larval habitat. There is also some evidence that Ae notoscriptus may displace 
the native natural container-breeding Cx. pervigilans from some of these sites. This appears 
consistent with a high level of environmental adaptability as indicated by wider distribution 
in Australia and south Asia. The expanding geographic range of Ae. notoscriptus in New 
Zealand, particularly in the North Island, represents potential risk for RRV transmission in 
rural, urban and sylvatic transmission cycles. The presence, although in small numbers, of the 
cosmopolitan vector Cx. quinquefasciatus in the surveillance areas, indicates potential for 
transmission of several pathogens in New Zealand, including RRV. 
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6.2 Background 
Environmental drivers of disease transmission have been widely used in statistical and 
mechanistic modelling studies to predict mosquito-borne disease transmission [113, 226, 
795-798]. Some studies have utilised the actual microclimate to which the mosquitoes are 
exposed, while others have used weather station or remotely sensed based data [52, 104, 
113, 799-804]. Weather station and remotely sensed based data are available from most of 
national meteorological station websites and easily accessible. The use of microclimatic 
variables, however, appears to have been limited by the practical difficulties in measuring 
these variables from different habitats and heights [52]. Several studies suggest that 
predictive models would be improved by including measurements of microclimatic variables 
[52, 58-63]. 
Routine mosquito surveillance in New Zealand is limited to air and sea ports and carried out 
for biosecurity purposes. Incidental records for resident species are expected to represent 
port areas and surroundings but may not represent the species mix encountered more 
typically as wider human exposures [12, 27, 805] and, therefore, would show limitations in 
large-scale research studies. For example, the predicted absence of Ae. (Finlaya) notoscriptus 
(Skuse)found in Chapter 5 in some urban areas was due to the restricted geographical 
representation of the training dataset, which was obtained from the routine mosquito 
surveillance records. The lack of absolute adult mosquito count data were identified as a key 
knowledge gap in a modelling study to investigate the potential for RRV emergence in New 
Zealand [31]. 
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Trap catches for selected sites were matched with on-site temperature and relative humidity 
measures. The objectives of this study were: i) to monitor overnight and seasonal activity of 
mosquito species at sites in residential aeras, ii) examine association of weather and site 
characteristics with mosquito trap catch, iii) to compare the use of weather station data and 
on-site measurements for predicting build-up of mosquito populations as a research tool, and 
potential public health tool to anticipate high risk conditions. This information will contribute 
to better understanding of environmental factors favourable for mosquito vector activity, and 
therefore, arbovirus transmission. 
6.3 Methods  
6.3.1 Study sites 
Urban/rural profile classification: Field surveillance was undertaken in three urban areas in 
the south-west North Island of New Zealand (Figure 35); two main areas at Kapiti and 
Palmerston North, and less intensive surveillance at a third area in north Wellington for 
further comparison. Selection of the main areas was based on previous information and 
contacts in Kapiti [254, 806] and Palmerston North [807]. According to Statistics New Zealand 
urban/rural profile classification [808], Kapiti (trap sites at Waikanae & Paraparaumu), 
Palmerston North City and north Wellington (trap sites between Johnsonville & Tawa at the 
northern end of Wellington City) are classified as “main urban areas” because their 
populations exceed 30,000 (i.e. about 215,000, 56,000 and 88,300, respectively, at 30 June 
2019) (Figure 35) [809]. 
Climate: Due to its geographical location surrounded by ocean, the New Zealand climate is 
dominated by large-scale climate systems (e.g. El Niño and La Niña events, the Southern 
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Annular Mode, the Interdecadal Pacific Oscillation). It is typically temperate with a north-
south gradient. There is also a marked difference between the wetter western side, where 
the surveillance sites were located, and drier eastern sides due to prevailing westerly and 
south-westerly winds and mountainous backbone along both islands [810]. 
The National Institute of Water and Atmospheric Research (NIWA) has identified 12 broad 
climate zones. The three study areas are located in “South-West North Island” climate zone 
[811]. In general, this climate zone has a mild, temperate marine climate, and is relatively 
windy and wetter in winters and springs due to westerly winds from the Tasman. Wellington, 
however, is known for its southerly winds in winter (mean annual speed of 22.1 km/hr [812]), 
which make the temperature feel colder than measurements suggest. 
Winter (June, July and August) has maximum air temperatures range between 10°C and 14°C, 
with some light overnight frost in each area, especially inland at Palmerston North during 
settled conditions. Summer (December, January and February) is warm, with maximum air 
temperatures between 19°C and 24°C, and rarely exceeding 30°C. 
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Figure 35: Urban/rural profile categories of the North Island, New Zealand (Source: Statistics New 
Zealand) with study areas indicated 
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6.3.2 Mosquito trapping 
Overnight surveillance trapping was undertaken using standard CO2 baited light traps (CDC 
Miniature Light trap model 512, supplied by John W.Hock Co.Gainesville, Fla USA) placed at 
fixed sampling stations about 1-1.5m above ground. In Kapiti (Table 22; Figure 36) and 
Palmerston North (Table 22;Figure 37), ten traps were set at 12-15 day intervals (depending 
on weather), during the peak period of mosquito activity (February-May 2019 and December-
May 2020)3, and monthly (June-November 2019)4 to follow the seasonal occurrence and 
relative abundance of species across sites. Supplementary samples with up to five traps were 
taken monthly in Wellington north area (Table 22; Figure 38). Trap sites were selected, with 
the permission and support of local councils and private landowners, to represent public 
recreational areas (13/25 traps) and standalone residential properties urban settings (12/25 
traps). These were placed in pairs of similar habitat type and at least 100m apart to provide a 
point of reference in case of damage or vandalism to traps, or otherwise unusual catch (Table 
22).  
On each occasion, traps were set 60-90 minutes before dusk and mosquitoes were collected 
next morning (08:00-09:00 AM). The date of that sampling was defined as the day on which 
the catch net was collected. No trapping was undertaken during rainfall events. The catch was 
despatched and transported to the laboratory in a container with residual dry ice. Trap counts 
were recorded and female mosquitoes were identified to the species level according to 
current keys for New Zealand culicidae [813]. Uncertain or damaged specimens were 
identified in the New Zealand Biosecure Entomology Laboratory (NZBEL). 
 
3 Sessions between March-April 2020 were missed due to the national lockdown in response to the Covid-19 
pandemic 
4 No trapping was undertaken during June and October 2019 due to the continuous rainfall 
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Table 22: Location and main use of the trapping sites 
Area  Station label Trap location 
Kapiti K1 (private property)  40°53'44.8"S 175°00'27.2"E 
K2 (private property) 40°52'47.3"S 175°00'25.3"E 
K3 (Waimeha Lagoon 1)  40°52'06.4"S 175°01'06.9"E 
K4 (Waimeha Lagoon 2) 40°52'07.1"S 175°01'10.9"E 
K5 (Otaihanga Domain 1) 40°52'39.0"S 175°01'03.9"E 
K6 (Otaihanga Domain 2) 40°52'36.0"S 175°01'03.3"E 
K7 (Nga Manu Nature Reserve 1)  40°51'48.4"S 175°03'34.3"E 
K8 (Nga Manu Nature Reserve 2) 40°51'42.7"S 175°03'39.2"E 
K9 (Southward Car Museum 1) 40°53'42.3"S 175°01'44.9"E 
K10 (Southward Car Museum 2) 40°53'43.0"S 175°01'47.5"E 
Palmerston North P1 (private property) 40°21'57.9"S 175°37'22.3"E 
P2 (private property) 40°21'41.1"S 175°37'20.6"E 
P3 (private property) 40°21'56.0"S 175°37'21.1"E 
P4 (private property) 40°20'58.2"S 175°36'05.6"E 
P5 (private property) 40°19'33.3"S 175°38'52.8"E 
P6 (private property) 40°22'07.3"S 175°38'22.8"E 
P7 (Victoria Esplanade 1) 40°22'19.1"S 175°36'56.9"E 
P8 (Victoria Esplanade 2) 40°22'16.9"S 175°36'52.0"E 
P9 (Victoria Esplanade 3) 40°22'14.1"S 175°36'54.7"E 





W1 (private property) 41°13'09.2"S 174°48'49.2"E  
W2 (private property) 41°12'25.3"S 174°48'22.3"E 
W3 (private property) 41°11'11.4"S 174°50'09.4"E  
W4 (private property) 41°09'26.1"S 174°49'39.6"E 
W5 (Lakewood Reserve) 41°12'20.9"S 174°48'22.2"E 
 
6.3.3 Characterization of mosquito trapping sites  
For each trapping site, categories of vegetation cover (mature trees with canopy or 
shrubs/recent plantings sparse or no canopy), distance to nearest inhabited dwelling (<10, 
10-100 or >100m) were recorded. These were the two criteria used to select the trapping 
sites. Distances less than 10m were measured on-site with a tape, while greater distances 
were calculated using “Measure Distance” tool on Google Maps®. 
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Figure 36: Kapiti sampling stations, trap sites K1-K10  
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6.3.4 Meteorological variables 
Weather information was obtained from both government meteorological stations and data 
loggers placed onsite. 
Meteorological stations: Weather data (temperature, relative humidity and precipitation) 
were obtained from Cliflo (www.cliflo.niwa.co.nz), the National Climate Database, between 1 
February 2019 and 31 May 2020 for each of the nearest climate stations. These conform to 
the standards of the World Meteorological Organization (e.g. weather station should be 
positioned far from obstacles, urban areas or other complex landscapes, and representative 
of a large area between 100 -1000 km2) [814], so are not necessarily representative of areas 
where mosquitoes are most active, or with potential human exposures. Climate stations are 
located at Palmerston North Airport (AWS-93399, 40°19'23.9"S 175°37'14.6"E), Paraparaumu 
Airport (AWS-93420, 40°54'12.4"S 174°58'50.8"E), and Porirua City (AWS-93483, 41° 05.25'S 
174° 52.33'E), about 2.3 km, 2.5 km and 6.4 km from the nearest data logger, respectively. 
On-site: Additional measures were linked to particular trapping sites to examine the relation 
of flight activity with small-scale temperature and moisture conditions. On each surveillance 
session five data loggers (Onset HOBO® MX2301 Temp/RH Data Logger, Bourne, MA, USA) 
were pegged about 0.5 metre above the ground, within a one metre radius of selected traps 
(avoiding the CO2 plume) to record hourly ambient temperature and moisture conditions 
during the trapping period. Daily and overnight means and minimum temperatures, daily and 
overnight maximum temperature, average, minimum and maximum humidity were obtained 
from this information. 
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6.3.5 Statistical analysis 
Relationships of mosquito counts to weather conditions during the time mosquito traps were 
running were examined using negative binomial regressions. Mosquito counts and selected 
trap site characteristics were examined similarly. The glimmix procedure of statistical package 
SAS 9.4 (SAS Institute Inc, Cary NC) was used, with a spatial power covariance structure for 
each trap site. The Kenward and Roger standard error and degrees-of-freedom correction was 
applied. 
Mosquito trap catches in Kapiti and Palmerston North were examined initially in relation to 
mean overnight temperature and mean overnight RH recorded on-site and remotely, and 
remotely recorded rainfall totals from seven days preceding each trap session, as an indicator 
for the ambient moisture, as well as water pooling, which creates mosquito breeding sites. 
Results that showed highly significant relationships were then used to fit the mosquito counts 
to weather variables and trap site categories (location, vegetation cover and distance to 
nearest inhabited dwelling). The rainfall records (meteorological station only) were included 
in both offsite and on-site computations.  
For Ae. notoscriptus, Cx. (Cx.) pervigilans Bergroth, Cx. (Cx.) quinquefasciatus (Say) and Ae. 
(Ochlerotatus) antipodeus (Edwards), the “Kapiti vs Palmerston North” mosquito count ratio 
estimates how many times higher or lower Kapiti counts are than Palmerston North, adjusted 
for mature trees with canopy and distance to nearest inhabited dwelling. and weather 
variables. Coquillettidia (Coq.) iracunda (Walker). was captured on only 17 out of 308 trapping 
occasions and was excluded from further analysis because of low numbers. The mature tree 
mosquito count ratio indicates how many times higher (or lower) the counts are for sites with 
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mature trees (mainly native with canopy) than for other habitats. The “distance to nearest 
inhabited dwelling” categories test the null hypothesis that the counts for <10m, 10–100m, 
and >100m sites are the same. The “10–100m / <10m” mosquito count ratio indicates how 
many times higher (or lower) the counts are for 10–100m than <10m. 
Analyses were conducted on mosquito counts over the full 17-month surveillance period to 
examine the seasonal pattern of species counts in relation to month, temperature and 
rainfall. A more detailed analysis of species summer counts (Dec.-Mar.) was focussed on local 
weather and site conditions associated with mosquito counts and therefore hence biting 
activity and the extent to which this might be used predictively. 
6.4 Results 
6.4.1 Mosquito relative abundance and species composition  
 A total of 17,116 female mosquitoes were trapped over a 17-month period (Feb. 2019-June 
2020) at 25 trap sites. Five species belonging to three genera were recorded, although were 
not all represented at each location (Table 23). Overall, Cx. pervigilans (72.5%) was the most 
abundant species, followed by Ae. notoscriptus (21.5%). While Ae. notoscriptus was the most 
widespread species (25 trapping sites), followed by Cx. pervigilans (22 trapping sites). Coq. 
iracunda was the less abundant made up only 0.86% only from six Kapiti trap sites. 
The species composition and relative abundance of species varied across the three study 
areas. In the Kapiti area, all five species were represented, although Cx. pervigilans was clearly 
dominant (83%). Of these, however, the majority came from two traps set in the Nga Manu 
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Nature Reserve (79%). Ae. notoscriptus was dominant in Palmerston North and north 
Wellington, comprising 91% of the trap catch in each location (Table 23). 
Mosquito counts per trapping session in Kapiti (mean 100.5; 95%CI 57.0, 177.1) were greater 
than in Palmerston North (16.4; 8.8, 30.8) and Wellington (4.8; 2.2, 10.4). Mosquito numbers 
were 6.1 (95%CI 2.6, 14.3; p<0.0001) times higher in Kapiti than in Palmerston North and 20.9 
(95%CI 8.0, 54.2; p<0.0001) than in Wellington. While they were 3.4 (95%CI 1.3, 9.2; p=0.016) 
times higher in Palmerston North than in Wellington.  
Table 23: Trap catch and sampling effort 
Species Kapiti (max*) Palmerston North (max) Wellington North (max) Total (%) 
Ae. notoscriptus 1576 (98) 1821 (120) 277 (19) 3674 (21.5) 
Cx. pervigilans 12319 (3011) 69 (10) 29 (4) 12417 (72.5) 
Cx. quinquefasciatus 122 (25) 71 (27) 0 193 (1) 
Ae. antipodeus 638 (199) 47 (13) 0 685 (4) 
Coq. iracunda 147 (41) 0 0 147 (1.0) 
Total (%) 14802 (86.5%) 2008 (11.8%) 306 (1.7%) 17116 (100%) 
Total trap nights 138 107 63 308 
Mean/trip session ± SD 107.3 ± 409.3 18.8 ± 24.6 4.9 ± 5.8 55.6 ± 277.8 
% of effort 44.8 34.7 20.5 100 
*Maximum number of female mosquitoes per trap night 
6.4.2 Meteorological variables 
There was little difference between mean overnight temperatures and RH recorded on-site 
and remotely (Appendix M). However, a greater range of temperatures and lesser range of 
humidity were recorded by the met stations. Both sets of measurements indicate a clear 
seasonal pattern (Figure 39 and Figure 40). In the three areas, rainfall totals recorded by 
meteorological stations from a week preceding each trap session showed fluctuations 
throughout the study period with a maximum occurring in July 2019 and minimum between 
September 2019 and February 2020. 
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Figure 39: Kapiti overnight mosquito trap catches and weather variables recorded by data loggers 




Figure 40: Palmerston North overnight mosquito trap catches and weather variables recorded by 




6.4.3 Monthly abundance 
More than 83% of the mosquito total was caught during the summer (December-February), 
although this period (biting season) also involved greater sampling effort. Only 1% the 
mosquitoes were collected in winter (June-August), and these were mainly Ae antipodeus 
(Figure 39 and Figure 40). Generally, Ae. antipodeus was active during cold months, 
particularly between late autumn (May) and late spring (November). Except July-September, 
Ae. notoscriptus was present in relatively high numbers in the three study areas throughout 
the year with the main peak in February (30% of all Ae. notoscriptus). Cx. pervigilans was 
mostly present between December and March and disappeared over the rest of the year. Cx. 
quinquefasciatus was only collected between January and March, while Coq. iracunda was 
only present in January and February (Figure 39 and Figure 40)  
6.4.4 Mosquito occurrence at maximum and minimum temperature and RH ranges 
Ae. notoscriptus was present in traps at the time of the highest overnight temperature 
(19.1°C) recorded on-site, while Ae. antipodeus (known as the winter mosquito) was the only 
species captured on the occasion of the lowest overnight temperature (5.1°C), but with Ae. 
notoscriptus also at the next lowest (7.1°C; Appendix N).  
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6.4.5 Relationships of temperature, RH and rainfall to mosquito counts 
 
Table 24 shows estimates of the relationships between the environmental variables and 
mosquito counts in Kapiti and Palmerston North during the 17-month study period (trap 
nights=75) and summer (trap nights=33). Remotely recorded temperature, RH and rainfall 
were strongly associated with Cx. pervigilans, Ae. antipodeus, Coq. iracunda and total trap 
catches of all species reported during the 17-month study period. While Ae. notoscriptus and 
Cx. quinquefasciatus trap catches were not statistically associated with these variables. Cx. 
quinquefasciatus numbers, however, showed a strong positive correlation with RH (p<0.0001)  
Table 24: Relationship of on-site and climate station weather records to mosquito counts for Kapiti (Kp) 




On-site weather records Remotely weather records 
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*Yellow highlight = statistically significant  
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While on-site recorded temperatures were significantly associated with greater catch of all 
reported species in Kapiti and Palmerston North during the study period, on-site RH was a 
significant predictor of Cx. quinquefasciatus catches only. During the summer, however, and 
in addition to Cx. quinquefasciatus, RH was significant predictor of Cx. pervigilans catches. 
The trap catches of Cx. pervigilans, Ae. antipodeus, and total trap catches of all species in 
Kapiti were significantly higher than in Palmerston North (P<0.0001, P<0.0001 and P= 0.0007, 
respectively).  
Temperature, RH and rainfall recorded by meteorological stations were used for the 
estimates in Table 25. These provided a more complete record and showed an overall greater 
association with the individual species and overall counts of mosquitoes than the data 
obtained from the data loggers. 
6.4.6 Relationships of temperature, RH and rainfall recorded by meteorological stations and 
physical characteristics of trapping site habitats to mosquito counts 
Table 25 shows the results of the combined analysis, which describes the relationship between 
remotely recorded meteorological variables and habitat characteristics of trapping site to 
mosquito trap catches in Kapiti and Palmerston North during the 17-month study period (trap 
nights=245) and summer (trap nights=146).  
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Table 25: Combined analysis of relationships between Kapiti and Palmerston North mosquito counts, 
for selected weather measures and trap site characteristics 
Species Predictors 
17 months, Trap. night=75 (42 for Kapiti) Summer (Dec.-Mar.), Trap. night=33 (16 for Kapiti) 
Count ratio*(95% CI) p Count ratio**(95% CI) p 
Ae. 
notoscriptus 
Kp vs PN 0.96 (0.32, 2.89) 0.95 0.99 (0.11, 8.96) 0.99 
Temperature 1.18 (0.95, 1.45) 0.13 1.07 (0.72, 1.59) 0.74 
RH 0.97 (0.82, 1.16) 0.73 0.96 (0.81, 1.15) 0.66 
Rainfall (week) 0.98 (0.94, 1.03) 0.44 0.97 (0.91, 1.04) 0.42 
Mature trees 3.48 (0.57, 21.20) 0.17 3.72 (0.28, 48.61) 0.31 
Distance to nearest 
inhabited dwelling 
 0.95  0.96 
10-100m / <10m 0.72 (0.10, 5.48) 0.75 0.63 (0.01, 29.85) 0.81 
>100m / <10m 0.84 (0.21, 3.39) 0.80 0.73 (0.06, 9.00) 0.80 




Kp vs PN 41.68 (16.17, 107.46) <0.0001* 42.91 (15.0, 122.8) <0.0001 
Temperature 1.53 (1.39, 1.67) <0.0001 1.13 (0.99, 1.29) 0.061 
RH 0.91 (0.87, 0.95) <0.0001 0.91 (0.87, 0.95) <0.0001 
Rainfall (week) 1.3 (1.1, 1.41) 0.0001 1.6 (1.2, 1.73) <0.0001 
Mature trees 16.68 (8.33, 33.41) <0.0001 15.03 (6.65, 33.98) <0.0001 
Distance to nearest 
inhabited dwelling 
 <0.0001  <0.0001 
10-100m / <10m 0.90 (0.53, 1.52) 0.68 0.94 (0.46, 1.91) 0.85 
>100m / <10m 0.05 (0.02, 0.09) <0.0001 0.07 (0.03, 0.14) <0.0001 




Kapiti vs Palmy 1.82 (0.56, 5.92) 0.32 1.09 (0.30, 3.99) 0.89 
Temperature 1.12 (1.06, 1.18) <0.0001 1.07 (1.05, 1.16) <0.0001 
RH 1.08 (1.05, 1.11) <0.0001 1.07 (1.04, 1.10) <0.0001 
Rainfall (week) 1.03 (1.02, 1.04) <0.0001 1.02 (1.01, 1.03) 0.002 
Mature trees 46.17 (6.07, 351.08) 0.0002 42.68 (6.73, 270.7) <0.0001 
Distance to nearest 
inhabited dwelling 
 0.0001  0.001 
<10m / 10-100m 0.42 (0.16, 1.10) 0.077 0.49 (0.15, 1.66) 0.25 
<10m / >100m 0.08 (0.02, 0.26) <0.0001 0.08 (0.02, 0.31) 0.0003 




Kp vs PN 9.97 (1.63, 61.14) 0.013 22.72 (4.78, 107.96) 0.0001 
Temperature 0.97 (0.93, 1.02) 0.31 0.93 (0.83, 1.03) 0.16 
RH 1.08 (1.05, 1.11) <0.0001 0.95 (0.92, 0.97) 0.0002 
Rainfall (week) 0.99 (0.98, 1.00) 0.010 0.95 (0.93, 0.97) <0.0001 
Mature trees 3.14 (0.80, 12.33) 0.10 1.69 (0.54, 5.31) 0.37 
Distance to nearest 
inhabited dwelling 
 0.0005  0.027 
10-100m / <10m 3.17 (1.11, 9.10) 0.032 0.70 (0.21, 2.35) 0.56 
>100m / <10m 0.39 (0.12, 0.44) 0.047 0.23 (0.08, 0.68) 0.008 
>100m / 10-100m 0.12 (0.04, 0.35) 0.0001 0.33 (0.09, 1.21) 0.093 
Total 
Kp vs PN 2.47 (1.30, 4.71) 0.006 2.60 (1.15, 5.89) 0.023 
Temperature 1.20 (1.10, 1.29) <0.0001 1.10 (0.98, 1.24) 0.095 
RH 0.96 (0.92, 1.00) 0.061 0.94 (0.90, 0.98) 0.002 
Rainfall (week) 0.98 (0.96, 0.99) 0.006 0.96 (0.94, 0.98) 0.0001 
Mature trees 6.77 (3.43, 13.39) <0.0001 8.48 (3.58, 20.08) <0.0001 
Distance to nearest 
inhabited dwelling 
 0.0004  0.003 
10-100m / <10m 0.96 (0.37, 2.51) 0.93 1.04 (0.27, 3.97) 0.95 
>100m / <10m 0.28 (0.14, 0.56) 0.0005 0.25 (0.10, 0.61) 0.003 
>100m / 10-100m 0.29 (0.12, 0.70) 0.006 0.24 (0.07, 0.78) 0.019 
*
Yellow highlight = statistically significant  
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On the basis of these findings conditions in which the flight (host seeking) activity of individual 
species might be expected to increase are as follows. 
Ae. notoscriptus counts showed a distinct seasonal pattern in numbers (Figure 39 and Figure 
40) with peaks in February although there was no clear association with tested site or weather 
variables (Table 25) that might be used predictively. 
Cx. pervigilans was more likely to be found in greater numbers during warmer but less humid 
conditions following rainfall, and in areas near human habitation and with mature tree canopy 
coverage (Table 25). 
Cx. quinquefasciatus was more likely to be found in greater numbers in warmer and more 
humid conditions following rainfall, and in areas of more than 100m away from the nearest 
inhabited dwelling with mature tree canopy coverage (Table 25). 
Ae. antipodeus was more likely to be found in higher counts in cooler conditions and after 
heavier rainfall and in areas nearby human habitation regardless its vegetation coverage 
(Table 25). 
6.5 Discussion 
Responses of host seeking female mosquitoes to local conditions are an important influence 
on human exposures [815]. Temperature, relative humidity, rainfall and land-use cover have 
been used in several studies to predict favourable/high risk conditions for transmission of 
various mosquito-borne diseases [816]. This case study examined the association of seasonal, 
environmental and weather conditions with the activity of particular mosquito species in 
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areas where human exposures are likely, and considered the extent to which this might be 
useful as an indicator of high-risk conditions 
Of the five species present in the surveillance samples three are of particular concern from a 
public health perspective. This discussion will focus on the known human arbovirus vectors 
(Ae. notoscriptus and Cx. quinquefasciatus) and an endemic species (Cx. pervigilans), which is 
a known vector of bird pathogens and potential vector of human infection. 
6.5.1  Influence of environmental factors on mosquito catch and potential arbovirus 
transmission  
Aedes notoscriptus 
Overall, after Cx. pervigilans (72.5%), Ae. notoscriptus was the second most abundant species 
(21.5%). However, it was the dominant species in Palmerston North and Wellington (91% of 
the trap catch in each area). While Cx. pervigilans is primarily a bird biter, about 96% of its 
catch in Kapiti were from only two trapping sites at a nature reserve with caged birds. By 
excluding the catches of these two locations, Ae. notoscriptus would also be the most 
abundant species in Kapiti, particularly in domestic and peri-domestic areas. These findings 
support the conclusion that a key limitation of the model constructed in Chapter 5 is that the 
predicted absence of Ae. notoscriptus in built environments was due underrepresentation in 
the training dataset of habitat in residential areas. The surveillance exercise undertaken in 
this chapter addressed this limitation in part. 
These findings also support the accumulating evidence of mosquito species replacement 
reported elsewhere [14, 15, 18]. While Slaney and Derraik (2007) [18] reported the 
replacement of the native Cx. pervigilans by the introduced Ae. notoscriptus in Auckland 
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region, this study shows the dominance of Ae. notoscriptus and the near absence of Cx. 
pervigilans (apart from a nature reserve adjacent to a Kapiti residential area) in built areas 
much further south. Several factors have facilitated Ae. notoscriptus establishment and Cx. 
pervigilans apparent retreat in the North Island, including (i) habitat anthropogenic change 
[18] as the loss of native ecosystem potentially favours more domesticated exotic species 
[817-819], (ii) availability of artificial larval habitats [14, 15, 28, 47, 48], (iii) the lack of larval 
predators of container-utilisers in small temporary water bodies, unlike breeding habitat of 
Cx. pervigilans (e.g. forest ground pools), which may be rich in the larger aquatic invertebrate 
predators (e.g. corixids, notonectids, dragonfly larvae and adults, damselfly larvae) [47], iv) 
the adaptability of some more domesticated Aedes species as demonstrated by the ability to 
produce both desiccation-resistant eggs, and cold tolerant larvae, and v) the high dispersal 
capacity of Ae. notoscriptus (e.g. its presence in all trapping locations around Kaipara Harbour 
suggests their ability to fly from neighbouring built areas outside of the saltmarsh) [820].This 
suggests that Ae. albopictus would face limited competition for artificial containers in 
anthropogenic habitats in urban areas of New Zealand. The biological characteristics of Aedes 
species that make them successful colonisers are discussed in Chapter 7. 
Increased vector population densities and dispersal have led to the emergence, re-
emergence, and increased incidence of mosquito borne diseases worldwide, including RRV 
and BFV [821] infections in Australia and malaria in Malaysia and West Africa [822]. Ae. 
notoscriptus is one of the major four competent vectors of RRV in Australia [488]. Some 
studies claim that the absence of locally acquired RRV cases in New Zealand is due to the low-
moderate level (on the scale used for surveillance in Australia [823]) of Ae. notoscriptus 
abundance [18, 824]. Yet, the current study shows that the increasing densities and 
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geographic range of this species in New Zealand, particularly in the North Island, are becoming 
an important risk factor for RRV epidemic emergence. Further, its close association with 
anthropogenic habitats [262, 271, 487, 785], ensures a potential role in RRV urban 
transmission. The local transmission risk is compounded by a continuing increase in the arrival 
of imported cases from Australia and Pacific Islands (see Chapter 3). In addition, availability 
of artificial water containers and the apparent displacement of local species from these where 
present would facilitate the establishment of other domesticated species. Ae. notoscriptus is 
a potential vector of DENV [255, 258] and might also have the capacity to sustain the 
transmission cycle in synergy with other major vectors like Ae. albopictus or Ae. aegypti, if 
they become established. 
There were no significant associations between Ae. notoscriptus counts and the five 
environmental factors tested. These findings are consistent with the wide geographic range 
of this species. In a 42-month ecological study conducted in Kaipara Harbour, there were 
strong positive correlations between temperature and abundance of Ae. notoscriptus. 
However, given the saltmarsh environment of the harbour, Ae. notoscriptus was the rarest 
collected species (0.6%) [820]. This species was also collected from all trapping sites, which 
included residential properties, public recreational areas, domestic and peri-domestic 
settings, remnant forest with mature canopy trees, areas with shrubs or recent plantings 
(sparse or no canopy) and open exposed areas (e.g. lawn). The model developed in chapter 
five also has indicated a clear association between Ae. notoscriptus occurrence and rural 
areas. Ae. notoscriptus was also the most frequently recorded species being collected from 
all sites in a field study carried out in eight different native forest sites the Auckland region 
[819]. Occurrence of Ae. notoscriptus is urban, rural and disturbed remnant forests in 
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relatively high counts would facilitate maintaining RRV in the urban, rural and sylvatic cycles, 
respectively. Further details on the RRV transmission cycles are discussed in Chapter 7. 
The lack of strong correlation between Ae. notoscriptus and rainfall might be explained by the 
ability of their eggs to withstand drought. Ae. notoscriptus mosquitoes typically deposit their 
eggs in habitats where they are exposed to desiccation conditions with fluctuating water 
levels [825, 826]. An Australian study reported that Ae. notoscriptus eggs can tolerate 
desiccation for up to 367 days, under different of conditions, with about 9‐13% egg survival 
reported. This prolonged egg viability reflects the history of introduction and subsequent 
establishment this mosquito in non‐native ecosystems, as well as its increasing abundance 
and geographical widespread distribution in New Zealand and Australia. The range of Ae. 
notoscriptus in Australia extends from the tropical Queensland [827] down to the cool 
temperate Tasmania [828]. In New Zealand, it has also been reported [829] that this species 
may overwinter as active larvae and these can survive under surface ice. This might contribute 
to the presence of some adults (but not necessarily biting) through the winter. In warming 
conditions this situation would allow the early maturation of biting adults.  
Ae. notoscriptus adults were prominent in samples throughout most of the year in all three 
surveillance areas. This species has been reported to pass winter in both larval and adult 
stages [829]. This would lengthen the biting and transmission seasons [98] and, therefore, 
increase the human population at risk and, potentially, the disease incidence [18, 181, 721, 
722]. The major abundance peak of Ae. notoscriptus was in February (30% of all collected Ae. 
notoscriptus). According to findings of chapter 3, the monthly totals of imported arbovirus 
infections in New Zealand also peaked in February. Further, monthly visitor arrivals to New 
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Zealand from Australia, the source of all imported RRV infections in New Zealand, peaks 
between December-March. Coinciding of key components of the RRV infection in time and 
space is the key determinant that would trigger a local transmission in New Zealand. 
Further, Ae. notoscriptus was found at the highest (19.1°C) and the second lowest on-site 
overnight temperature (7.6°C), after Ae. antipodeus (5.1°C), the winter mosquito. These 
findings indicate its ability to tolerate seasonal and daily fluctuations, which may positively 
influence its vectorial capacity [100, 825]. 
Culex quinquefasciatus 
The cosmopolitan Cx. quinquefasciatus is an important vector of several important parasites 
and arboviruses of concern worldwide and readily feeds on human, mammalian and avian 
hosts. Further details on the public health significance of Cx. quinquefasciatus are provided in 
Review Two, Section 2.2.1.1. The New Zealand strain of Cx. quinquefasciatus is a proven 
competent experimental vector of BFV, RRV and MVEV [27]. Isolates of RRV have been 
obtained from field-collected mosquitoes in arid regions of Western Australia [830] and New 
Caledonia during the 1979-1980 Pacific major epidemic [271]. 
Cx. quinquefasciatus was present in relatively small numbers (1% of total catch) and, unlike 
Ae. notoscriptus, was strongly seasonal in occurrence and had a clear association with 
particular sites and weather conditions. More details on the distribution of Cx. 
quinquefasciatus in New Zealand are provided in Review Two, Section 2.2.1.1. This species 
was only collected from Kapiti and Palmerston North and exclusively during the warm season 
between January and March. Hence, Cx. quinquefasciatus counts were significantly correlated 
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with the higher mean temperatures and humidity occurring at this time of year. This species 
disappeared from the traps during late autumn, winter, early spring, and probably 
overwinters in this region as eggs. These findings are also in agreement with previous studies, 
which have found higher temperature and humidity to favour habitat selection and 
oviposition by Cx. quinquefasciatus females [831, 832], as well as increase abundance and 
accelerate larval development [833-836]. Warmer conditions would both facilitate its 
geographic expansion in New Zealand and extend the biting. 
Rainfall is another factor that may limit distribution and seasonality of Cx. quinquefasciatus. 
During the summer, unlike Ae. notoscriptus, Cx. quinquefasciatus showed a strong positive 
correlation with rainfall. Increased rainfall would increase the availability of breeding sites 
that, together with higher mean temperatures, might result in higher RH, a lengthened 
abundance and biting season, and higher transmission level. It can, therefore, be assumed 
that relationships examined in this study showed the positive effects of temperature, RH and 
rainfall at a biologically plausible time lag and locations that would provide for a basis for 
planning vector control strategies in Kapiti and Palmerston North, during potential arbovirus 
outbreaks, particularly RRV. 
Most of Cx. quinquefasciatus were collected from disturbed remnant vegetation (i.e. small 
fragmented forest patches, mainly in public reserves) with large mature canopy trees and 
medium-sized artificial ponds and water streams (e.g. Nga Manu Nature Reserve). This finding 
is consistent with the current knowledge of Cx. quinquefasciatus breeding habitats in New 
Zealand, which are medium-sized artificial waterbodies, particularly of polluted and high 
nutrient contents [47], which are likely to be associated with wastewater drains or leakage or 
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pastoral agriculture (typically outside the surveillance locations). However, in contrast to the 
current literature that reported its occurrence in close association with human habitation [46, 
250, 837], Cx. quinquefasciatus was not collected from most of the residential properties, had 
low counts if the distance from the trapping site to the nearest inhabited dwelling is less than 
100m, and significantly had more counts in areas with mature trees (e.g. natural reserves). 
Cx. quinquefasciatus in New Zealand seems to be less anthropophilic and domesticated than 
in other countries such as USA, where it is well-known as the “southern house mosquito”. 
Given the RRV isolates from field collected Cx. quinquefasciatus in New Caledonia during the 
1979-1980 Pacific epidemics [271], and the absence of the traditional marsupial reservoir 
hosts, Weinstein suggested that the species is capable of transmitting RRV in virgin soil 
outbreaks via an urban cycle [21]. In the same study he reported that “the occurrence of large 
populations of Cx. quinquefasciatus in gully traps near international airports in New Zealand 
is particularly worrisome in this context”, hypothesizing that the urban cycle of RRV is more 
likely to happen in New Zealand than the other transmission cycles. Derraik in 2005 [278] 
reported the absence of Cx. quinquefasciatus in his investigation carried out in a relatively 
pristine native coniferous-broadleaved forest in the Waitakere Ranges Regional Park, West 
Auckland, New Zealand. Further, according to the findings of Chapter 4, of the 565 suspected 
mosquito interceptions in the period between 2001 and 2018, 321 were of New Zealand 
origin. Of these, Cx. quinquefasciatus comprised about 61.5% (n=257). Absence of Cx. 
quinquefasciatus at forest remnants and their occurrence of large populations in urban 
Auckland at and around AIA, PoA and their transitional facilities support Weinstein’s 
suggestion that these could become part of an RRV urban cycle with Ae. notoscriptus in 
Auckland. 
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However, given the association of Cx. quinquefasciatus counts with longer distances to the 
nearest inhabited dwellings and mature trees with canopy, and its sparse occurrence in the 
human habitation in the three study areas, this study does not support Weinstein’s 
assumption. These findings, however, are consistent with the fact that Cx. quinquefasciatus 
is a primary enzootic vector for WNV in North America [838]. 
Culex. pervigilans 
Cx. pervigilans is primarily ornithophilic and occasionally bites mammals, including humans 
[253]. It is a competent vector of a number of avian diseases, such as Whataroa virus [280], 
avian reovirus, avian malaria [253] and avian pox viruses [839]. Whataroa virus is the only 
known mosquito-borne virus in New Zealand. The primary cycle is between birds and 
mosquitoes. Serological studies suggest that this virus also might infect humans but no 
associated syndrome has been detected.[840]. Under laboratory conditions, it is a poor vector 
of RRV, DENV and WNV [27]. More details on the public health significance of Cx. pervigilans 
are provided in Review Two, Section 2.2.1.1. 
While Cx. pervigilans was collected in greatest numbers (72.5% of overall count) and from 
22/25 of the trapping sites, most of these (79%) came on a few occasions from two Kapiti 
sites at the Nga Manu Nature Reserve. This is a 26 Ha patch of remnant swamp forest with 
large mature trees, open to visitors and surrounded by housing on three sides. The high 
counts may have been associated with birds (including caged birds) in the Reserve.  
Although Cx. pervigilans was collected from most trapping sites, numbers were associated 
with lower RH, higher temperature (exclusively collected in the hot months between 
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December and March, with a peak in February, overwinter in immature stages), and higher 
rainfall (their eggs are not desiccation resistant) [249]. Cx. pervigilans also showed a strong 
positive correlation with mature trees. This is inconsistent with some local studies that 
reported higher prevalence of Cx. pervigilans in urban and rural areas than forest covers [278]. 
However, Cx. pervigilans showed a positive correlation with human habitation as it was 
collected from most of the residential properties, but with low counts. Apparently, Cx. 
pervigilans is the only native species that capable of inhabiting anthropogenic habitats due to 
its ability to breed in almost anywhere there is a waterbody [277, 278]. 
Derraik and Slaney confirmed that Cx. pervigilans is “very rarely” found to feed on humans. 
However, there have been number of severe mosquito biting incidents where cases sought 
medical follow up due to high mosquito densities at Nga Manu Natural Reserve during 
February 2020 [841]. In February 2020, a total of 5,816 females of Cx. pervigilans were 
collected over one night with two traps at two locations in Nga Manu Reserve verves about 
90 Ae. notoscriptus females. In February 2019, about 2,791 Cx. pervigilans females were 
collected from the same locations with only 45 Ae. notoscriptus females. Hence, Cx. 
pervigilans is suspected in the biting incidents. According to the scale of abundance used for 
surveillance in Australia, these counts fall under “very high” category (>1000/trap.night) 
[842]. Snell [254] also found unusually high counts of this species in the same area and at the 
same time of year (February 2004) for a short period, and attributed this to extensive flooding. 
In this study, however, there was no flooding events. More investigations are needed to 
understand conditions associated with this high counts.  
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6.5.2 Using data loggers to assess the influence of meteorological factors on mosquito 
population dynamics  
Several studies indicate the value of on-site data obtained by sensors placed 
centimetres/metres to mosquito breeding/trapping sites [52, 53], and that resolution might 
be improved by including on-site measurements [52, 58-63]. However, utilising such fine 
spatial scales appears to have been limited by the lack of data, and the practical difficulties in 
measuring these variables from different habitats and heights [52]. Several ecological and 
epidemiological studies, however, have confirmed the reliability of predicting mosquito 
population build-up using weather conditions at relatively coarse spatial and temporal 
resolutions [843-845]. Present findings indicate that while on-site measures may be valuable 
for research, more remote meteorological measures from reasonably adjacent scientific 
stations are suitable for public health surveillance purposes. 
6.6 Conclusion 
Seasonal and environmental conditions favourable for mosquito host seeking were evaluated 
in this case study. Three of five species found are of particular concern as potential vectors of 
human disease in New Zealand. Ae. notoscriptus was the most widespread in traps, the most 
abundant (in two locations) and was also present in relatively high numbers throughout most 
of the year. Apart from seasonal variation in temperature, the absence of any clear link of Ae. 
notoscriptus counts with environmental variables suggests that this species appears less 
constrained by, and more adaptable to local weather and site conditions. Hence, it is able to 
utilize opportunities and mammalian hosts available in built environments. The expanding 
geographic range of Ae. notoscriptus in New Zealand, particularly in the North Island, 
represents potential risk for RRV transmission in rural, urban and sylvatic cycles, if 
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temperatures become sufficient to promote virus build-up. Cx. pervigilans was the most 
numerous species around Kapiti. Unlike Ae notoscriptus, counts of this species had a 
significant association with temperature and humidity, and with recent rainfall through 
effects on ambient moisture. However, about 80% of its total counts were collected from only 
two trap sites at a Kapiti nature reserve. Notably, more than 8,600 females Cx. pervigilans 
were collected here over two nights in February 2019 and 2020. In February 2020, this is also 
coincided with a number of severe mosquito biting incidents reported at the reserve during 
Cx. pervigilans peak numbers which sought medical follow up. This species clearly has the 
ability to build up quickly to high numbers compared to a much lower background rate. 
Although it is generally considered to be a bird biter and is known to carry several avian 
pathogens, spill over to humans may be a future concern. Conditions associated with these 
high counts need further investigation. The cosmopolitan Cx. quinquefasciatus, however, was 
present in relatively small numbers and was strongly associated with particular sites and weather 
conditions. Unlike in many parts of the world, Cx. quinquefasciatus seems to be less domesticated in 
New Zealand.   
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Chapter 7 : Scenarios for local transmission of arbovirus infections 
in New Zealand 
7.1 Introduction 
With the exception of one case of Zika being locally sexually transmitted, to date, there has 
not been a confirmed locally acquired arbovirus infection of humans in New Zealand. 
However, the risk of a virgin soil outbreak is perceived to be increasing since risk factors 
connected to key components of arbovirus disease transmission (imported virus cases, 
competent mosquito vector or co-vector, increasingly suitable climate and environment and 
susceptible population) are already present. On the basis of findings presented in Chapters 3-
6 and literature discussed in Chapters 1 (Introduction) and 2 (Reviews One-Four), in this 
chapter, likely scenarios are proposed and conditions and combinations of circumstances 
identified, under which the components of DEN and RRV transmission coincide to trigger an 
outbreak in New Zealand. Further, limiting factors of local transmission of each infection are 
identified and described. 
These two infections have been selected because each has different transmission cycles (i.e. 
urban and rural) and limiting factors and, according to the findings of Chapters 3-6, appear to 
be the most likely infections to cause outbreaks in New Zealand under current and/or future 
climatic conditions and transmission circumstances. These scenarios will inform guidelines 
and supporting data to design and evaluate prevention and control strategies. This, in turn, 
would provide foundations to develop EWSs of mosquito-borne diseases with different 
transmission pathways for use by public health agencies, and identify further research needs 
for appropriate local responses. 
220 
7.2 A scenario for dengue fever outbreak in New Zealand 
Dengue fever, in terms of cases, is the most widespread and best known arbovirus diseases 
[3, 846]. Worldwide, it is estimated that more than three billion people are at risk of infection, 
with more than 50 million infections each year, including at least 500,000 hospitalisations 
[846, 847]. In New Zealand, there has never been a confirmed indigenously acquired case of 
dengue and all reported cases have been imported [11, 17, 666]. Furthermore, New Zealand 
has been free of vectors that can transmit DENV [11, 12, 14, 17, 20, 666]. The establishment 
of introduced mosquito vectors can lead to mosquito-borne disease outbreaks via three paths 
[848, 849]: 
i. Introduced vector transmitting native pathogen: e.g. In Brazil, native Anopheles species 
were responsible for malaria transmission in restricted areas until the introduction of a 
more efficient vector (Anopheles gambiae sensu lato) in the 1920s by shipping traffic 
from Senegal. This changed the disease transmission from endemic to epidemic resulting 
in widespread outbreaks by the 1930s [849]. This path is considered low risk for New 
Zealand, as there are no known indigenous arbovirus mammalian pathogens. 
ii. Simultaneous introduction of a vector and a pathogen (via infected mosquitoes): e.g. 
Outbreaks of yellow fever in northern USA, particularly New York, followed the 
introduction of both Ae. (Stegomyia) aegypti (Linnaeus)and the virus via slave ships from 
Africa in the 17th and 18th centuries. However, since this tropical mosquito lacks any 
means of overwintering, it has not became permanently established there [9]. While this 
is a possible pathway into New Zealand, virus importation by way of infected mosquitoes 
arriving on aircraft or shipping has rarely been reported globally [850], and is probably 
overestimated as a source of infection [666, 684, 851]. 
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iii. Independent introductions of a vector (via biosecurity breach) and a pathogen (via 
infected travellers): Locally-transmitted infections associated with viraemic travellers 
have been increasingly recorded in non-endemic, but vector-established areas (e.g. 
Australia (DENV) [229], Europe (DENV and CHIKV) [230-232], the Americas (DENV, CHIKV 
and ZIKV) [233, 235-238] and Pacific Islands (DENV, CHIKV, ZIKV and RRV) [11, 23, 239-
241]). This is the most common pathway of arbovirus outbreaks globally [848], and the 
most likely scenario for a dengue outbreak in New Zealand. This scenario, therefore, 
requires two events to take place: mosquito vector invasion and DENV importation. Next, 
I consider each of these events in turn (Figure 41). 
7.1.1 Mosquito vector invasion: arrival, establishment and spread  
New Zealand is still free of major DENV mosquito vectors. However, Ae. aegypti and Ae. 
(Ochlerotatus) antipodeus (Edwards), the main vectors of the most important arbovirus 
diseases, including dengue, are regularly intercepted at the New Zealand border [Chapter 4]. 
The introduction and establishment of either species would complete requirements for virus 
transmission to occur within New Zealand. The term ‘invasive’ is applied to mosquito species 
that have arrived, established and dispersed, creating the potential for impacts on resident 
species and ecosystems [848]. 
- Arrival (ports of entry, pathway and source of origin): According to evidence presented in 
Chapter 4, Ae. aegypti and Ae. albopictus were the most commonly intercepted unwanted 
mosquito species at New Zealand ports in the past 17 years (32% and 22% respectively, of 
all interceptions). As both species were only intercepted at Ports of Auckland and Auckland 
Airport [Chapter 4], the most likely point of entry would be Auckland (Figure 41). 
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Figure 41: Risk factors (blue and grey) and urban transmission pathway and components (green) involved in DENV outbreak by exotic Aedes species in New 
Zealand (NZ) 
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Used tyres and machinery were the main mode of entry for the two species [Chapter 4]. 
However, following a recommendations by Laird [46], new import regulations resulted in 
an 86% decline in the quantity of imported used tyres (from more than a half of a million 
in 2001 to about 85,000 in 2017). This decline occurred in the context of the total gross 
weight of New Zealand’s sea imports increasing by more than 60% over the same period 
[Chapter 4]. Another possible means of arrival would be “wet-footed” plants [714, 852-
854].  
Ae. albopictus is most likely to be imported by sea from Japan as the majority of this 
species were intercepted as larvae via shipping vessels. Japan, where Ae. albopictus is 
indigenous, was New Zealand’s largest supplier of both used tyres and vehicles and was 
also the largest source of Ae. Albopictus [Chapter 4]. Sailing time from Japan to Auckland 
is between 10–12.5 days [735]. With suboptimal food, Ae. albopictus larvae can survive 
between 58 and 80 days [733]. A further adaptation allows Ae. albopictus to survive this 
long journey is that their eggs are cold and desiccation tolerant and can remain viable for 
several months [161].  
In contrast, the majority of Ae. aegypti intercepted at New Zealand’s borders were 
transported by air as adults with unknown country of origin [Chapter 4]. Since adults 
cannot survive starvation for more than seven days [737], neighbouring countries, where 
Ae. aegypti is endemic and with direct and frequent flights to New Zealand, would be the 
probable source, possibly Queensland, Australia. The most frequent international flights 
to New Zealand in the past 17 years were from Australia. The tourist destinations, 
Brisbane (capital of Queensland) and Coolangatta (Queensland Gold Coast) are, 
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respectively, the first and the fourth highest source of international flights to New 
Zealand from airports where Ae. aegypti is established [Chapter 4]. The majority of 
Australian residents travelling to New Zealand departed from Brisbane [292]. 
- Establishment: Establishment could succeed because of the following characteristics of 
the mosquito invaders: 
1- Frequent introductions: Between 2001-2017, Ae. aegypti and Ae. albopictus were the 
two most frequently intercepted species [Chapter 4]. An annual increase of 20% was 
significant for Ae. aegypti. 
2- The ability to initiate diapause at the egg stage under temperate conditions: Cold 
hardiness in temperate populations of Ae. albopictus results from egg diapause, which 
is absent in the tropical species, Ae. aegypti [855, 856]. Prevalence of Ae. albopictus 
in temperate countries of similar latitude, climate and size to New Zealand (e.g. 
Japan), and the widespread and establishment of the introduced Ae. notoscriptus 
[Chapter 6] suggests that New Zealand is vulnerable to the establishment of this cold-
hardy species. 
3- The ability to lay desiccation-resistant eggs, which promote survival in inhospitable 
environments for long time [160, 223]. In Chapter 6, Ae. (Finlaya) notoscriptus (Skuse) 
counts showed an insignificant correlation with rainfall, potentially due to the ability 
of their eggs to resist desiccation for several months. 
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4- The ability to feed on a range of hosts: Ae. albopictus females are opportunistic 
feeders (feed on both mammals and birds), with a preference for humans [857]. 
5- The ability to utilise a variety of breeding habitat: In general, Aedes mosquitoes utilise 
a wide variety of larval habitats. For example, in Chapter 6, occurrence and abundance 
of Ae. notoscriptus showed an insignificant correlation with any of the tested 
ecological and meteorological predictors. This illustrates the ecological plasticity of Ae. 
notoscriptus, which refers to the range of breeding habitats that this container 
breeder can utilise, ranging from tree-holes to a wide variety of man-made containers. 
Ae. aegypti and Ae. albopictus larvae have been reported in a wide range of natural 
[e.g. phytotelms (water bodies held by terrestrial plants, such as tree holes) and rock 
pools] and artificial fresh water-holding containers (mainly discarded receptacles, but 
also water tanks, rubber tyres, wells and sinks) [858, 859]. Their immature stages have 
also been found in large fresh water bodies (e.g. lakes and ponds) and, surprisingly, in 
brackish (lagoons, estuaries) habitat [860]. 
Between 2004 and 2017 high numbers of Ae. notoscriptus, which co-occur in larval 
habitats with Ae. aegypti [784, 861] and Ae. albopictus [780], were recorded around 
busy ports and airports in northern North Island by routine surveillance at 
international ports of entry [Chapter 5]. The constructed model in Chapter 5 predicted 
high occurrence probability of Ae. notoscriptus in New Zealand’s rural and peri-urban 
areas, where most of ports and airports are located. Considering the sympatric 
coexistence of Ae. notoscriptus and Ae. albopictus larvae in the islands of the Torres 
Strait, Australia [780], the predicted distribution of Ae. notoscriptus suggests that Ae. 
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albopictus is likely to find a suitable habitat around New Zealand ports of entry in the 
warm areas of northern North Island, particularly Port of Tauranga (New Zealand's 
largest port in terms of total cargo volume and container throughput), Ports of 
Auckland (New Zealand's 2nd largest port) and Auckland International Airport (the 
country's largest and busiest airport). 
6- Skip oviposition: Aedes species exhibit variable oviposition patterns [862, 863], where 
gravid females deposit eggs across different oviposition sites rather than at the same 
site. This will decrease sibling competition and allow greater distribution of progeny. 
7- Adaptive ability and opportunities in built environment: A likely case for New 
Zealand, is that a foreign species may occupy new areas by filling an “empty niche” 
(i.e. unoccupied or unsaturated habitat with unused resources) [864]. Several studies 
have reported that mosquito larval habitats in northern New Zealand are 
underutilised [14, 15, 28, 48]. The establishment of invasive species is also likely to 
result in declines or elimination of ecologically similar species [865]. Ae. notoscriptus 
was the most abundant species in all trapping sites of Palmerston North and 
Wellington, as well as the residential properties of Kapiti [Chapter 6]. These findings 
suggest there may be some displacement of other domesticated species such as Cx. 
(Cx.) quinquefasciatus (Say)and Cx. (Cx.) pervigilans Bergroth in these areas and 
contribute to the accumulating evidence of mosquito species replacement occurring 
in anthropic environments such as the North Island surveillance areas. Several field 
and laboratory experiments have demonstrated competitive superiority of larvae of 
both Ae. aegypti and Ae. albopictus over resident larvae from other mosquito species. 
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For example, displacement by Ae. albopictus of Cx. pipiens Linnaeus [42, 848], Cx. Cx. 
(Cx.) quinquefasciatus (Say)[848], Ae. Triseriatus (Say) [865, 866], Ae. (Ochlerotatus) 
sierrensis (Ludlow), Ae. (Finlaya) japonicus (Theobald)[867], Ae. (Finlaya) koreicus 
(Edwards) [868] and Ae. (Howardina) bahamensis Berlin [869] and Ae. aegypti [868, 
870, 871] has been demonstrated. Similarly, displacement by Ae. aegypti of Cx. 
quinquefasciatus [872] and Ae. triseriatus [873] has been demonstrated in 
experimental studies. This suggests that the two Aedes species are aggressive invaders 
(since they are adaptable and with generalist habit) and New Zealand native 
mosquitoes may not be a substantive barrier to invasion since they tend to be locally 
distributed and typically with specialist habit. 
8- Occupying human-dominated habitats and association of invasion with human 
disturbance (i.e. man-made modified habitat). Both Aedes mosquitoes are highly 
adapted to urban and urbanized environments. The prominence and habitat spread 
of Ae. notoscriptus reported in urban and peri-urban areas [Chapter 6] suggests 
availability and abundance of domestic water-bearing containers, which provide 
suitable breeding sites for Aedes species. 
Dispersal: Climate limits the ranges of most invasive species. While local transportation 
and trading networks may disperse invaders after introduction [874], their establishment 
and spread are only possible under suitable climatic conditions [545]. Climate change 
makes New Zealand an increasingly suitable environment for the establishment of 
temperate and less tropically adapted exotic mosquito vectors. According to a national 
correlative modelling study [28], and under the current temperature and rainfall 
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conditions, Auckland and Northland regions are the most suitable areas in New Zealand 
for the establishment of Ae. albopictus [306]. However, projected increases in 
temperature, rainfall, and humidity could make these areas suitable for Ae. aegypti and 
extend the geographic distribution of Ae. albopictus to the south [28, 306].  
Using a mid-range climate projection, Pearce et al. [743] reported that Auckland’s mean 
temperature is expected to increase by 0.5 to 4.0 °C by 2040–2110, depending on future 
concentrations of greenhouse gases in the atmosphere [743]. These findings are 
consistent with Ryan et. al. (2019) [306], who mapped current and future temperature 
suitability for cumulative monthly dengue transmission at global scale for and Ae. 
albopictus and Ae. aegypti. This mechanistic temperature dependent R0 model (refer 
Review One, Section 0) predicted that if a temperature range shifted to include the 
optimal temperature for transmission (19.9–29.4˚C for Ae. albopictus; 21.3–34.0˚C for Ae. 
aegypti), distributions are likely to expand to higher latitudes. This would increase 
climate-driven risk of dengue transmission from both mosquitoes for most of temperate 
countries, including New Zealand. According to this model, under present mean monthly 
temperatures, Auckland and Northland are optimal for the establishment of Ae. 
albopictus, while the two main islands of New Zealand are protected by cooler 
temperature from the transmission risk by tropical Ae. aegypti. By 2050, under the high 
greenhouse gas emission scenarios (Representative Concentration Pathway, RCP 8.5), 
warming temperatures are expected to expand the risk area transmission for dengue by 
Ae. albopictus transmission to include almost all of the North Island, and make Auckland 
and Northland receptive to transmission by Ae. aegypti. By 2080, RCP 8.5 would increase 
the transmission risk of Ae. albopictus to include much of the South Island, while most of 
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the North Island would be increasingly suitable for viral transmission by Ae. aegypti. Even 
under the best climate change scenarios (RCP 2.6), in 2080, the North Island will be 
potentially vulnerable to outbreaks of arbovirus disease transmitted by both species 
[306]. 
In summary, it is suggested that physiological adaptations of Aedes larvae and globalization 
will facilitate their arrival, while suitable (i.e. modified) underutilised anthropophilic habitats 
around the ports of entry, ecological flexibility of these species and suitable climatic 
conditions in the New Zealand’s northern latitudes will facilitate their establishment, and 
climate warming will facilitate their spread into cooler, southerly latitudes.  
7.1.2 Introduction of dengue virus: means, source, season, location 
Means of introduction: While DENV is endemic and predominantly transmitted in tropics and 
subtropics, globalized travel and trade, particularly air travel since World War II, has 
accelerated the introduction of the virus to new regions by means of viraemic travellers and 
infected mosquitoes [850]. Aircraft disinsection and mosquito abatement programmes in 
airports have been implemented, as pathogen introduction by infected mosquitoes seems to 
be less complicated than introduction by infected travellers. However, according to a recent 
modelling study estimating risk of vector-borne pathogen introduction associated with 
infected mosquitoes and infected humans aboard aircraft [850], DENV are 200 times more 
likely to be imported by infected travellers than infected mosquitoes. The low probability of 
pathogen importation by mosquitoes is due to low counts of mosquitoes being recorded on 
aircrafts, high mortality and low infection prevalence among mosquitoes in the source 
locations [684, 850]. Further, unlike mosquitoes arriving on aircraft or shipping, pre-
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symptomatic or asymptomatic infected travellers are not subject to scrutiny [684]. However, 
even without disinsection and under optimal conditions, introduction of mosquito-borne 
pathogens via viraemic travellers is far more likely than the incidental importation by infected 
mosquitoes. Hence, the risk of introduction of mosquito-borne pathogens by mosquitoes 
aboard aircraft is overestimated [850, 875], and substantially lower than risk posed by 
travelling humans.  
Findings presented in Chapters 3 and 4 support the claim that viraemic travellers are the most 
likely means of introducing DENV to New Zealand. There were 1912 imported cases of six 
arboviruses (dengue, Zika, chikungunya, RRV infection, Barmah Forest virus infection and 
Japanese encephalitis) reported between 2001—2017 [Chapter 3]. There were no mosquito-
borne pathogens identified by molecular methods among the 244 border interceptions of 
exotic mosquitoes recorded in the same period [Chapter 4]. With the exception of one case 
of Zika, which was sexually transmitted locally, all recorded cases were notified following 
overseas travel [Chapter 3]. More than 80% of all reported cases were dengue fever [Chapter 
3]. This suggests that, of all reported arboviruses, in terms of virus introduction, DENV poses 
the greatest potential threat to public health in New Zealand. Although the overall dengue 
notification rates per 100,000 traveller arrivals and 100,000 population are low (2.2 and 2.7, 
respectively; Chapter 3), Weinstein et al. suggested that level of DENV circulating in humans 
in Auckland and its surroundings could be sufficient to initiate an outbreak, assuming the 
presence of a competent mosquito vector [11]. 
Chapter 3 findings highlighted another factor that would facilitate the introduction of DENV 
via traveller arrival, which is the lack of effort made by the majority of infected New Zealand 
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travellers to avoid mosquito bites even during high-risk periods and outbreak. Only 4.8% (48 
of 1004 cases) always used all the recommended bite‐avoidance measures (i.e. use of bed 
nets, mosquito repellent, wearing of protective clothing, screened or air conditioned 
accommodation). This suggests that New Zealand travellers might underestimate or are not 
aware of the risk of travel-related mosquito borne infections. 
There are several factors adding to the increasing risk of arbovirus introduction, especially. 
DENV. There have been significant increases in imported arbovirus notifications in New 
Zealand over the 17-year period (2001-2017), especially in the final four years, in which more 
than half of all the arbovirus cases (976 cases) were recorded [Chapter 3]. This increase can 
be explained by the global ongoing outbreaks of arboviruses and the rapid and explosive pace 
at which these arboviruses spread. In the last five decades, a 30-fold increase in global cases 
of arbovirus infections has been reported [313]. For example, the Americas, South-East Asia 
and Western Pacific recorded more than 1.2 million cases in 2008 and 3.2 million cases in 
2015 [315]. In 2019, 3 million cases of dengue were reported in the Americas alone, recording 
the highest number of dengue cases in history [876]. National human and financial resources 
of the health systems of these countries are usually limited [29]. As a result, the identification 
of any new outbreaks in the Pacific region is likely to be delayed. This would give a “false” 
sense of security for travellers to these endemic and epidemic popular tourist destinations. 
For example, over the last decade, number of cases of RRV disease in travellers from Fiji 
suggests that RRV is likely to be still circulating in the Pacific region [18]. 
Pathogen introduction risk is also exacerbated by the under-reporting of viraemic travellers. 
The underreporting is likely because i) a large proportion of symptomatic cases have mild, 
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self-limiting, non-specific symptoms, and might not seek medical treatment, ii) both medical 
staff and victims may lack awareness of mosquito-borne diseases, iii) as molecular and 
serological diagnosis are often unavailable at the time of care, the clinical decision-making 
process frequently relies on the non-specific clinical manifestations [674], iv) overlapping 
clinical presentation with other infectious diseases and cross-reactivity in the serology of 
arboviruses [877], v) visitors who show symptoms of illness during their stay may delay 
seeking medical advice until they return to their home country [23]. 
Source of introduction: The most likely source of DENV introduction to New Zealand is the 
Asia-Pacific region [Chapter 3]. The most commonly reported countries of travel among 
dengue cases were Samoa, Fiji, Indonesia, Cook Islands, Tonga and Thailand [Chapter 3]. This 
reflects the high burden of arbovirus diseases in this predominantly endemic area [878]. 
Between 2008 and 2015, the number of recorded cases of DEN within the Pacific region 
doubled from about 200,000 to more than 450,000 [611, 878]. In 2016, several widespread 
outbreaks were reported in the region, with more than 375,000 suspected cases [315]. 
Globally, several studies of imported arbovirus infections [678, 680-683] report that the 
majority of the notifications reported a history of travel to South Asian and/or Pacific 
destinations. Increasing notifications in New Zealand may reflect the increasing number of 
New Zealanders traveling to these destinations [38]. About 50% of the international travellers 
arriving in and leaving New Zealand are from Oceania [285]. Further, travel to Pacific Islands 
by New Zealand travellers has shown the strongest growth in the last decade. In 2016, for 
example, numbers of visitor arrivals in New Zealand from the Pacific Islands grew by 3.7%. In 
the same year, Australia and New Zealand were also the major source of visitors to the Pacific 
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Islands representing 52% of the total travellers [679]. This is consistent with earlier 
epidemiological studies described in other countries that showed a strong correlation 
between volume of international travel to and from particular destinations and the 
emergence or re-emergence of infectious diseases (e.g. [38, 670-672]). 
International air travel to New Zealand from the Pacific Islands (and Australia, the major 
source of RRV) has increased dramatically in the last decade [285]. About 50% of the 
international travellers arriving in and leaving New Zealand are from Oceania [285]. Australia 
and New Zealand were also the major source of visitors to the Pacific Islands representing 
52% of the total travellers in 2016 [679]. A strong correlation between international travel 
volumes and the emergence or re-emergence of infectious diseases have been shown in 
earlier epidemiological studies in other countries [38, 670-672]. Therefore, current border 
closures (2020-2021) due to Covid19 pandemic would be expected to temporarily reduce 
these risks. 
Point of introduction: The most likely point of DENV entry is Auckland. Auckland is the largest 
city and the most populous metropolitan area in New Zealand. The city is served by Auckland 
International Airport, New Zealand’s largest and busiest airport, with over 19 million 
passengers (of which over 10 million were international passengers) for the year ended March 
2017. It handles about 85% of New Zealand’s airfreight traffic and 15% of the value of its 
international trade [739, 879]. Over 68.5 % (1062/1550) of dengue cases were reported in the 
upper North Island, of which more than 86% (909/1062 cases) were in the Auckland region 
[Chapter 3]. 
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Seasonal timing of the introduction: The majority of imported dengue notifications were 
recorded in the summer and autumn months (January, February and April; Chapter 3). This 
seasonality is likely to reflect a preference for visitors from New Zealand to travel during the 
Christmas holiday season (December, January, and February), and Easter (April). Short-term 
international visitor arrivals to New Zealand show a pattern with regular annual peaks during 
summer and autumn months [Chapter 3]. This is partly due to strong family ties between the 
Pacific region and Auckland, which is known as Polynesia’s largest city [880]. Observed peaks 
of dengue in New Zealand tend to follow these annual travel peaks, which coincide with 
warmer months and rainy seasons, and therefore dengue transmission season, in dengue 
endemic and epidemic tourist destinations in the Asia-Pacific region, which are also the major 
source countries for the notified cases [Chapter 3]. Hence, the most likely timing of the year 
for DENV to be introduced to New Zealand via viraemic travellers is between January and 
April. In 2015, however, a dengue outbreak was reported in northern Queensland during 
winter. The repetition of this unusual event may affect the seasonality of dengue notifications 
in New Zealand.  
7.1.3 Limiting factors for local DENV transmission in New Zealand 
In the light of the above-mentioned discussion, the main limiting factor for local DENV 
transmission in New Zealand seems to be the absence of a competent mosquito vector. 
Although several laboratory and field studies in Australia indicated that Ae. notoscriptus is 
unlikely to be an important vector of DENV, Maguire (1994) [264], Watson and Kay (1998) 
[258] and (1999) [255] reported New Zealand Ae. notoscriptus to be an experimental vector 
of DENV. However, invasion of a major DENV mosquito vector, particularly Ae. albopictus, due 
to a biosecurity breach is the most likely scenario for a dengue outbreak in New Zealand. Ae. 
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notoscriptus, however, might have the capacity to sustain the transmission cycle in synergy 
with other competent species like Ae. albopictus or Ae. aegypti, assuming their establishment 
or introduction. 
I suggested that the effectiveness of current New Zealand pre-border biosecurity measures is 
the main reason that the introduction and establishment of exotic DENV component vectors 
(and, therefore, local DENV transmission) has been prevented to date [Chapter 4]. However, 
“ambient temperature” is another possible limiting factor. Temperature has been most 
frequently identified as a limiting factor for arbovirus emergence and re-emergence [3]. 
Ambient temperature increases, within the viable temperature range of the mosquito vector, 
are not only associated with higher vector abundance, development, maturation, fecundity 
and bites rate, but also a shorter extrinsic incubation period and a faster rate of viral 
replication within the vector. Review One discusses temperature-dependant components of 
mosquito vectorial capacity in further detail. 
Hence, the fact that present mean monthly temperatures (MMT) of Auckland (14-16 °C) [881] 
and Northland (14-16.5°C) [882] are probably optimal for the establishment of cold-hardy Ae. 
albopictus, does not necessarily mean that these cities are optimal for DENV transmission by 
Ae. albopictus. A meta-analysis has showed that the amplification of DENV in Ae. albopictus 
accelerates, and the EIP reduces within temperature range of 16-37°C [143, 146, 147]. When 
temperature drops below 14oC, DENV transmission stops because virus replication is lower 
and the EIP is longer [114]. Hence, Ae. albopictus will not be able outlive the EIP of the DENV 
[113] (i.e. the shorter the lifespan of the female vector beyond the EIP the lower its vectorial 
capacity). Accordingly, under the present MMT of Auckland (14-16 °C) and Northland (14-
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16.5°C), Ae. albopictus can establish in northern New Zealand, but low temperatures are likely 
to limit or reduce its ability to transmit DENV. However, in Auckland, where all Ae. albopictus 
interruption records were reported, the warm season lasts for about three months, from 21 
December to 22 March, with an average daily high temperature of about 22°C. Considering 
that the monthly interception records of Ae. albopictus peaked in summer between 
December and February [Chapter 4], and assuming its establishment or introduction, local 
transmission of DENV might occur in the city. 
7.3 A scenario for Ross River Virus infection outbreak in New Zealand 
RRV is endemic in Australia, Papua New Guinea [287-291] and, recently discovered, in 
American Samoa [241]. There is neither a treatment nor a vaccine for the disease [845]. Unlike 
dengue, findings of Chapters 3-6 show that all of the component causes required to initiate a 
RRV epidemic in New Zealand currently exist. These are imported RRV, a competent mosquito 
vector, reservoir hosts, suitable climate, and a susceptible population. The following is the 
current status of each component, its role and how it would work to trigger an RRV outbreak 
in New Zealand.  
7.3.1 Ross River pathogen 
The scenario of RRV introduction to Fiji in 1979, which caused a major epidemic in the South 
Pacific with over 500,000 cases [471], may serve as a blueprint for the introduction of this 
virus to New Zealand. The explosive nature of the Fijian outbreak is believed to be due to low 
herd immunity of the population [471, 519]. This virgin soil epidemic was triggered by the 
introduction of RRV into Fiji by a single viraemic traveller from Australia [240, 472, 474]. This 
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case demonstrates the possibility of a novel disease outbreak via infected travellers in non-
endemic, but vector-established, areas with major health consequences.  
Serological studies confirmed that viraemic travellers have introduced RRV into New Zealand 
on many occasions. [264]. Yet, as shown in Chapter 3, in the period between 2001 and 2017, 
relatively few cases of RRV infections were reported in New Zealand (notification rate = 0.1 
per 100,000 traveller arrivals), with a majority (about 90%; n = 45) imported from Australia. 
Kelly-Hope et al. (2002) [883], however, estimated that more than 100 viraemic travellers 
with clinical and sub-clinical infections of RRV enter New Zealand annually from Queensland, 
where the virus is endemic and where 60% of RRV cases in Australia occur [292]. Since 1991, 
RRV infection notifications in Australia have averaged approximately 5,000 per annum [845]. 
In 2018, more than 250,000 New Zealand travellers arriving in Australia (19% of the total) 
visited Brisbane, the capital of Queensland [884], with an average length of stay of 9-10 days 
[292]. Infected individuals maintain an infective viraemia for up to one week during the febrile 
illness period, and most arrive in Auckland Airport within several hours of their departure 
from Brisbane Airport [22]. Therefore, Australia, particularly Queensland, is the most likely 
source of RRV introduction to New Zealand. Summer and autumn may be viewed as high-risk 
seasons for RRV within New Zealand populations, since these are the seasons in which most 
RRV notifications occur in Queensland [292]. 
The Kelly-Hope et al. (2002) estimation is consistent with Weinstein et al. (1995) [22], who 
argued that there are enough RRV viraemic travellers entering New Zealand to initiate a local 
outbreak. The authors supported their argument with evidence that, at that time, over 
300,000 Australians travelled to New Zealand every year, and a single viraemic case would be 
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enough to initiate an outbreak, referring to the 1979 outbreak in Fiji. In 2019, the number of 
visitor arrivals from Australia to New Zealand had increased 5-fold (1.5 million visitor arrivals) 
[654]. This rise increases the likelihood of a RRV outbreak in New Zealand, considering that 
RRV infection is the most common arbovirus affecting humans in Australia (20 
cases/year/100,000 population), with 2-8 thousand cases reported annually [213]. Reported 
cases of RRV entering New Zealand are probably a considerable under-representation 
[Chapter 3]. 
7.3.2 Mosquito vectors 
More than 30 mosquito species have been implicated in RRV transmission on epidemiological 
grounds [240]. In Australia, the main mosquito vectors are Ae. (Ochlerotatus) vigilax (Skuse), 
Ae. camptorhynchus, Cx. (Cx.) annulirostris (Skuse) [472, 486-488] and Ae. notoscriptus [488]. 
Ae. notoscriptus is implicated in most RRV transmission in tropical and subtropical areas in 
Australia [488]. Hence, after the successful eradication of Ae. camptorhynchus from New 
Zealand in 2010 [730], Ae. notoscriptus is the only established species in New Zealand that 
has been confirmed to transmit RRV in the field [18, 22]. Miles (1984) [824], however, when 
30 confirmed cases arrived to New Zealand from Fiji during the 1979 epidemic, assumed that 
“Ae. notoscriptus populations in New Zealand are either inefficient vectors of RRV or the local 
population was not dense enough at the time to initiate an outbreak” [18]. This assumption is 
supported by other theoretical studies [18, 23]. 
However, unlike the findings of Snell (2005) [813], who reported the native bird-biter Cx. 
pervigilans to predominate in urban areas around Wellington, findings of the field surveillance 
conducted in Chapter 6 show that. Ae. notoscriptus was the most abundant species collected 
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from the residential areas and Cx. pervigilans was nearly absent in these areas. In agreement 
with several studies [14, 18, 859, 885], these findings suggest that native mosquito fauna is 
being replaced by the introduced Ae. notoscriptus in urban North Island, mainly as a result of 
anthropogenic land use change and habitat modification. Between 1881 and 2001, New 
Zealand’s urban area increased by over 150-fold [886]. Given the increasing abundance of Ae. 
notoscriptus in urban areas, the assumptions of Kelly-Hope et al. [883] and Weinstein et al. 
[22] regarding the number of RRV viraemic travellers entering New Zealand, and the 
increasing number of traveller arrivals from Australia, urban transmission of RRV within New 
Zealand is probable (Figure 42) [18, 258]. 
Ae. notoscriptus counts showed insignificant correlation with all tested environmental and 
meteorological predictors tested in Chapter 6, which indicates its high suitability to a wide 
range of habitats and climatic conditions. Hence, it was the most widespread species and 
collected in high counts throughout most of the year. Ae. notoscriptus has been collected in 
high counts from urban areas [Chapter 6] and disturbed [Chapter 6] and undisturbed [14, 819] 
indigenous forests is also estimated to be found in rural areas and forestry [Chapter 5]. 
Occurrence of Ae. notoscriptus different habitat would facilitate different RRV transmission 
cycles (Figure 42). 
While Ae. notoscriptus is abundant and widespread throughout the North Island’s 
anthropogenic habitats [Chapter 5 and 6], all urban cosmopolitan centres in the North Island 
(e.g. Auckland, Hamilton, Wellington) would be vulnerable to an RRV outbreak. This 
assumption is supported by findings of Chapter 3 that about 67% (n = 45) of the RRV notified 
cases in New Zealand were reported in the North Island (17 cases in Auckland and 14 cases in 
the rest of the North Island). Maps developed in Chapter 5 also indicated the highest 
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probability of Ae. notoscriptus female presence in the North Island, mainly northern 
Northland PHU (50-70%), Auckland and along all the coasts of Waikato, Toi Te Ora, Tairāwhiti 
and Hawke’s Bay PHUs. 
Isolates of RRV have also been obtained from field-collected Cx. quinquefasciatus in Australia 
[830] and New Caledonia during the major 1979-1980 Pacific epidemic [271]. The New 
Zealand strain of Cx. quinquefasciatus was proved to be a competent experimental vector of 
RRV [27]. Given the association of Cx. quinquefasciatus counts with longer distances to the 
nearest inhabited dwellings and mature trees with canopy, and its sparse occurrence in the 
human habitation in the three study areas [Chapter 6], and main role in enzootic transmission 
of WNV in North America [838], Cx. quinquefasciatus might have the capacity to work in 




Figure 42: Potential transmission cycles and risk factors (rectangles) of RRV in New Zealand  
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In Fiji, the two introduced mosquito vectors, Ae. vigilax and Cx. annulirostris, have been 
implicated in RRV major outbreak in 1979 [18]. The outbreak took place 21 years after the 
introduction of Ae. vigilax in Fiji [887]. As indicated in Chapter 4, Ae. vigilax and Ae. 
(Ochlerotatus) camptorhynchus (Thomson) and Cx. annulirostris, the major RRV vectors in 
Australia, have been intercepted at New Zealand borders, as well as competent vectors from 
Pacific Islands such as Ae. polynesiensis, Ae. aegypti and Ae. albopictus. Given the previous 
establishment of exotic mosquitoes in New Zealand [45, 48], the frequent introductions of 
these mosquito species, under climate change scenarios, could facilitate the establishment of 
another RRV vector in New Zealand. The scenario for the introduction of a novel disease 
system (virus, vector and non-immune population) to New Zealand could resemble the 1979 
Fijian epidemic. According to Kelly-Hope et al. (2002) [883], based on the overall infection 
rate in human populations during the 1979 RRV epidemic in the South Pacific, a virgin soil 
epidemic of RRV in Auckland could involve up to 590,000 individuals at a cost of up to $33.6 
million to $1.475 billion. 
7.3.3 Reservoir host  
In its native Australia, RRV is maintained by animal-mosquito-animal transmission (sylvatic 
cycle) [888]. There is also a strong evidence [516] for human-mosquito-human transmission 
(urban cycle), which occurs during large epidemics (i.e. high-titred viremia), but such 
transmission cannot be maintained for a long time [889]. In Fiji’s 1979-1980 major RRV 
epidemic, urban cycle transmission occurred. However, the virus failed to establish, most 
likely due to the absence of a suitable marsupial host (i.e. macropod species, including 
kangaroos and wallabies) [21]. 
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Besides the primary amplifying marsupial hosts, the brushtail possum has also been 
implicated as a RRV reservoir host in Australia [256, 286, 289, 473, 486]. In New Zealand, 
brushtail possums occupy 97% of the land area, with more than 60 million animals [113, 114]. 
They are mainly occupying forests, where they exist at numbers and densities higher than in 
their native Australian range [819]. In New Zealand, given that this species is sufficiently 
biologically and behaviourally flexible to exploit resources within modified environments 
[890], habitat fragmentation has enhanced their habitat in rural (farm crops, orchards and 
gardens) [789] and, but with less extent, in urban areas, such as parks and reserves. Given the 
absence of indigenous terrestrial mammals, brushtail possum would likely be the main source 
of the blood meals, especially within native forests of New Zealand. Ae. notoscriptus has been 
shown to feed on T. vulpecula and humans in a native forest in Auckland [790]. Occurrence of 
both Ae. notoscriptus [Chapter 5and 6] and brushtail possum in forest, rural and urban areas 
would facilitate sylvatic, rural and urban RRV transmission cycles, respectively (Figure 42). 
It should also be noted that, despite the absence of a primary amplifying animal hosts, 
serosurveys in Fiji during 2013–2015 have indicated that endemic circulation of RRV in Fiji 
continued, or recommenced at a lower level, after 1979–1980 [499]. This finding adds to 
earlier implications, based on serological and/or epidemiological grounds, that RRV might 
come to be maintained as a rural infection via domestic animals. RRV has been identified in 
21 native mammalian hosts [500], including bats [81, 491, 492], horses [81, 493], rabbits [81, 
492], dogs and cats [495]. Several species of these animals that can maintain RRV are well 
established in New Zealand [891]. This suggests the possibility of rural transmission of RRV in 
New Zealand (Figure 42). 
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7.3.4 Susceptible population  
Infection with RRV likely affords a lifelong immunity against RRV infection, as no confirmed 
reports of a case having a second RRV clinical infection (i.e. with pre-existing RRV-specific 
immunoglobulin G antibodies) [892]. Levels of immunity in tropical populations have been 
estimated by seroprevalence studies to be 50% or higher.[893, 894]. Accordingly, actual risk 
to non-immune populations doubles [292]. The high population seroprevalence of a virus may 
also provide heterologous immunity [895] (i.e. cross-protective immunity established over 
decades against related or unrelated pathogens [896]). This hypothesis is strongly supported 
by several epidemiological [226, 897] and laboratory [898, 899] studies in different parts of 
the world. Further, individuals who have been previously exposed to an arbovirus infection 
and become infected with a new arbovirus are less likely to transmit the new virus to 
mosquitoes [877]. All these factors suggest that New Zealand human population is 
predominantly non-immune and susceptible to mosquito-arboviruses in general, and DENV 
and RRV in particular. This would likely increase the risk of large viral epidemics of an explosive 
nature. 
7.3.5 Suitable climate: a possible limiting factor of RRV transmission 
Climatic conditions, particularly temperature, have a profound effect on the ecology and 
physiology of mosquito vectors and pathogens and, therefore, disease transmission [113, 
156]. The suitability of the current temperatures in New Zealand for the survival and 
performance of Ae. notoscriptus mosquitoes is demonstrated by their persistence and wide 
distribution [Chapter 5, Chapter 6]. However, this does not necessarily mean current 
temperatures are suitable for RRV transmission. In Australia, transmission of RRV occurs 
across a range of climates (temperate, tropical and subtropical) and vectors (most 
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transmission to humans occur via four species: Cx. annulirostris, Ae. notoscriptus, Ae. vigilax 
and Ae. camptorhynchus. Ae. notoscriptus is more commonly involved in transmission in 
tropics and subtropics [787]. 
An Australian study, using a mechanistic model for temperature-dependent transmission of 
RRV, reported that RRV transmission peaks at moderate temperatures of 26-27°C and 
declines to zero at thermal limits of 17.0 and 31.5°C [488]. At the upper thermal limit, R0 was 
constrained by fecundity and adult life span, while it was constrained by fecundity and 
survival at all stages at the lower thermal limit [488]. Factors influencing R0 are discussed in 
Review One. Hence, similar to DENV, under the current MMT of Auckland (14-16 °C) and 
Northland (14-16.5°C), temperature could reduce or inhibit the ability of Ae. notoscriptus to 
transmit RRV. However, with an average daily high summer temperature of about 22°C in 
Auckland, RRV has the potential to become a highly seasonal emerging epidemic during the 
summer. Tasmania, Australia, which has MMT only 0.2 °C less than Auckland [900] and 
average maximum daily summer temperatures between 20 and 22°C [828], and sharing the 
same latitude with Wellington, has reported a number of significant RRV outbreaks [816, 
828]. However, Ae. camptorhynchus (which is not current present in New Zealand) has been 
implicated as the primary vector, while Ae. notoscriptus was present only in low numbers and 
did not yield any virus [828]. 
Some authors have attributed the absence of indigenously acquired RRV cases in New Zealand 
to the absence of a main competent vector [23], the low abundance [18, 824], or the 
insufficient vector capacity of potential local vectors (e.g. Ae. notoscriptus) [18, 31, 292, 824] 
to initiate an outbreak. Others have hypothesised that this naïve situation is entirely 
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fortuitous as there are no identifiable reason that make New Zealand intrinsically immune to 
the local transmission of arboviruses [21, 47]. However, low MMT and/or short favourable 
transmission season might constrain the local transmission of RRV.  
In conclusion, RRV and DENV have the potential to become emerging “virgin soil” epidemics 
in New Zealand. Independent introductions of exotic Aedes vectors (via biosecurity breach) 
from Australia or Japan and the pathogen (via infected travellers) from the Pacific Islands to 
Auckland is the most likely scenario for a dengue outbreak in New Zealand. Given that all of 
component factors required to initiate a local RRV epidemic exist in northern New Zealand, 
low temperatures and/or short transmission season might be the limiting factors of the local 




Chapter 8 : Main findings, recommendations, and conclusion 
8.1 Main findings 
This research project has identified and described the major risk factors and the conditions 
likely to facilitate local transmission of arbovirus infections in New Zealand. Identifying and 
monitoring disease risk factors are essential for anticipating and managing disease 
transmission. 
Between 2001 and 2017, New Zealand experienced a significant increase in dengue 
notifications combined with the emergence of reported cases of Zika and chikungunya, with 
more than half of these cases occurring since 2013. Most identified cases were international 
arrivals into Auckland from the Pacific Islands during summer and early autumn. These cases 
reported making little effort to avoid mosquito bites during high-risk periods. This finding 
suggests that some New Zealand travellers underestimate, or are unaware of, the travel-
associated risk for mosquito borne disease. 
Ae. (Stegomyia) albopictus (Skuse) and Ae. (Stegomyia) aegypti (Linnaeus)are the main 
vectors of the most important arbovirus diseases globally and are the most commonly 
intercepted unwanted exotic species at New Zealand borders. The number of the 
interceptions of both species is likely to be higher than reported, since 20% of all interceptions 
were taxonomically unidentifiable or identified to genus level only. Auckland was the main 
city of entry (more than 82.5% of all interceptions) and the only points of entry for both Ae. 
aegypti and Ae. albopictus. Most Ae. albopictus interceptions probably originated from Japan, 
where it is indigenous. Historically Japan has been New Zealand’s largest supplier of both used 
tyres and motor-vehicles. Most Ae. albopictus interceptions have been larvae found in these 
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imports arriving by sea. New import regulations resulted in an 86% decrease in the quantity 
of imported used tyres. 
The majority of Ae. aegypti have been intercepted as adults transported by air, via Australia. 
In addition to the two Aedes species, Ae. (Ochlerotatus) vigilax (Skuse), Ae. (Ochlerotatus) 
camptorhynchus (Thomson) (briefly established before eradication in 2010), and Cx. (Cx.) 
annulirostris (Skuse), the major RRV vectors in Australia, have been recorded at New Zealand 
borders, as well as competent vectors from Pacific Islands such as Ae. (Stegomyia) 
polynesiensis (Marks). Established species, mainly Cx. (Cx.) quinquefasciatus (Say), of 
presumed foreign origin were also intercepted  
Routine surveillance at international ports of entry into New Zealand showed that, between 
2004 and 2017, the number of adult Ae. (Finlaya) notoscriptus (Skuse)mosquitoes collected 
from Northland PHU (n = 13,889), which includes the major port of Whangarei, was 40 times 
more than that collected from all other PHUs. Northland also had the majority of their 
trapping sites positive for Ae. notoscriptus. This mosquito was identified in approximately 1% 
of the trapping sites in Toi Te Ora, Auckland Regional, Public Health Service, and Community 
and Public Health, PHUs that had highest total occurrence records. In addition to Hawke’s 
Bay, these northern PHUs also had the highest mean temperatures (MAT) and Ae. 
notoscriptus occurrence percentages. Waikato, Public Health South, Taranaki and Tairawhiti 
PHUs, which had low MATs and mid-high latitudes, never recorded the occurrence of Ae. 
notoscriptus. These findings are consistent with the distributions of Ae. notoscriptus predicted 
by the logistic regression model developed in this study. The model indicated that mean 
annual temperatures are key correlates of the distribution of adult Ae. notoscriptus in New 
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Zealand. In addition, Ae. notoscriptus is 14 times more likely to be present in rural and forest 
habitats than “major urban areas” (the baseline category). Since the mosquito records used 
in this study have been collected for biosecurity purposes, the predicted absence of Ae. 
notoscriptus in large urban areas and in some PHUs (e.g. Wellington) is probably explained by 
the restricted geographical representation of the training dataset. The surveillance exercise 
undertaken in Chapter 6 confirms that this species is becoming widespread in residential-type 
urban and peri-urban environments in New Zealand. 
Of approximately 17,000 female mosquitoes collected in the Kapiti, Palmerston North and 
Wellington north areas, Ae. notoscriptus was the most widespread, the most abundant (in 
two locations) and was also present in relatively high counts throughout most of the year. The 
level of abundance and wide distribution suggest that Ae. notoscriptus may come to replace 
the widespread native Cx. pervigilans, in residential and peri-urban areas. This scenario is 
supported by absence of any statistically significant correlation between Ae. notoscriptus 
counts and all tested ecological and meteorological predictors. 
The current assessment of risk factors indicates that all the conditions needed for a local RRV 
outbreak in New Zealand are present. By contrast, the key limiting factor preventing local 
transmission of DENV, CHIKV and ZIKV in New Zealand seems to be the absence of competent 
mosquito vectors. More than 80% of all reported imported cases were dengue fever. Hence, 
RRV and dengue diseases appear to be the most likely infections to cause outbreaks in New 
Zealand under current and future climatic conditions. 
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Viraemic travellers are the most likely means of introducing DENV to New Zealand, with 
January-April the most likely timing of the year for the introduction. The most likely source of 
DENV importation is the Asia-Pacific region, with Auckland the most likely point of 
introduction. Although the overall dengue notification rates per 100,000 traveller arrivals and 
100,000 population were low (2.2 and 2.7, respectively), Weinstein et al. [11] suggested that 
the level of DENV circulating in humans in Auckland and its surroundings could be sufficient 
to initiate an outbreak, assuming the presence of a competent mosquito vector. 
The introduction and establishment of Ae. aegypti or Ae. albopictus would complete 
requirements for the scenario of locally-transmitted DENV associated with viraemic travellers. 
Ae. albopictus is most likely to be imported as larvae by sea vessels from Japan, while Ae. 
aegypti, is more likely to come by air as adults from Australia or the Pacific Islands. Ae. aegypti 
cannot survive inhospitable environments (e.g. desiccation nor cold conditions) for long 
periods or travel long distances. Given the new import regulations requiring disinsection of 
used tyres, “wet-footed” plants would be another possible means of arrival. 
Considering the coexistence of Ae. notoscriptus and Ae. albopictus in the islands of the Torres 
Strait, Australia [780], the predicted distribution of Ae. notoscriptus suggests that, besides 
Ports of Auckland and Auckland Airport, Ae. albopictus is likely to find a suitable habitat 
around other New Zealand ports in the North Island, particularly Port of Tauranga. This 
situation is compounded by the recent proposal of the New Zealand government to move 
Ports of Auckland to Northland [781], the country’s warmest area, and where about 98% of 
all adult Ae. notoscriptus were collected by the routine surveillance at international sea ports. 
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Both exotic Aedes species would face limited competition for artificial water containers 
around urban habitations in northern New Zealand. 
Despite the relatively low number of notified RRV cases (which are likely to be greatly under-
recognised), these infections are the most likely means of introducing the virus to New 
Zealand. The predicted and observed widespread geographic dominance of Ae. notoscriptus 
in urban, rural and peri-urban remnant forest areas in New Zealand, combined with 
widespread occurrence of introduced Australian possums, would facilitate transmission or 
maintenance of RRV in urban, rural and sylvatic RRV cycles, respectively. This ecology is 
further facilitated by the fragmentation of remnant forest around rural and peri-urban 
habitats, which benefits both the mosquitoes and a potential marsupial reservoir host. Given 
the three established exotic mosquito species and two incursions (Ae. camptorhynchus and 
Cx. sitiens), the frequent introductions of RRV mosquito vectors from Pacific Islands and 
Australia could facilitate the establishment of another RRV vector in New Zealand. 
8.2 Key recommendations: 
i. Disease notification system 
− Raising awareness among medical and health professionals: The number of reported 
arbovirus cases in general, and RRV infections in particular, are likely to represent only 
a small percentage of the actual number of imported cases entering New Zealand. A 
particular focus on improving awareness among professionals, who have a 
responsibility to report is recommended since symptoms are generally non-specific, 
and cases may move beyond the Auckland area. Improved awareness on presentation 
of arbovirus infections, their geographical distribution and current risk levels are 
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important to maintaining a high level of suspicion with regard to travellers returning 
from high-risk areas. This awareness should be combined with more extensive 
confirmation by laboratory testing to support accurate identification of cases. 
− Extension to the Case Report Form for arbovirus infections: It would be useful to 
review and upgrade the data collected on cases to support improved understanding 
of the modifiable risk factors for infection.  For example, an assessment of patient 
prior knowledge of the disease status of their travel destinations could be added to 
the CRF. This information will help to identify whether the responsibility for risk of 
infection during travelling rests with the New Zealand travel industry/authority or the 
travellers themselves. 
In addition, “residency status” of individuals with notified cases should be considered 
in the CRF. This information would help to identify the extent to which the infection 
risk during travel and associated risk for establishing local transmission could be 
reduced through the New Zealand travel industry or authorities and by targeting 
traveller arrivals directly. 
− Improving awareness among New Zealand travellers to high-risk destinations: The 
majority of notified arbovirus cases reviewed for this study reported taking few steps 
to avoid mosquito bites even during high-risk periods and outbreaks. New Zealand 
travellers to endemic or epidemic areas, mainly in the Asia-Pacific region, should be 
informed about ongoing risks according to season and epidemic activity at the 
destination and updated on the latest disease situation and new trends, particularly 





ii. Mosquito surveillance system 
− Increasing the use of molecular methods to identify strains and, where possible, 
sources of intercepted specimens: About 50% of the 650-suspected interceptions in 
the study period were of New Zealand origin. Most of the latter were Cx 
quinquefasciatus. While no references indicate a molecular identification, this species 
is the most widespread and abundant in Australia. Molecular identification of the 
geographic origins of mosquitoes (see [901]) at and around Auckland’s ports of entry 
might reveal foreign origins of mosquito species identified as “New Zealand origin”. 
Further, about 11.5% of mosquito interceptions were of unknown origin and only a 
third of interceptions linked to aircraft have a specified port of origin. Effective 
biosecurity surveillance of mosquitoes will depend on having a high level of confidence 
in identifying mosquito species and origins. 
− Require scientific overview of all surveillance cover: Scientific overview (coordination 
of agencies and standardisation of practices, methodology and data recording) is 
needed to ensure that best use can be made of surveillance information. This overview 
will cover both biosecurity concerns and provide a means to monitor any change in 
the abundance or mix of resident species and, to predict high-risk conditions for 
species of concern. 
− Expand the national mosquito surveillance programme to include the following: 
Wider geographic coverage to include high-risk environments: Routine mosquito 
surveillance in New Zealand is limited to air and sea ports and carried out for 
biosecurity purposes. Periodic extended surveillance programmes are recommended 
taking a strategic geographic and seasonal cover of high-risk locations other than port 
areas during the summer-autumn season. This should involve baseline surveys for 
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future reference and then periodic surveys such as the post-eradication surveillance 
of Ae. camptorhynchus [820]. Previous studies, including the present project in the 
Kapiti area, could provide additional baseline data. 
− Regular surveillance and monitoring of known breeding sites around Auckland’s 
ports: In addition to container habitats, Ae. albopictus and Ae. aegypti immature 
stages have been found in large freshwater habitats, such as lakes and ponds [27]. 
Hence, large water bodies and other potential breeding habitats within the 1600 
meter-zone (the dispersal distance of Aedes mosquitoes [28]) around Ports of 
Auckland and Auckland International Airport (Figure 43), as well as Northport 
(Whangarei), should be regularly surveyed/ treated. 
 
 
Figure 43: Large freshwater bodies (red circles) within 1600 metre-zone around Auckland 
International Airport (map source: Google Maps™) 
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− Public educational campaigns to support source reduction: Improving public 
awareness of mosquito control by educational campaigns in Auckland in general, and 
for residents of properties around Auckland’s ports in particular. This education could 
encourage the public to be active participants in the prevention/control process by 
reducing/eliminating potential mosquito container habitats in their yards (e.g. regular 
cleaning of gutters), an activity known as source reduction. Active education using 
community peer educators can also be a valuable means of source reduction by 
removing/draining breeding sites of urban mosquitoes [902]. 
iii. Research  
The following research areas and scientific practices are suggested to support development 
of the national public health surveillance and risk assessment strategies for arbovirus 
diseases: 
− Ecological studies: i) to investigate influence on native species by Ae. notoscriptus in 
larval habitats in residential and especially peri-urban areas and around fragmented 
forest areas and ii) to investigate conditions or timing associated with occasional 
population spikes observed for Cx. pervigilans 
− Vector competence studies: These could focus mainly on local and regional mosquito 
species. This would improve measures of risk assessment, surveillance, and control. In 
the last 10 years, only one vector competence study was conducted using local field 
collected mosquito species from New Zealand. Vector competence assays were 
conducted in New York, USA [27]. Vector competence assays have a key role in 
assessing the capacity of mosquitoes to become infected and amplify a pathogen, 
therefore, transmit infection. 
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− Species Distribution Models (SDMs): Consolidating SDMs and risk maps studies in 
order to identify high-risk areas of local mosquito vector distribution and forecast 
potential establishment areas of Ae. albopictus and Ae. aegypti under different 
climate change scenarios. This will allow public health authorities to target and 
eliminate mosquito potential breeding sites in high-risk areas. 
− Interdisciplinary studies: Promote the need to provide financial support and 
incentives for cross-disciplinary studies in the area of mosquito-borne disease 
surveillance and forecasting and public understanding at the national level. Such 
studies would be supported by strengthening cooperation between public health 
academic organisations and relevant research institutes (e.g. ESR, NIWA). 
− Cost-benefit analysis: of the cost of surveillance, the cost of an outbreak, or overall 
introduction of a given arbovirus. 
iv. Towards an EWS in New Zealand  
The major challenge in developing an integrated EWS in general, and in New Zealand in 
particular, lies in linking surveillance information from the several separately operating 
monitoring systems and in bridging the knowledge and reporting gaps among the various 
stakeholders, which, in turn, will affect response and assessment approaches. A conceptual 
framework for an EWS has been developed by integrating of entomological, environmental, 
socio-economical and event-based surveillance systems into the existing notifiable disease 
system infrastructure (Figure 44). 
More specific recommendations on the national public health surveillance and risk 




Figure 44: Conceptual framework for an EWS developed by integrating entomological (green), environmental (red), socio-economical (orang) 
and event based surveillance (grey) systems into existing notifiable disease system infrastructure (blue). Source: author 
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8.3 Conclusion 
The conditions for introduction, local transmission, and outbreaks of arboviruses are present 
in New Zealand. This risk is exacerbated by several factors, including an increase in imported 
human cases, a rise in imported exotic mosquitoes (based on increased border interceptions 
of mainly Ae. aegypti and Ae. albopictus), growth of international trade and travel with 
arbovirus endemic and/or mosquito vector-established areas, and ongoing expansion of Ae. 
notoscriptus in areas with potential human exposures. RRV and dengue diseases are the most 
likely infections to cause local outbreaks. All the component factors required to initiate a local 
RRV outbreak exist, while the absence of the component vector appears to be the limiting 
factor for DENV transmission in New Zealand. Auckland is the most likely point of virus and 
vector entry. The most likely means of virus introduction are viraemic travellers entering the 
country through Auckland from Oceania, while Oceania and Japan are the most likely source 
of the vector. Northland is more likely than other regions to see the establishment of RRV. 
This vulnerability is due to the number of adult Ae. notoscriptus mosquitoes identified in this 
region; 40 times greater than all other regions. While Auckland is more likely than other 
regions to have a dengue outbreak as Ae. albopictus and Ae. aegypti were only intercepted in 
this region. Key control measures would include improved awareness among travellers, 
medical and public health authorities on the imminent threat of arbovirus transmission in 
New Zealand, high-risk conditions and appropriate prevention or protection measures. 
Important infrastructure would include improved surveillance and monitoring systems 
integrated into a national EWS to support rapid identification and management of a local 
epidemic.   
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Appendix A: Climate change and mosquito-borne diseases 
1. Climate change evidence 
According to the Intergovernmental Panel on Climate Change (IPCC), climate change is 
defined as a broad range of long-term changes in the measures of global and regional climatic 
systems due to natural variability and anthropogenic activity [723]. However, the recent and 
accelerating global warming [903] is largely attributable to human activity (e.g. emissions of 
greenhouse gases, such as methane, chlorofluorocarbons and carbon dioxide). Climate 
change does not only refer to global warming, but also to alternations in means of 
precipitation, humidity and wind, with time scales varying from months to millions of years 
[904]. More broadly, this biophysical phenomenon refers to changes in atmosphere (gaseous 
envelope surrounds the Earth), hydrosphere (water on Earth surface), cryosphere (ice, snow 
and permafrost beneath and on the surface of the land and oceans), and biosphere 
(ecosystems) [904]. Changes in the climate have had widespread impacts on human and 
natural systems. Changing weather patterns are associated with expansion and shifting in the 
geographic range, transmission intensity and seasonality of selected climate-sensitive 
infectious diseases (e.g. dengue) and increasing incidence of exotic species [8]. 
There is much scientific evidence showing that climate change is unequivocal [903]. Over the 
past one hundred years, the global average surface temperature increased by 0.9 °C and the 
rate of temperature rise has nearly doubled in the last five decades (Figure a) [903, 905]. 
Information from tree-rings, ice cores and corals indicate the period between 1983 and 2012 
was the warmest 30 years in at least the past 1400 years in the Northern Hemisphere. Up to 
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2016, the 17 warmest years on record globally have all recorded since 1998, with 2016 being 
the warmest [547]. According to NASA [903], much of the increased heat has been absorbed 
by the uppermost part of the ocean (down to about 700m) showing warming of more than 
0.2 °C since 1969. Mainly due to melting glaciers and thermal expansion of seawater, sea 
levels are rising at ever greater rates (2.5 to 3 mm increase per year). 
 
Figure a: Temperature data from four international climate leading scientific organizations. (Source 
[903]) 
2. Climate change and global warming projections 
Global warming refers only to the temperature element of climate change. The Earth’s 
climate has always been changing, ranging from long periods when the planet was almost 
completely covered by ice (millions of years ago) to the recent warming trend (began in the 
early decades of the 18th century) [82]. Such changes are entirely natural. However, as agreed 
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by 97% or more of actively publishing climate leading scientific organizations and researchers 
[906], human activities, particularly the burning of fossil fuels, are the major driver of the 
current warming mode [82, 906]. Before late 1970s, when global temperatures were 
decreasing, it had been thought that particulate industrial pollutants might exert a global 
cooling effect [907]. Since then, as the global climates switched to a warming mode, interest 
has turned to the greenhouse effect, by which atmospheric gases (e.g. water vapour, nitrous 
oxide, carbon dioxide, methane) capture solar radiation in the form of heat [82]. According to 
NASA, over the past century, the average global temperature has been increased by 0.8°C at 
a rate of about 0.15–0.20°C per decade [908]. For the next two decades, according to the IPCC 
in 2018, Earth’s average temperature will rise about 0.2°C, and 1·5-2°C by 2100 [723]. 
Between current-day and global warming of 1.5-2°C, climate models project significant 
variations in global and regional climate characteristics. These variations include increases in: 
average temperatures in most land and oceans (the estimated rate of warming is greater than 
any recorded temperature man have experienced in the last 1000 decades [97]), the 
frequency of extreme weather events (e.g. daily minimum and maximum temperatures) and, 
subsequently, the risk of heat waves floods, droughts and precipitation deficits, the intensity 
and frequency of extreme El Niño, intensity of precipitation events, with longer periods 
between rainfall events, the global sea level (1–88 cm by the year 2100) and sea level 
pressure, mainly over the subtropics and mid-latitudes [723], ocean acidification, mid-latitude 
storms, peak wind intensities and tropical hurricanes and typhoons [723, 909]. Further, the 
projected long-term elevation in temperature is estimated to influence the distribution, 
expansion, and competence of mosquito vectors (mainly Aedes) and have a potentially direct 
impact on the epidemiology and dynamics of vector-borne diseases (mainly arboviruses) 
inactions globally [131]. 
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3. Global warming and arbovirus infections  
As the association between temperature and mosquito-borne disease incidence is well 
understood, a large number of epidemiological models have been developed to project 
potential future occurrence of arbovirus diseases based on temperature or a combination of 
weather parameters, including temperature [92]. An East African study [116] reported that 
the number of malaria outpatients would increase by 80-95% in a scenario of a 1°C increase 
in the maximum temperature with a 60-150 day lag time and 1°C increase in the minimum 
temperature with a 30-60 day lag time. A study undertaken in Mexico in 2013 predicted that 
by 2030, 2050 and 2080, climate change could cause an increase in dengue incidence by about 
12-18%, 31%, and 33-42% , respectively [910]. In the USA, for long-term future climate 
scenarios, models estimated that seasonality of dengue transmission will not change (without 
becoming a year-round event) throughout the south-eastern areas, except in southern 
Florida, which may experience some winter activity of DENV [546]. Research from China 
suggested that, with climate change, by 2100 the distribution of the DENV transmission area 
in China would extend northwardly and shift to high latitude areas [911]. 
Along with future projections, computer modelling outputs can quantify long-term past 
events [30, 547]. A study in Singapore investigating urban dynamics and climate change linked 
the increase in local dengue incidence over the past 40 years to population growth (86% of 
the model) and an increase in temperature (14% of the model) [912]. An Australian study 
reported that a 1°C increase in average monthly temperature and 1-mm increase in average 
monthly rainfall would result in a 6% increase in locally acquired dengue [913]. In addition, in 
Brazil and China a 1˚C increase in average monthly temperature has been associated with a 
45% increase in the dengue incidence in following months [199]. In spite of being located at 
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a latitude of 1300m, Kathmandu, the capital and largest city of Nepal, has experienced 
ongoing dengue outbreaks that have been correlated with the increase in the city’s lower 
mean temperatures [914]. A recent study in Puerto Rico reported that a 1 °C increase of the 
SST was associated with an increase of dengue incidence by a factor of 3.4 in a 19-year period 
(between 1992 and 2011) [915], with an expected further increase in dengue incidence as 
warming for SST, as well as air surface temperatures (AST) are now obvious [916]. 
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Appendix B: Climate-based Early warning systems for mosquito-borne diseases 
1. Definition 
EWSs have been identified by many studies [157, 207, 917] and organizations [30, 918] as a 
key monitoring adjunct to the public health response to predict and, therefore, decrease the 
risk of mosquito-borne disease outbreaks occurring or, at least, reduce the severity and 
spread. EWS of an infectious disease is a management tool to predict the likelihood of an 
outbreak (or other notable public health aberrations) in time and space by analysing 
surveillance information (e.g. linking disease incidence with climatic and demographic data 
[919, 920]) with specialized technologies (usually modelling) and act accordingly by eliciting 
appropriate predetermined prevention and control responses [917]. The purpose of EWS, in 
short, is reducing vulnerability and increasing preparedness [30]. Within statistical or/and 
mechanistic framework, numerous studies have been undertaken to identify the correlations 
between climate elements and the occurrence of infectious diseases and/or their vectors to 
predict the spatiotemporal patterns of infections  
As spatiotemporal distribution of mosquito-borne diseases are associated to climate, using 
weather-based estimates as predictive indicators in infectious disease EWS has long been a 
focus of interest [30, 917]. IPCC has described the development of EWS as a “crucial 
intervention” to deal with the health risks caused by climate variability [918].Figure b shows 
a hypothetical mosquito-borne infection outbreak, without (Figure b.i) and with (Figure b.ii) 
the timely public health intervention informed by weather-based prediction [207]. Using 
traditional surveillance techniques, a delay between the beginning and detection of the 
outbreak can be between one (for testing of infected mosquito) to four (for diagnostic testing 
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and reporting of an infected patient) weeks (Figure b.i). Hence, by the time the outbreak is 
detected, it is largely over. While Figure b.ii shows the possible outcome of an early public 
health response triggered by a climate based EWS. The early intervention cause reduction in 
the severity of the outbreak by decreasing the numbers of infected mosquitoes [157, 207]. 
 
Figure b: Impact of weather-based prediction on an early public health response to a WNV outbreak. 
(b.i) In the absence of the response (b.ii) In the presence of the response. Abbreviations: WNV, West 




 Framework for developing climate-based EWS for infectious diseases 
Most of EWS guidelines provided by international health organization (e.g. WHO , CDC ) and 
other public health bodies are flexible (rather than prescriptive) for identifying satisfactory 
measures and levels of predictive performance [29, 30]. According to the WHO [30], the 
framework of an efficient climate-based EWS includes four phases (Figure c) (1) four 
preliminary phases, (2) EWS phase, (3) response phase, and (4) assessment and evaluation 
phase. The WHO review, “using climate to predict infectious disease outbreaks [29]”, 
discussed these phases in detail.  
2.1. Limitations of EWS approach 
Beside the challenges of the modelling approaches described in Section 2.3.3, climate based-
EWS approach success has been limited by a number of factors, including: 
− Climate/weather represents only few input variables of many predictors that could be 
fed into an EWS.  
− Early warning of an epidemic might reduce the risk of epidemic transmission, with no 
guarantee of prevention. 
− Organizing responses against an epidemic at the country level using an EWS is a 
multidisciplinary and intersectoral approach; i.e. responsibility is not placed only on 
health sector but also in the social, economic, and political spheres. 
− In many cases, the purpose of early warning is not approached due delay for relief as a 
result of poor management at the donor and/or country level. 
− Governments, especially of developing countries, are not directly accountable to 
populations at risk.  
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Figure c: Framework for constructing climate-driven EWSs for infectious diseases by the WHO 
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Appendix C: Recommendations on the national public health surveillance and risk 
assessment strategies for arbovirus diseases  
8.3.1.1 National notifiable disease surveillance system 
− Reducing underreporting rates: The following approaches are suggested to reduce 
notifiable disease underreporting:  
i. Improving awareness of practitioners who have a responsibility to report 
ii. Simplifying reporting (e.g. accomplished automatically at the push of a computer key 
or at scheduled times) 
iii. Widening the reporting net (e.g. developing alternative approaches for conducting 
surveillance such as using secondary sources of data) 
iv. Implementing and supporting regular nation-wide training and education 
programmes for medical practitioners, nurses, laboratory staff and auxiliary health 
care workers, publishing regular bulletins 
v. Increasing the visibility of surveillance via medical presentations and seminars, and 
providing a 24-hour telephone line, memory aids, more training on notification 
procedures, and continued feedback from public health authorities via well-
structured communication channels 
− Include sentinel surveillance programs for arboviruses during events of outbreaks in 
the Pacific region. 
− Adding human travel patterns between mosquito-borne endemic countries (especially 
the Pacific area) and New Zealand to notifiable disease surveillance system database. 
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Identifying and analysing of travel patterns will improve risk assessments and identify 
potential routes of entry for arboviruses.  
− Shift the burden: this method involves passive surveys of healthcare providers to more 
completely identify infected cases to increase the number of cases and the percentage 
of identified-to-incident cases. This approach promotes closer personal ties among 
health department staff and providers. However, this approach is relatively expensive. 
Practically, it is usually limited to short-term intensive monitoring, disease elimination 
programmes of seasonal infections (e.g., certain arbovirus diseases). 
− Reduce the variation in the reporting of diseases: For this, Jernigan et al. [921] 
recommended to developed standardised messaging formats. Further, Weir et al [621] 
suggested that laboratory confirmation of all suspected cases should be requested by 
medical practitioners to ensure picking-up and counting of all cases of a disease under 
laboratory-based notification. 
− Effective communication between sources of notification: While sharing the 
notification responsibility between medical practitioners, laboratories and public 
health nurses increase the timeliness of notifications received by PHUs [922], several 
studies [923, 924] have confirmed that multiple sources of information need to work 
collaboratively to create a comprehensive surveillance system. 
− Ensure that notified disease surveillance system are machine readable and available 
in real time to support real-time predictive models.  
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8.3.1.2 ESR Laboratory diagnosis and diagnostic tests 
− Promote nucleotide sequencing and molecular genotyping in the national laboratories 
to determine the genetic relatedness among circulating arbovirus strains in the pacific 
area. When accurate travel history is not available for PHUs, this technique will 
contribute in disease management and affirming geographical outbreak sources and 
epidemiological links. Phylogenetic studies can also provide early warning of an 
impending arbovirus epidemic for optimal public health response [611]. 
− Ongoing collection and storage of reference arbovirus isolates to maintain timely 
detection of co-circulating viruses, assist in vector competence studies, identifying 
antiviral resistance, and the development of vaccines, as well as explain taxonomic 
relationships mainly between isolates collected across diverse scales of space and time 
[611, 925]. 
− Link national surveillance systems and laboratories through a regional network (i.e. 
Pacific region) to assist in near real-time data on disease outbreaks, as well as on 
syndromic and laboratory-confirmed infections.  
− Proper level of investment of human and financial resources to obtain effective 
laboratory-based surveillance. 
− WHO consultation: Under the International Health Regulations (2005) [926], mosquito-
borne activity may require notification to or consultation with WHO, depending on the 
risk assessment, such as confirmed indigenously acquired arbovirus infection in a 
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previously unaffected area, the establishment of a major mosquito vector, introduction 
a new dengue serotype. 
− Strengthen laboratory capacity in the country and expand the suite of diagnostic 
algorithms based on current epidemiology and co-circulation of arboviruses. 
− Promote funding and emergency resources for outbreak response as an important 
component of preparedness and response plans (e.g. clinical supplies) [313]. 
8.3.1.3 National mosquito surveillance system  
Recommendations to improve the national mosquito surveillance system (such as 
increase the use of molecular methods in exotic mosquito identifications, review 
aircraft disinsection procedures, use research-based surveillance) are covered in more 
details in chapter four. 
8.3.1.4 Event base surveillance system 
− Develop a real-time tracking and forecasting national internet search-based 
surveillance system as an effective approach to complement traditional disease 
surveillance. 
− Use the electronic information platforms: Promote availability of arbovirus 
surveillance information to engage with international public health efforts using 
electronic information platforms such as GPHIN HealthMap, ProMED, and 
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BioCaster. This will add to the development of national event-based surveillance 
system. 
8.3.1.5 Integrated EWS  
− Integrate arbovirus surveillance data reporting systems (i.e. epidemiological, 
entomological, meteorological, ecological and socioeconomic) to allow development 
and implementation of a holistic epidemic forecasting framework to enhance capacity 
to early predict detection of emerging arboviruses and temporal anomalies in disease 
incidence, as well as allow more accurate illness burden estimates. This would allow the 
maximum utilisation of the advanced monitoring systems in the country. 
− Apply Early Warning Alert and Response System (EWARS): To address the need for a 
holistic alarm system for mosquito-borne infection outbreaks, the Special Programme 
for Tropical Disease Research and Training (co-sponsored by WHO) together with 
national dengue control services and academia in partner countries initiated the 
development the EWARS of arbovirus infection. The EWARS is a simple and cost-
effective approach to promptly set up an arbovirus infection surveillance system. This 
early warning model does not only use case records but utilises a wide spectrum of 
epidemiological, meteorological, and entomological data to inform about a forthcoming 
mosquito-borne epidemics [927]. WHO has recently complemented the EWARS tool by 
computer-assisted user’s work book [928]. EWARS showed a positive impact on 
different mosquito-borne infection outbreaks in many countries including 
Indonesia[929], Bangladesh [930], Nepal [931], Syria [932], and Mexico [933]. 
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− Adoption of a holistic approach that emphasizes multi-stakeholder collaborations, 
including, but not limited to, physicians, entomologists, ecologist, virologists, 
epidemiologists, bioinformaticians, mathematical modellers and veterinarians [522]  
Assess current disease surveillance approaches and the quality (e.g. temporal resolution), 
quantity, completeness of related disease data to ensure their suitability for models 
development and early detection of epidemics.  
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Appendix E: Average annual notification rates by DHB, 2001-2017 
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 Appendix F: Epidemiological status of the countries commonly visited or lived in 
during the NZ notification peaks (Source: author)  
  
Disease 
Date of the peak County commonly 
visited or lived in during 
the peak 
Epidemiological status of the country during the peak 
year months 
Dengue 2001 4 & 6-11 Samoa Outbreak was ongoing. DENV is endemic [934] 
2007 1-6 Cook Islands Outbreak was ongoing [935] 
2009 3-8 Cook Islands On May 2009, the Cook Islands experienced a serious 
dengue outbreak, with over 1214 cases reported by 18 
Jun.[936] 
1-3 Tonga It is unlikely that DENV will become endemic in Tonga. 
However, the highest recorded level of dengue was in 2008 
and 2009 with more than 300 cases [937, 938] 
2014 1-8 Fiji Outbreak was ongoing during 2014 since Oct. 2013, with 
25,300 suspected cases and 15 deaths [24] DENV is 
endemic [355] 
2016 1-6 Samoa Outbreak was ongoing. As of August 2016, 1507 cases since 
June 2015 peaked in Jul. & Aug.[939] 
2-12 Indonesia Outbreak was ongoing. DENV is hyper-endemic [940] 
Zika 2014 3-6 Cook Islands Outbreak was ongoing since Feb 2014 with 932 suspected 
and 50 confirmed cases [24] 
2016 1-3 Tonga Outbreak was ongoing from August 2015 onwards. As of 
May 2017, 167 cases were reported [941, 942] 
1-3 Samoa Outbreak was ongoing from late 2015 onwards [942]. As of 
Feb. 2016, 869 suspected cases were reported (857+12 
confirmed cases) [943] 
Chikungunya 2014 9-12 Samoa Outbreak was ongoing since June 2014 Onwards. As of Aug 
2014, 433 cases reported over four weeks [24] 2015 1-4 Samoa 
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Appendix G: Dengue high-risk destinations in Asia Pacific region for New Zealand 
travellers: 
Dengue: According to the WHO latest Pacific syndromic surveillance report [944] and dengue 
Situation Update in the Western Pacific Region [349], the following countries are considered 
to be high risk destinations for New Zealand travellers as DENV circulation is ongoing: 
(northern hemisphere) Cambodia, China, Lao PDR, Malaysia, Philippines, Singapore, Vietnam, 
(southern hemisphere) Wallis and Futuna, American Samoa, French Polynesia, New Caledonia 
and Australia. The following table shows dengue high-risk countries in Asia Pacific Region with 






Summary Current status Reference 







Dengue is endemic in 
Cambodia 
As of 20 Dec. 2018, Cambodia 
reported a total of 9,122 suspected 
cases. Following a seasonal trend, the 
number of suspected cases has 









Dengue is endemic in China, 
with peak transmission from 
June to November 
In Nov. 2018, 728 cases were detected 
in China. To this date, a total of 4,957 








Dengue is endemic in Laos 
A total of 4,435 cases in 2018, as of 20 
Dec. Epidemic is still ongoing and 









Dengue is endemic in 
Malaysia 
National annual incidence increasing 
from around 6543 reported cases in 
1995 to 75,612 with 135 deaths in 
2018, as of 15 Dec., with an upward 








Dengue is endemic in 
Philippines, with peak 
transmission during the rainy 
season, May through 
November.  
Between 1 Jan.-24 Nov., Philippines 
reported 186,319 cases. Following the 
seasonal trend, the number of 








Dengue is endemic in 
Singapore 
In 2018, Singapore reported a total of 
1,855 cases reported. Dengue activity 
in this year is considered low, with a 








Dengue is endemic in 
Vietnam 
 
From 19 to 25 Nov. 2018, 5,046 new 
cases with one death was recorded, 
bringing a cumulative number of cases 
to 113,850 with 16 deaths in 2018, 
with an upward trend from 28 May 
onward. 







Summary Current status Reference 







There have been 222 cases 
since November 2017 
including 23 hospitalisations. 
Of these cases 208 were in 
Wallis and 14 cases were in 
Futuna.  
Dengue serotype-1 is in circulation. 









As of 1 September, 2018 
there have been 1,092 
confirmed cases since 1 
November 2016.  
Ongoing dengue serotype-2 outbreak 
in American Samoa. The outbreak 









Endemic in French Polynesia, 
with peak transmission from 
August to November. 
From November 26 to Dec. 9, 2018, 









Dengue is endemic in New 
Caledonia, with peak 
transmission during the 
warm wet months, from 
February to May 
As of 18 Dec., New Caledonia 
reported 1,997 cases with 2 deaths 
since Jan. 2018, with an upward trend 













Despite the current 
frequency of epidemics, 
dengue cannot be considered 
endemic in Australia because 
transmission is interrupted, 
in every epidemic, by 
effective vector control 
strategies. Dengue, however, 
is a locally acquired infection 
in Australia, with peak 
transmission in the summer 
months. A marked increase in 
notified cases of dengue 
infection were recorded from 
2010 onwards. 
As of 12 Sep. 2018, 532 cases have 
been reported in Australia since the 
beginning of this year. Compared to 
the past 5 years, lower number of 
cases were reported in 2018. 
 [38, 349, 
951] 
 
Zika: According to most updated WHO ZIKV country classification scheme [462], the following 
Asia pacific countries currently classified as ‘high risk’, especially for pregnant women, due to 
ZIKV local transmission: (Asia): Bangladesh, Burma, Cambodia, India, Indonesia, Laos, 
Malaysia, Maldives, Pakistan, Philippines, Singapore, Thailand, Timor-Leste (East Timor), 
Vietnam. (Pacific Islands): Fiji, Papua New Guinea, Samoa, Solomon Islands and Tonga [56]. 
Chikungunya: As of May 29, 2018, according to CDC, [952] the following are countries and 
territories where chikungunya cases have been reported as their local mosquitoes are 
infected with CHIKV: (Asia): Bangladesh, Bhutan, Cambodia, China, India, Indonesia, Laos, 
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Malaysia, Maldives, Myanmar (Burma), Nepal, Pakistan, Philippines, Singapore, Sri Lanka, 
Thailand, Timor-Leste, Vietnam. (Pacific Islands): American Samoa, Cook Islands, Federal 
States of Micronesia, Fiji, French Polynesia, Kiribati, Marshall Islands, New Caledonia, Papua 
New Guinea, Samoa, Tokelau and Tonga.  
RRV infection: In Australia RRV is endemic in Australia and outbreaks occur intermittently. 
During December 2018, 117 cases recorded, bringing the cumulative number of cases in 2018 
to 3108 confirmed cases, as of 31 December 2018. From 2000 to 2018, more than 87,000 
laboratory-notified cases were reported to the National Notifiable Diseases Surveillance 
System in Australia peaking in 2015 with about 10,000 cases [515]. The virus is endemic in all 
states, however Queensland has almost three times higher more cases reported annually 
than any other state. The notifications numbers of RRV in Australia are generally thought to 
be an underestimate [240]. Outside Australia, RRV is also endemic in Papua New Guinea [287-
291] and Solomon Islands [286]. A large epidemic occurred in the Pacific in 1979 and 1980, 
affecting more than 60,000 people. The epidemic was believed to have been initiated by an 
infected traveller from Australia to Fiji [240, 472, 474] and spread by the Australian vectors 
Cx annulirostris and Ae vigilax [241]. This demonstrates the ability of infected travellers to 
introduce infectious diseases to new areas and cause major health impacts imported cases. 
  
334 
Appendix H: Ports of entry of mosquito interceptions in New Zealand, July 2001–
March 2018 
Port name Coordinates  Location  Description Reference 
Auckland 
International 
Airport (AIA)  
37°00'23.3"S 
174°47'05.0"E 
Located 21km (14 miles) south of 
the city centre of Auckland city, 
on the edge of the Manukau 
Harbour, and to the south of 
Māngere (residential suburb) 
and Airport Oaks (service hub 
suburb) 
The country largest and busiest 
airport, with over 19 million 
passengers (of which over 10 million 
international passengers) for the 
year ended March 2017. It handles 
about 85% of New Zealand’s 
airfreight traffic and 15% of the 








On the east coast on the 
Waitemata harbour next to the 
central business district of 
Auckland and 
New Zealand’s largest container 
import port and main gateway for 
international trade. POA consist of 3 
ports, two seaports and one inland 
port. The main port includes 9 
wharves. The second is a smaller sea 
facility. The third is a dry port, 
connected to the Waitemata 
seaport by rail. POA connect the 
country with over 165 international 
ports in about 70 countries, hosting 
more than 1,700 ship calls every 
year, an average of five a day. Nearly 
35% of New Zealand’s annual trade 
passes through POA each year, 
about of 61% ($17.4 billion) of 






On the west coast in Onehunga 







Airport (CIA)  
43°29'10.9"S 
172°32'12.4"E 
Located in the Harewood suburb, 
12 kilometers away from 
northwest of central 
Christchurch 
The first New Zealand’s international 
airport and the second busiest 
airport in the country after Auckland 
Airport by aircraft movements and 
annual passengers, with 6,732,730 





43° 33' 58.4'' S 
172° 41' 7.9'' E 
Located on the northern shores 
of Lyttelton 
Harbour/Whakaraupō and about 
9.5km southeast of Christchurch 
city centre 
The South Island’s largest and most 
significant international gateway in 
terms of the value of imports and 








Located at the south end of 
Wellington city in the suburb of 
Rongotai, approximately 8km 
southeast from the city centre. 
AIA is bordered by residential 
areas to the west and east, Lyall 
Bay to the south and Evans Bay 
to the north  
The third busiest airport in the 
country, handling a total of about 6 
million passengers in the year by 
2017, but handles only less than 1% 







Located in central Wellington 
city and in the geographical 
centre of the country’s transport 
network. 
The country's third largest port by 
tonnes across the wharf, and the 
most strategically situated, linking 
road, rail, and domestic and 
international trade. CentrePort is 
moving about NZ$3 billion of cargo 
and approximately 730,000 heavy 
vehicles to market, and nearly one 
million passengers every year 
[960] 
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Located in Tauranga city on the 
north coast of the North Island, 
200km from Auckland. The port 
is a natural harbour protected by 
Matakana Island and Mount 
Maunganui. 







Located next to Tauranga 
Harbour in the suburb of Mount 
Maunganui, nearly 3km 
northeast of Tauranga city 
centre.  
Domestic airport serving Tauranga 
city. It’s the tenth-busiest airport in 
the country, with about 350,000 






Located in the upper north 
island, 15km south of Hamilton 
city in the Waikato region.  
A limited international airport, only 
have short distance international 
flights. By 2017, the airport was the 
eleventh-busiest airport in New 







Located about 4.7km northwest 
of Napier city centre and 
approximately 23.3km north of 
Hastings City centre 
Sometimes referred to as Napier 
Airport, is a domestic airport serving 
Napier city. It’s the 7th busiest 
airport in New Zealand, with 
652,426 passengers the 12 months 
to June 2017  





The seaport is located in the 
Northland region to the east of 
the province of Whangarei.  
Refers to Northport (general cargo 
port), the Portland Cement Terminal 
and the Oil Refinery jetties. Port of 
Whangarei is New Zealand’s largest 
importer by volume, accounting 
about 28% of all the country’s 
seaport imports, and the third by 
value, behind Auckland and 
Tauranga, with 12% of all New 
Zealand’s seaport imports. The 
import value is relatively lower than 
its volume due to the main import 
commodities being crude oils, coal, 






The airport is located 8km west 
of Blenheim city centre in the 
Marlborough region.  
Sometimes referred to as 
Woodbourne Airport or Blenheim 
Airport, is a small domestic airport 
serves the city of Blenheim. The 
airport was the 12th busiest in New 
Zealand during 2017 by passenger 
numbers, with 302,884 passengers 
[965]  
Port Otago  45°48'52.1"S 
170°37'19.6"E) 
Located at Port Chalmers in 
Dunedin Harbour on the lower 
east coast of the South Island of 
New Zealand 
Port Chalmers is the primary port for 
exports for that region and country’s 
3rd-largest port by volume, moving 
logging, forestry, and manufacturing 
and dairy products. Port Chalmers 




Appendix I: National concerns and development of responses for mosquito 
interceptions 
In early 1993, the need for updated biosecurity measures towards mosquito interceptions in 
New Zealand was highlighted when Ae albopictus larvae were found in a wet used tyre 
shipment from Japan. This finding was consistent with the steady increase in used tyre 
importations between 1980 and 1990. As a quick response, from February 1993, all used tyre 
imports became subject to inspections. Later in the same year, compulsory offshore methyl 
bromide fumigation was required [45, 640]. In mid-1993, the Biosecurity Act was introduced 
to update laws and regulations relating to protection of New Zealand from imported 
organisms. The “Act” covers pre-border risk management and standard setting, border 
management readiness and response and long-term pest management. To test the updated 
measures, another extensive survey was undertaken between spring 1993 and autumn 1994, 
focusing on artificial breeding habitats, mainly used tyres and machinery. The survey showed 
negative results for any exotic Aedes mosquitoes [46]. 
In 1996, the Ministry of Health commissioned a review of the New Zealand programme for 
exclusion of exotic mosquitoes of public health significance [967]. Kay [967] reported many 
flaws in the programme, including an overall underdevelopment with a lack of systematic 
independent examination, a general deficiency of entomological expertise dealing with 
mosquitoes, and a non-compliance of the New Zealand authorities with the International 
Health Regulations at international points of entry. One year after the Kay review, the 
establishment of Ae. camptorhynchus in New Zealand was discovered and then subjected to 
an 11-year successful eradication programme began initiated in January 1999 and costing $71 
million [730]. 
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Kay’s recommendations were to set new standards and upgrade port surveillance activities. 
Between 1998 and 2000, the Ministry of Health worked with MPI (the former Ministry of 
Agriculture and Forestry, MAF) to introduce new guidelines and strategies, and improvement 
policies for exotic mosquito surveillance. This included the incorporation of import health 
standards and controls in relation to used tyres, and used machinery, disinsection of aircraft, 
responses to suspected interceptions of exotic mosquitoes at international airports, sea ports 
and transitional facilities [968]. A year later, New Zealand BioSecure Entomology Laboratory 
was established to provide entomological (mainly mosquito) identification services and 
technical advice for the Ministry of Health. Biosecurity New Zealand developed Import Health 
Standards for risk goods, including new and used vehicles, machinery and tyres. Import Health 
Standards state the requirements that must be met by importers to obtain biosecurity 
clearance. The requirements are regularly updated considering the scientific research 
advances and the infestation situation of the exotic vector species in the exporting countries. 
[640]. In 2007, the Biosecurity Science Strategy discussed the future priorities for biosecurity-
related science and highlighted the central role of research in biosecurity. 
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Appendix J: Limitations of logistic regression approach 
In the event the target variable is drawn from a small sample size (i.e. high dimensional) or 
not linearly separated, then a more complex model (e.g. decision trees or other non-
parametric algorithms) might be required to achieve higher prediction accuracy as logistic 
regression models become inefficient and performs poorly for binary predictions [969]. 
Complex models can have very high variance (i.e. variability in predictions), but low bias often, 
if not properly tuned, leads to overfitting (excellent predictively for the training set, but poorly 
for out of sample datasets) [970]. On the other hand, the less complex parametric based 
models like logistic regression, may lead to less variability in their predictions, but can result 
in a higher bias. This, if not tuned properly, may lead to underfitting (the model performs 
poorly on the training data) [759, 969, 970]. A general rule is that, complex models will 
decrease the bias in the expense of the model variance and that might overfit. Conversely, 
decreasing the variance with simple models will increase the bias but that might underfit [970, 
971] There is an optimal model complexity, maintaining a proper balance between overfitting 
and underfitting. Practically, there is no analytical approach to find this optimal point for 
model complexity. Instead, the complexity level that minimizes the overall error is chosen by 
using an accurate measure of prediction error and exploring different levels of model 
complexity [970]. A further approach is the “one standard error rule”, which means choosing 
the most parsimonious (i.e. simplest) model whose error estimate is within a standard error 
of the best performing model [970, 972]. 
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Appendix K: Port and airport cities and large urban areas of surveillance 





































Appendix L: Candidate environmental predictors  
1- Urban rural classification (1=major urban area to 8=inlets) 
2- Mean annual temperature, MAT (ºC) 
3- Mean annual vapour pressure deficit, VPD (kPa) 
4- induration (process of hardening rocks/soil via cementation; 1=non-indurated to 
5=strongly indurated) 
5- Mean minimum temperature of the coldest month (ºC) 
6- Mean annual solar radiation (MJ/m2/day) 
7- Monthly water balance ratio (ratio), Slope (º) 
8- Drainage (1=very poor to 5=good) 
9- Acid soluble phosphorus (1=v. low to 5=v. high) 
10- Exchangeable calcium (1=low to 5=v. high)  
11- Particle size (1=clay/silt to 5=boulders–massive) 
12- Soil  
13- Age (1=raw/recent, 2=older),  
14- Chemical limitations (1=low, 2=saline),  
15- Mean winter solar radiation (MJ/m2/day).  
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Appendix M: Mean and range overnight temperatures and RH recorded on-site 
(DL) and remotely (MS) 
Area 
Overnight temperature Overnight RH  
Mean Range (date) Mean Range (date) 
DL MS DL MS DL MS DL MS 
Kapiti 13.3 14.5 
7.3 (Jul.2019)- 8.4 (Sep. 2019)- 
81.5 78.1 
72.6 (Mar. 2020)- 67.1 (Feb.2019)- 




5.6 (Aug. 2019) 
17.9 (Mar. 2020) 
8.2 (Jun.2020)- 
80.7 78.3 
76.8 (Feb. 2020)- 65.4 (Feb.2020)- 
19.6 (Feb.2020) 85.4 (Nov. 2019 86.8(Nov.2019) 





74.4 (Mar. 2020)- 64.9 (Feb. 2019)- 
19.8 (Feb.2020) 92.6 (Sep. 2019) 89.1(May 2020) 
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Appendix N: Mean overnight minimum and maximum temperatures at which 





Mean overnight min. 
temperature 
Mean overnight max. 
temperature 
Mean overnight min. 
RH% 
Mean overnight max. 
RH% 
(month, year, area) (month, year, area) (month, year, area) (month, year, area) 
Ae. notoscriptus 
7.1 19.1 71.0 88.9 
(Sep. 2019, Wg) (Jan. 2020, Kp) (Nov. 2020, Kp)  (Apr. 2019, PN) 
Cx. pervigilans 
10.0 19.1 71.0 88.9 
(Nov. 2019, Kp) (Jan. 2020, Kp) (Nov. 2020, Kp) (Apr. 2019, PN) 
Cx. 
quinquefasciatus 
11.5 18.9 76.8 87.4 
(May 2020, Kp) (Jan. 2020, Kp) (Feb. 2020, PN) (Jan. 2020, Kp) 
Ae. antipodeus 
5.6 18.9 71.0 87.4 
(Aug. 2019, PN) (Jan. 2020, Kp) (Nov. 2019, Kp) (Jan. 2020, Kp) 
Coq. iracunda 
16.1 18.9 83.1. 88.5 
(Feb. 2020, Kp) (Jan. 2020, Kp)i (Feb. 2020, Kp) (Feb. 2019, Kp) 
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Appendix O: Peer reviewed articles published/in press  
Article 1: Intercepted Mosquitoes at New Zealand’s Ports of Entry, 2001 to 2018: 
Current Status and Future Concerns 























Article 2: Imported arbovirus infections in New Zealand, 2001 to 2017: a risk factor for 
local transmission 
Status: In press. Accepted for publication in Journal of Travel Medicine and Infectious Disease 
on March 30, 2021 
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